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Bacteroides thetaiotaomicron is an important human gut commensal organism that facilitates 
polysaccharide utilization, but can act as an opportunistic pathogen outside of this environment 
causing anaerobic bacteraemia and abscess formation. There is a growing resistance by 
B. thetaiotaomicron and other opportunistic pathogens to metronidazole, the leading drug of 
choice. This dissertation aimed to use physiological, molecular and biochemical analyses to 
elucidate the possible mechanism/s of metronidazole resistance in B. thetaiotaomicron, in order to 
extend the understanding of metronidazole resistance at a genetic level. A B. thetaiotaomicron 
VPI-5482 transposon-generated metronidazole resistant mutant, named B. thetaiotaomicron Tn 
MetR, that displayed a MIC = 8 I!g/ml was isolated and characterized. Southern hybridization was 
used to identify the insertion of a single copy of the transposon in an intergenic region of a gene 
cluster involved in the uptake and catabolism of L -rhamnose. 
RNA hybridization studies confirmed that the genes in B. thetaiotaomicron Tn MetR were 
transcribed in the presence and absence of the substrate, L -rhamnose. In addition, five of the 
catabolic genes were expressed as an operon, rhaKlPAO. A monocistronic gene, rhaR, located 
downstream of the transposon insertion site had predicted amino acid sequence similarity to a 
group of AraC/XylS transcriptional regulators. Insertional inactivation of the coding sequence of 
this gene, using the pGERM suicide vector rendered this mutant, B. thetaiotaomicron rhaR", 
unable to utilize L-rhamnose. Introducing RhaR in this strain, on a plasmid, restored growth in the 
medium supplemented with L -rhamnose as the sole carbon source, confirming that rhaR is a 
positive regulator of the rhamnose operon. The transcriptional regulation of the rhamnose pathway 











identified. The link between increased L·rhamnose metabolism and metronidazole resistance was 
further investigated by creating an overexpressor of the positive transcriptional regulator, named 
B. thetaiotaomicron (pL YLrhaR). The B. thetaiotaomicron Tn MetR and B. thetaiotaomicron 
(pL YLrhaR) exhibited resistance to metronidazole in medium with L-rhamnose as the sole carbon 
source, and displayed elevated levels of lactate dehydrogenase and decreased levels of pyruvate 
oxidoreductase activity. These two enzymes have been linked to the electron flux required for the 
intracellular anaerobic activation of metronidazole and this phenotype has previously been 
described in metronidazole resistant B. fragilis clinical isolates. This study demonstrated that the 
overexpression of the rhamnose pathway in B. thetaiotaomicron VPI-5482 resulted in 
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The human microbiota found in the gut consists of approximately 500-1000 bacterial species 
and over 99.9 % of the culturable bacterial population are obligate anaerobes (Xu and Gordon, 
2003). The genera found include Bacteroides, Clostridium, Fusobacterium, Veillonella and 
Bijidobacterium (Xu and Gordon, 2003; Xu et al; 2004, Suau et al., 1999) of which the 
Bacteroides spp. account for 25 % of the colonic bacteria isolated from faecal samples (Salyers 
et al., 2004; Shoemaker ef al., 2001; Xu and Gordon, 2003). Bacteroides spp. are the most 
abundant of the normal gut microbiota (Kuwahara et al., 2004) and are Gram-negative, 
anaerobic opportunistic pathogens (Spence et al., 2006). As commensal organisms, 
Bacteroides spp. assist in breaking down host dietary products and polysaccharides, and this 
provides nutrients and vitamins that the host is unable to produce. However, B. fragilis and 
B. fhetaiotaomicron are also opportunistic pathogens if they escape from the colon as a result 
of abdominal trauma or surgery, and are capable of causing abscesses in the abdomen, the 
female genital tract and the brain, as well as resulting in life-threatening septicaemia (parker 
and Smith, 2004; Shoemaker et al., 2001; Spence et aI., 2006). B. fragilis accounts for 0.5 % ­
1 % of total the Bacteroides spp. in the human intestine (Robertson et al., 2006) whereas 
B. thetaiotaomicron accounts for 12 % of total the Bacteroides spp. (Sonnenburg et al., 2006). 
B. fragilis is the organism most commonly isolated from anaerobic infections (50 - 70 %) 
followed by B. thetaiotaomicron (17 %) (Robertson et al., 2006; Cerdeno-Tarraga et ai., 2005). 
One of the main drugs used to treat these anaerobic infections is metronidazole. 
Metronidazole [1-(2-hydroxyethyl-2-methyl-5-nitroimidazole] has been used in the treatment 
of anaerobic microbial and protozoan infections, as well as in yeast infections (Upcroft et ai., 
2006). However, metronidazole resistant clinical isolates of bacteria and protozoa have been 











This chapter will review the literature on Bacteroides spp., with the focus on B. fragi/is and 
B. thetaiotaomicron, and will consider their metabolic characteristics, virulence and 
pathogenicity, and their mechanisms of resistance to metronidazole. Other well studied 
microbial systems that display resistance to metronidazole will also be addressed. Finally, this 
thesis will address a novel connection between carbohydrate metabolism and antibiotic 
resistance, possibly at the regulatory leveL 
I 
$ 
1.2 Phylogeny and General Characteristics of Bacteroides 
Originally, the Bacteroides spp., were classified as Gram-negative, anaerobic, pleomorphic I 
I 
~ 
rods that did not share similar characteristics to any other known genera (Holdeman et al., ~ 
[ 
1984). Investigators then redefined this group of bacteria by using physiological 
characteristics, bacteriophage typing, and 5S-16S rRNA gene sequence comparisons (Johnson 
\ 
! 
fand Alut, 1978; Paster et al., 1994; Weisburg et al., 1985). This information led to the current 
t 
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and Collins, 1989). The latter two genera are more closely related to members of the 
Bacteroides genus than any other bacterial genera and together form the Bacteroidacea family. I 
i 
t, 
While Bacteroides spp. are commonly found in the large intestine, Prevotella and 
Porphyromonas spp. are commonly associated with the rumen and oral cavity, respectively. 
Bacteroides spp. belong to the order Bacteroidales, class Bacteroides and phylum 
Bacteroidetes, which are known as the Cytophaga-Flavobacteria-Bacteroides group (Xu and 
Gordon, 2003; Kuwahara et al., 2004). 
The genus Bacteroides consists of approximately 22 different species including B. fragilis, 
B. thetaiotaomicron, B. vulgatus, B. ovatus, B. distasonis, and B. uniformis (Kuwahara et al., 
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carbon and energy sources by hydrolyzing host dietary carbohydrate molecules. Their 
additional characteristics include having an average G + C DNA-base composition of 40-43 % 
(Kuwahara et ai., 2004), and their membranes contain a mixture of long chain fatty acids, 
sphingolipids, and straight chain saturated anteiso-methyl and iso-methyl branched acids 
(Shah, 1992). 
1.3 Bacteroides metabolism 
The human colon lacks oxygen, making it a very competitive environment for diverse 
anaerobic organisms. In order for Bacteroides spp. to maintain their high numbers, they need 
to compete favourably with other organisms for nutrients. They benefit from the host by 
obtaining carbon and energy sources from fermentation of carbohydrates, utilizing host 
nitrogenous substances as well as recirculating enterohepatic bile acid and facilitating bile acid 
transformation (Hylemon et ai., 1983). 
1.3.1. Carbohydrate metabolism 
The majority of sugars are absorbed in the human small intestine and are not generally 
available to the microbiota in the colon. Bacteroides spp. utilize simple sugars like glucose 
(Varel and Bryant, 1974), however, this is not their sole carbon and energy source, as these 
species are able to utilize more complex polysaccharides that the host cannot digest (Salyers et 
al., 1977a; Salyers et al., I 977b). For example, degraded plant cell wall polysaccharides 
(cellulose and xylan) can be used by B. thetaiotaomicron and B. ovatus (Anderson and Salyers, 
1989). Starch, in the form of amylose, pull ulan, amylopectin and their component 
maltooligosaccharides, is used by B. thetaiotaomicron (Reeves et al., 1997; Reeves et aI., 
1996; D'Elia and Salyers, 1996a; D'Elia and Salyers 1996b). Polysaccharide degrading 
















et al., 1992). The major end products of the Bacteroides glucose metabolism are acetate and 
succinate, whereas propionate, lactate and acetol are the lesser products (Pan and Imlay, 2001). 
Bacteroides spp. produce several enzymes such as chondriotinase (Linn et ai., 1983) and 
glycosidase (McFarlane and Gibson, 1991) that facilitate the digestion of the carbohydrate 
moieties of compounds, such as chondroitin sulphate, hyaluronic acid, mucin and other muco­
polysaccharides (Xu and Gordon, 2003; Comstock and Coyne, 2003; Cheng et ai., 1995). 
In silico genomIc analyses of B. fragilis YCH46 (Kuwahara et ai., 2004) and 
B. thetaiotaomicron VPI-5482 (ATCC 29148) showed that both these organisms contained 
genes with the potential for encoding numerous substrate specific polysaccharide degrading 
enzymes: 132 in B. fragilis and 259 in B. thetaiotaomicron (Kuwahara et ai., 2004). The 
B. thetaiotaomicron VPI-5482 (ATCC 29148) genome has revealed unprecedented 
information showing that this organism may be predominately dedicated to harvesting host 
polysaccharides and sugars. Its glycobiome consists of 226 genes that encode for glycoside 
hydrolases, 24 sugar specific transporters with 8 fucose permeases (Sonnenburg et ai., 2006; 
Xu et ai., 2003). Approximately, 106 genes are homologous to the SusC family of outer 
membrane proteins, of which half are located near glycohydrolases, and 57 genes are 
homologous to SusD (Xu et ai., 2003, Xu and Gordon, 2003). 
Analysis of the B. thetaiotaomicron sus system revealed a complex eight component starch 
utilization system (sus) (D'Elia and Salyers, 1996b; Reeves et ai., 1996; Reeves et ai., 1997; 
Cho et ai., 2001). This system allows polysaccharides to bind to the bacterial cell surface, after 
which they are brought into the periplasm where they are hydrolyzed into mono- or 
disaccharides (Reeves et ai., 1997). The sus system consists of degradative enzymes and outer 











extracellular. Examples of these are, SusA (a neopullulanase) and SusB (an a-glucosidase), 
both of which can hydrolyze a-I,4 bonds. The OMP include SusC and SusD, where SusC was 
reported to be required for growth on starch and maltooligosaccharide (D'Elia and Salyers, 
1996b; Reeves et al., 1996; Reeves et al., 1997). All the sus genes are transcribed in two 
transcriptional units, SusA and SusB-G, in the same direction. Regulation of the structural 
genes was found to be mediated by SusR, encoded by the susR gene that is located upstream of 
the susA gene. SusR binds to maltose or oligo saccharides and activates the expression of SusB-
G (D'Elia and Salyers, 1996b). Later, a second sus regulator, MalR was also identified in 
B. thetaiotaomicron (Cho et al., 2001). 
In a recent study, Spence et al. (2006) characterized the starch utilization system in B. fragilis, 
which is encoded by a four-gene osu operon. This syst m contained two proteins that were 
similar to the SusC and SusD proteins of the sus system in B. thetaiotaomicron. Both the sus 
and osu systems were reportedly induced by starch as well as maltose, which is produced when 
a-amylase cleaves starch and glycogen. In B. fragilis, only one transcriptional regulator, OsuR, 
regulates anaerobic expression of the osu genes as compared to the two transcriptional 
regulators, MalR and SusR, found in B. thetaiotaomicron (Spence et al., 2006; D'Elia and 
Salyers, 1996; Cho et al., 2001). 
Hooper et al. (1999) used a mouse model to show that B. thetaiotaomicron VPI-5482 has the 
ability to instruct the host to produce hydrolyzable fucosylated glycoproteins or glycolipids. 
The organism cleaves the moieties of L-fucose, a methyl pentose sugar, from the host cell 
surface during the weaning period and uses this as energy source. The study also analyzed the 
reportedly novel fucose (jue) system found in B. thetaiotaomicron, revealing a five gene 
operon, under the regulation of fucose and a negative transcriptional regulator, FucR a member 











transcriptional regulator, a kinase, a pennease, an aldolase and an isomerase, respectively. Four 
of these genes are transcribed as an operon,jucRIAK. However, the pennease gene,jucP, was 
found to be regulated by an independent promoter (Hooper et ai., 1999). It was reported that L­
fucose induced the expression of the fucose enzymes, through binding of the substrate to the 
FucR repressor protein and reducing its interactions with the promoter, PR1AK• In addition to 
the presence of the fucose gene cluster in B. thetaiotaomicron, there is also a putative gene 
cluster, which might be involved in the utilization of rhamnose, a similar methyl pentose sugar 
to fucose. However, the genome of B. fragilis only shows the presence of a putative fucose 
utilizing gene cluster and lacks the genes for rhamnose catabolism. The ability of these 
organisms to utilize the L-fucose moieties of the host, as well as instruct the host to produce 
hydrolysable fucosylated glycans, serves as a competitive colonization advantage under 
nutrient limiting conditions. 
1.3.2 Nitrogen Metabolism 
In addition to carbohydrate utilization, the gut microbiota can also metabolize nitrogenous 
substances entering the large intestine (Fuller and Reeds, 1998). Nitrogen sources in the gut 
include proteins, peptides or ammonia (Cummings et ai., 1984). The protein sources obtained 
from the host include collagen, albumin and trypsin, and these can serve as substrates for the 
growth of colonic bacteria. Degradation of proteins to peptides, and in turn into amino acids, is 
facilitated by bacterial proteases (MacFarlane et ai., 1986). In the large intestine, Bacteroides 
spp. are the predominant proteolytic bacteria, and play an important role in protein degradation 
(Gibson et ai., 1989; McFarlane et a/. , 1986). B. fragilis has been shown to produce three 
proteases (PI, P2 and P3) which have specific activities against proteins such as fibrinogen, 
trypsin and casein (Chen et ai., 1995; Gibson and McFarlane, 1988a; Gibson and McFarlane f 














and functions to further break down peptides (Gibson and McFarlane 1988b), whereas P2 and 
P3 are endopeptidase, associated with cell surface and initiate proteolysis at this location. P2 is 
a 52 kDa metalloprotease whereas P3 is a 34 kDa cysteine protease (Gibson and McFarlane, 
1988b). Ammonia is assimilated relatively easily as it exists in a more reduced form than other 
forms of inorganic nitrogen and, therefore, serves as the preferred source of nitrogen for 
growth of many bacteria (Merrick and Edwards, 1995). In addition to ammonia, glutamate and 
glutamine also serve as good nitrogen sources. Glutamate serves as an amino group donor for 
biosynthesis of approximately 88 % of cells nitrogen requirements, while glutamine is an 
essential precursor for the biosynthesis of approximately 12 % of nitrogen compounds in the 
cells (Reitzer, 1996). Most of the knowledge about nitrogen metabolism and its regulation I 
comes from studies of enteric bacteria such as E. coli. However, Bacteroides spp. do not share r 
some aspects of these metabolic characteristics (Merrick and Edwards, 1995). 
IE. coli uses nitrogen sources such as amino acids and ammonia, which are assimilated by the 
metabolic processes involving glutamine synthetase/glutamate synthase (GS/GOGAT), or 
glutamate dehydrogenase (GDH) (Merrick and Edwards, 1995). These enzymes function I 
Iaccording to the amount of nitrogen source available. Under low ammonia, GS/GOGAT 
t 
sequentially catalyzes ammonia and glutamate into glutamine (GS), or converts glutamine to 
glutamate (GOGAT), whereas under high ammonia conditions, GDH functions to catalyze I 
t 
ammonia to glutamate (Merrick and Edwards, 1995). Bacteroides spp., however, are incapable t 
of utilizing amino acids as nitrogen sources and, therefore, rely on ammonia assimilation 
(Baggio and Morrison, 1996). The GS superfamily is comprised of four families, GSI, GSII I 
GSIII and GlnT (van Rooyen et al., 2006). While the GS found in E. coli is GSI, encoded by IginA, the glutamine synthetase in B. fragilis and B. thetaiotaomicron is a GSIII, encoded by f 
fginN (van Rooyen et al., 2006). In addition to the presence of this GSIII, B. fragilis and 
I 
B. thetaiotaomicron also contain the genes gdhA and gdhB, encoding two GDH enzymes that I 












are postulated to play a major role in nitrogen assimilation in this organism. The gdhA gene 
encodes a NAD(P)H-glutamate dehydrogenase that catalyzes assimilation of ammonia by 
reductative amination of a-ketogluterate to form L-glutamate, whereas gdhB encodes a NADH 
dependent glutamate dehydrogenase that is thought to catalyze the reverse reaction (Abrahams 
and Abratt, 1998). In B. thetaiotaomicron, it was reported that GdhA functions under low 
ammonia (Baggio and Morrison, 1996), whereas in B. fragilis, it was reported that GdhB 
activity was the highest when the organism was grown in the presence of high levels of 
ammonia or organic nitrogen. Under these same conditions, GdhA activity in B. fragilis was 
repressed (Abrahams and Abratt, 1998). 
1.4 Bacteroides virulence and pathogenicity 
B. fragilis occurs at low levels in the normal human gut microbiota, but it is one the most 
commonly isolated micro-organism from human intraperitoneal and intra-abdominal 
infections, causing up to 80 % of anaerobic infections (Cerdeno-Tarraga et at., 2005). 
B. thetaiotaomicron accounts for 29 % of the faecal microbiota and is associated with 17 % of 
infection cases (Cerdeno-Tarraga et al., 2005). Therefore, as mentioned earlier, Bacteroides 
spp. are opportunistic pathogens having various virulence factors which assist them in thriving 
outside of the gut. Some of these factors include the presence of a bacterial capsule, 
aerotolerance, and enzymatic activity (Gibson et al., 1998). 
1.4.1 Bacteroides capsule 
Abscess formation associated with intra-abdominal sepsis is the pathological host response of 
the immune system to the presence of the B. fragilis capsular polysaccharide (Tzianabos et al., 
I 994b ). The ability of this capsular complex to induce abscess is dependent on the presence of 











is thought to assist in adhesion of B. fragilis to epithelial cells (Gibson et ai, 1998) and 
interferes with phagocytic killing of cells (Onderdonk et al., 1990). Capsulated B. fragilis 
strains were shown to survive better than non-capsulated strain under aerobic conditions, while 
there was no difference under anaerobic conditions (Patrick et al., 1984). Different populations 
of B. fragilis strains have different capsule complexes, comprised of small or large capsules or 
an electron dense layer. Patrick et al. (1995) conducted studies in a mouse model which 
showed that the capsular populations of certain Bacteroides spp. could modify their capsular 
complexes going from large capsules to non-capsulated. Variation in capsular complexes has 
also been found in B. thetaiotaomicron populations, where some populations formed non-
encapsulated or encapsulated strains (Burt et al., 1978). 
The structure of the capsular polysaccharide elucidated in B. fragilis NCTC 9343 is unusual as 
it is composed of two distinct high molecular weight components PS A and PS B, which are 
expressed on the surface of cells (Tzianabos et al., 1994a). PS A and PS B have repeating 
subunits with free amino, carboxyl and/or phosphonate groups (Tzianabos et al., 1994a; 
Comstock et a/., 1999b). PS A and PS B both have positive and negative charged groups on 
each repeating unit (Comstock e/ al., 1999a). PS A is a tetrasaccharide repeating unit having 
one positive charged amino group and one negative charged carboxyl group, whereas PS B is a 
hexasaccharide repeating unit with a negative charged carboxyl group (Tzianabos et al., 
1994a). These oppositely charged side chains found in B. fragilis are essential for abscess 
formation (Comstock et a/. , 1999b). Krinos et al. (2001) identified a total of 8 loci involved in 
capsular polysaccharide biosynthesis (PS A-PS H). 
Comstock et al. (1999b) identified the genetic locus encoding the capsular polysaccharide in 
B. fragilis 638R and B. fragilis NCTC 9343 using transposon mutagenesis. Sixteen ORFs 































NCTC 9343, and fonned a new polysaccharide locus, PS Cl. A similar locus, PS C2, was 
identified in B. fragilis 638R (Comstock et al., 1999a). Wang et al. (2000) reported that one of 
the capsular polysaccharides, PS A2, in B. fragilis 638R was similar to PS A as it was found to 
have zwitterionic pentasaccharide repeats (Tzianabos et al., 1992) possessing both negatively 
and positively charged side chains and was also able to cause abscesses. The PS Al and PS Bl 
loci from B. fragilis were reported to contain ORFs showing identity to polysaccharide 
biosynthesis proteins (Coyne et al., 2000; Coyne et al., 2001). Deletion ofPS Al decreased the 
ability of B..fragilis to cause abscesses, reflecting the importance of the capsule as a virulence 
factor (Coyne et al., 2001). 
The PS loci in Bacteroides share a common genetic factor, two genes upx Y and upxZ, that are 
always located upstream of a set of genes involved in polysaccharide biosynthesis and 
transport. Expression of PS loci in B. fragilis is unique in that they under go phase variation 
and are regulated in an on-off manner (Kuwahara et al., 2004; Krinos et aI., 2001). An 
invertible region of the B. fragilis NCTC 9343 genome, fin, was found upstream of upxYin the 
polysaccharide biosynthesis loci PS 1-7 except for PS-2 and PS-7 and was shown to have 
inverted repeats at each end (Patrick et al., 2003; Cerdeno-Tarraga et al., 2005). All of the 
inverted repeats were reported to contain a consensus promoter, thought to control expression 
of genes downstream (Cerdeno-Tarraga et aI., 2005; Kuwahara et al., 2004). These inverted 
repeats, designated jixL and jixR, contained a functional promoter region between the two 
genes (Krinos et al., 2001; Patrick et aI., 2003). A chromosomally-encoded site specific-serine 
recombinase, Mpi, was shown to be involved in inverting these 7 polysaccharide biosynthesis I

loci (Coyne et al., 2003; Kuwahara et al., 2004). 
The published sequence of the B. thetaiotaomicron VPI-5482 genome identified 7 capsular 











an invertible promoter was found in four of these loci (Xu et al., 2003; Kuwahara et aI., 2004). 
The presence of the invertible promoters allows certain populations to express certain genes, 
allowing for interchangeable cell surface structures. This serves as an advantage to Bacteroides I 

spp., allowing them to colonize highly competitive environments, and their interchangeable 
cell surface also gives them an advantage in avoiding the immune response. 
1.4.2 Aerotolerance 
During the initial stages of infections, oxidative shock is inevitable when anaerobic bacteria 
shift from the anaerobic gut environment to oxidative conditions (Rocha and Smith, 1997). The 
oxygen tension in the peritoneal cavity is approximately 6-7 %. Therefore, whilst the capsule is 
an exceptional virulence factor, aerotolerance is also thought to contribute to the organisms' 
pathogenicity (Rocha et al., 2003). 
It was reported that B. fragilis can withstand oxygen for 48-72 h and, within the first 30 min of 
exposure to oxygen, over 28 new proteins are synthesized which are involved in neutralizing 
oxygen radicals (Rocha et al., 2003). It was also reported, that growth was terminated when 
B. fragilis anaerobic growth cultures were exposed oxygen (Rocha et al.. 2003). Several 
studies have been conducted that aimed at elucidating the genes and regulons that responded to 
oxidative stress. It was found that the major stress response genes were regulated by the redox 
sensitive transcriptional regulator, OxyR (Rocha et al., 2000; Rocha et aI., 2003). The OxyR 
dependent genes, encoding proteins that are responsible for neutralizing oxygen radicals and 
protecting the cellular components, are katB (catalase), ahpCF (alkyl hydroperoxidase), dps 
(DNA binding protein), tpx (thioredox peroxidase) and rbpA (the RNA binding protein) 
(Rocha et al., 2003; Rocha and Smith, 1995; Rocha and Smith 1999). The OxyR independent 
genes include sad, osu and czcd, coding for superoxide dismutase that eliminates superoxide 
16 
anions (Rocha and Smith, 1997), oxygen induced starch utilization (Spence et al., 2006) and a 
cation efflux pump, respectively (Rocha et aI., 2003). A katB mutant was reported to be more 
sensitive to hydrogen peroxide compared to the parent strain, confinning the role of catalase in 
protection of the cell against hydrogen peroxide toxicity. It was later found that KatB directly 
removed hydrogen peroxide by interacting with the transition metal and prevented the 
fonnation ofhydroxyl radicals (Rocha and Smith, 1997; Rocha et ai., 2003). 
Pan and Imlay (2001) conducted studies in B. thetaiotaomicron and showed that two of the 
central metabolic enzymes, pyruvate oxidoreductase and fumerase were inactivated by 
exposure to oxygen. It was also reported that these enzymatic activities, from the cultures 
exposed to 2 h of aeration, were reactivated within 40 min following anaerobiosis in the 
presence of a protein inhibitor. However, after 12 h of aeration, only 40 % of fumarase was 
reactivated, but pyruvate oxidoreductase activity could not be restored. These results highlight 
the ability of the organism to recover from transient oxygen exposure during pathogenesis. 
B. fragilis aerotolerance is assisted by the 6.6 kb Batl operon (Tang et al., 1999). DNA 
sequencing showed five ORFs corresponding to the bat genes (!1acteroides !!ero!olerance) 
from Batl operon. The five proteins, batA-E, fonn the Bati operon are reportedly involved in 
the reduction of periplasmic proteins allowing the organism to withstand oxygen (Tang et aI., 
1999). 
1.4.3 Other virulence factors 
Several bacterial enzymes have been suggested as potential virulence detenninants. Sialidases, 
fonnerly known as neuraminidases, have been implicated as virulence factors in pathogenic 
organisms including Vibrio choierae, Streptococcus pneumoniae, Prevotella and Bacteroides 
17 
spp. (Briselden et al., 1992). Sialidases are trypsin like proteases that are cell associated and 
cleave a-ketosidic links between sialic acid and glycosyl residues of glycoproteins. 
Bacteroides spp. obtained from pathological specimens were reported to have higher levels of 
sialidase activity than non-pathogenic strains (Ishikura et al., 2003). Akimoto et al. (1994) 
identified a nanH gene coding for neuraminidase from B. fragilis YCH46 that contained an 
Asp box with conserved residues found amongst neuraminidases. The high neuraminidases 
activity in B. fragilis is thought to playa role in the attachment of bacteria to animal cell walls 
and may explain possible entry mechanisms into the cells (Godoy et ai, 1993). 
The bacteria also protect themselves from the host's immune system by displaying surface 
molecules similar to that of the host and are, therefore, immunologically inert. For example, a 
study conducted by Coyne et al. (2005) showed that B. fragilis converts acquired L -fucose to 
GDP-L-fucose to incorporate it into multiple surface capsular polysaccharides. 
Although Bacteroides spp. in the gut are generally commensal, some strains have been 
reported to cause diarrhoea in humans and animals under certain circumstances (Moncreif et 
al., 1998). These strains were later named enterotoxigenic B. fragilis strains (ETBF). The toxin 
secreted by them was named fragilysin, and caused proteolytic degradation by targeting cell 
surface protein E-cadherin (Fulon et al., 2003). ETBF have the bft gene that encodes a 
preprotoxin of 44 kDa that is processed to yield an active toxin (20 kDa) (Franco et al., 1999). 
Studies showed that specific inhibitors ofmetalloprotease inhibited cytotoxicity, and prevented 
fluid secretions and tissue damage (Moncrief et al., 1998). Franco et al. (1999) also reported 
that bft was located in a 6 kb region of the genome found only in ETBF strains, and later 
reported that, in addition to bft, the region contained other metalloproteases indicating that bft 











island in B. fragilis isolated from human blood cultures and reported that prevalence of ETBF 





1.5 Antibiotic resistance 
Members of the Bacteroides genus are inherently resistant, or can become resistant, to a broad I 
range of antibiotics including aminogylcosides, ~-lactams, tetracycline, erythromycin, and !,, 
clindamycin. Resistance to metronidazole is also becoming increasingly evident. Their ; I 
I 
"f 
resistance can generally be categorized by four different mechanisms namely, 1) Production of 
ian enzyme that hydrolyzes the antimicrobial agent, 2) alteration of the antibiotic target site, f 
3) decreased permeability of the bacterial cells (Neu, 1995) and 4) active drug efflux pumps 
(Pumbwe et al., 2006). 
Resistance to certain antibiotics can be spread by conjugative transposons (CTns), mobilizing 
transposons (MTns) and plasmids, and nearly 80 % of natural isolates from Bacteroides spp. 
carry these elements (Shoemaker et al., 2001). Bacteroides spp. have been found to carry large 
self-transmissible elements called CTns (Cheng et al., 2000). CTns are elements that are 
integrated into the chromosome of a donor cell and can be excised to form a circular 
intermediate that can transfer into a recipient cell via conjugation (Cheng et al., 2000). They 
are 50-100 kb in size and responsible for over 75 % of Bacteroides tetracycline resistance 
(Shoemaker et al., 2001). MTns are smaller, 5-12 kb in size, and are a newly recognized class 
of transmissible elements. They consist of transposons and Non-replicating Bacteroides Units 
(NBU) that are not self-transmissible, relying on CTns for transfer (Rajeev et al., 2006; Cheng 
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CTnDOT is a Bacteroides conjugative transposon that has two antibiotic resistance genes, 
namely, tetQ and ermF (Wang et al., 2005; Cheng et al., 2000). The tetQ gene is responsible 
for mediating tetracycline resistance whereas the ermF gene is responsible in causing 
erythromycin resistance in Bacteroides spp. (Cheng et al., 2000). Clinical isolates showed that 
tetQ in Bacteroides spp. was carried on two types of CTns, CTnDOT and CTn7853. The tetQ 
gene encodes a protein which is able to modify the ribosomal target site of the tetracycline 
class of inhibitors (Nikolich et al., 1992). The tetQ resistance gene is transferable and 
inducible. However, unless the organism is exposed to tetracycline, the transfer of resistance is 
low (Jenkins, 2001). The transfer of CTnDOT is regulated by tetracycline and it was reported 
that exposure of cells to tetracycline resulted in 1000-10,000 fold increase in transfer 
frequency (Salyers et al., 2004). The transfer is mediated by three regulatory genes, rteA, rteB 
and rtec. Tetracycline in the cell culture causes the expression of the tetQ-rteA-rteB operon, 
and subsequently RteA and RteB activate the expression of rteC (Cheng et al., 200]). 
One of the first erythromycin genes to be found in Bacteroides spp. was ermF, which was 
found to be located on a self-transmissible plasmid (Rasmussen et al., 1986; Gupta et al., 
2003). The resistance genes ermF and ermG, are members of the macrolide-lincosaminde­
streptrogramin (MLS) family (Shoemaker et aI., 2001). The genes code for an rRNA 
methylase that acts on the ribosomal target sites (23S rRNA) causing a reduction in the affinity 
between the 50S subunit and the antibiotic (Arthur et al., ]987; Macrina and Smith, 1992). 
Both ermF and ermG genes have also been found on integrated self-transmissible CTns. It was 
reported that ermF was found on several CTns from the CTnDOT group as well as on three 
plasmids, whereas ermG was only found on CTn7853 (Shoemaker et ai., 2001). 
Recently, there has been a further interesting development in erythromycin resistance in 











Clostridium perjringens, has also been found in Bacteroides spp. (Gupta et al., 2003; 
Shoemaker et al., 2001). Gupta et al., (2003) showed that a B. uniformis strain carrying the 
ermB gene could transfer it to a B. thetaiotaomicron BT4001 strain via conjugation, which 
supported their hypothesis that genes coding for antibiotic resistance in the Bacteroides spp. 
are carried on conjugative transposons. These findings also highlighted the importance of 
investigating the occurrence of horizontal gene transfer events amongst bacteria in the human 
colon. 
~-lactam antibiotics are the most widely used group of antimicrobials, however, resistance to 
this drug is high amongst the Bacteroides spp. The mechanism of resistance involves 
production of ~-lactamase, reduced penetration of ~-lactam antibiotic and alteration of the 
penicillin binding protein (PBP) (Fang et ai., 2002a; Fang et ai., 1999). Most of the 
~-lactamases produced are reported to be chromosomally mediated and are produced 
constitutively (Jenkins, 2001). Bacteroides spp., use the ~-lactamase to hydrolyze ~-lactams 
causing resistance to these antibiotics. For example, the carbapenem-hydrolyzing ~-lactamase 
that is produced by B. jragilis, (encoded by the cftA and ccrA genes) confers resistance to 
practically all ~-lactams (Podglagen et ai., 2001). These genes in B. jragilis are metalIo-~ 
lactamase enzymes and have been found to inactivate ~-lactam antibiotics including 
penicillin-G (Rasmussen et ai., 1990; Rasmussen et ai., 1991). The PBP are targets of ~-lactam 
antibiotics and these are essential for bacterial growth. There are 3-5 PBP in Bacteroides spp. 
and they function in cell wall synthesis (Jenkins, 2001). The outer membrane proteins of the 
Gram-negative bacteria also make them intrinsically more resistant to ~-lactam antibiotics 
compared to the Gram-positive bacteria, since the outer membrane protein limits the antibiotic 
access to the cytoplasmic membrane (Fang et aI., 2002b). In Gram-negative organisms 
including Bacteroides spp. the interplay between the outer membrane permeability barriers, 
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ubiquitous periplasmic p-Iactamase and recently recognized multidrug resistance (MDR) efflux 
pumps all contribute to antibiotic resistance. 
Efflux pumps are known to be substrate specific and work in a manner to expel the 
antimicrobial from the cells into the surrounding spaces, the antimicrobial then have to pass 
through the outer membrane barrier to regain entry into the bacterial cells (Ueda et ai., 2005). 
B. fragilis and B. thetaiotaomicron have a variety of pump genes, these efflux pumps belong to 
the resistance-nodulation-division (RND) as well as the multidrug and toxic compound 
extrusion class (MATE). In B. fragilis, 16 RND-type pumps, named (BmeBI-Bme16) were 
identified in its genome. B. fragilis mutants that were resistant to at least three antimicrobial 
classes, including metronidazole, were reported to display overexpression of one or more of 
the bmeB genes (Pumbwe et ai., 2006a). Constitutive bmeB expression is prevalent in 
B. fragilis and 7 BmeB efflux pumps are functional in transporting antimicrobials in this 
organism (Pumbwe et ai., 2006b). B. thetaiotaomicron contains 60 proteins predicted to be 
components of drug efflux systems (Ueda et ai., 2005). The BexA pump, a member of MATE 
was characterized in B. thetaiotaomicron, and the inactivation of the bexA gene was reported to 
decrease the norfloxacin MIC from 128 Ilglml to 32 Ilglml (Miyamae et ai., 2001). 
The presence of antibiotic resistance genes in Bacteroides spp. makes it difficult to treat 
infections with certain drugs. One of the drugs that can still be used successfully IS 
metronidazole. However, resistance to this drug is also increasingly being reported. 
1.6 Introduction to Metronidazole 
Metronidazole is a nitroimidazole antibiotic that was introduced in the 1960s as the drug of 











1983). Surveys carried out in the I970s on metronidazole activity against anaerobic bacteria 
revealed that it had a very broad spectrum of antibacterial activity. In addition, it has also been 
used to treat infections caused by Trichomonas vaginalis, and is effective against parasitic 
infections caused by Gardia lamblia (Upcroft et al., 2006). It is also one of the drugs used in 
the triple therapy treatment for gastrointestinal infections caused by Helicobacter pylori 
(Marais et a/. , 2003). More recently, this class of drug has begun to be explored in the 
treatment of Mycobacterium tuberculosis under anaerobic conditions (Manjunatha et a/. , 
2006). The broad-spectrum activity of metronidazole is achieved by the low molecular weight 
of the drug, which allows it to penetrate all cell membranes, and its requirement for activation 
under anaerobic conditions to form the active drug. The specificity of the nitroimidazole 
derivatives, therefore, cuts across the line between prokaryotes and eukaryotes, since, 
nitro imidazole derivatives interact with biochemical syst ms and/or pathways in all anaerobes 
(MUller and Lindmark, 1976). The structure of the drug consists of an imidazole ring with a 




Figure 1.1: Structure of metronidazole. Reduction of the nitro-group (on the 5th position) activates the drug 
(Derived from Kulda et al., 1993) 
1.6.1 Mode of Action 
Metronidazole is an inert prodrug which needs to be activated intracellularly by the reduction 
of its nitro group (Fig. 1.1) resulting in a toxic derivative which causes single and double 












of the imidazole ring structure requires a single electron (Muller, 1983). Under anaerobic 
conditions, the reduction of the RN02 (where "R" represents CH2CH20H for metronidazole) is 
thought to generate short lived free radical anions (RN02-) Reduction of the free radical 
generates the nitroso derivative, and the cytotoxic species, which include a nitro so-free radical 
and a hydroxylamine derivative. In the presence of molecular oxygen, free radicals generate 
the nitro so derivative (RNO) and nitroso radical (RNO"). The presence of oxygen can also re-
oxidize the free radical anion (RNOt) and produce the parent drug with the production of the 
superoxide anion (0-) in a process called "futile cycling" (Edwards, 1993). The short lived 
reduction products oxidize DNA causing strand breakage and, in tum, cell death. 
Rustia and Shubick (1972) and Voodg et a1. (1974), reported that metronidazole caused 
carcinogenicity in mice and mutagenicity in bacteria, which suggested that metronidazole was 
targeting DNA. Although metronidazole is still very effective as an antimicrobial agent, 
clinical isolates have been reported to show resistance to the drug. There are three possible 
areas where resistance to metronidazole may be occurring. These are at the levels of 1) cell 
entry and uptake, 2) activation of the drug and 3) Repair of the DNA damage caused by the 
drug (Fig. 1.2). 
Drug entryl A 
Drug Activation2 
B Metronidazole Activated 
DNA Repair3 
c DNA Damage 
Figure 1.2: Schematic representation of the nitroimidazole ring structure and the levels of possible resistance 
mechanisms. "R" represents CH2CH20H group for metronidazole. Drug entry I , Drug Activation 2 and DNA 

















1.6.2 Entry and Uptake 
Metronidazole is well absorbed after oral administration and indirect evidence suggests that it 
enters the cells via passive diffusion (MUller, 1983). Studies conducted by MUller and 
Lindmark (1976) in Trichomonas using [14C] labelled metronidazole, showed that the 
formation of the toxic form of the drug decreased the intracellular concentration of the prodrug 
and generated a concentration gradient that caused the further uptake of metronidazole. As 
mentioned earlier, metronidazole has a low molecular weight, which facilitates its penetration 
through cell membrane. It also has a redox potential of -415m V, which makes it an efficient 
electron acceptor (MUller, 1983). There is no direct evidence for active transport of the drug 
into the cells, although Pumbwe et al. (2006a), reported that efflux pumps inhibitors reduced 
the MICs of the antimicrobials tested, including metronidazole, in the MDR B. fragilis 
mutants, suggesting that an energy-dependent efflux was a major mechanism of resistance. In 
an alternate study, it was reported that several imidazole derivatives competitively inhibited 
metronidazole uptake in H pylori, indicating a possible active transport system for specific 
types of structures (Moore et al., 1995). Not much is reported on uptake of metronidazole 
specifically in Bacteroides spp. However, there have been reports of clinical isolates of 
metronidazole resistant B. fragilis which have shown decreased uptake of the drug. This, 
however, was interpreted as decreased activation of metronidazole resulting in a slower 
diffusion rate of the drug (Britz and Wilkinson, 1979; Ingham et al., 1978; Ingham et al., 
1980). 
1.6.3 Activation 
Activation of metronidazole involves a low redox potential process that reduces the 5-nitro 
group forming the transient toxic radicals (Upcroft et al., 2006). The imidazole ring structure is 











hyroxyethyl)-oxamic acid (Muller, 1983, Koch and Goldman, 1979). Activation of the drug is 
thought to occur through interaction with a pyruvate oxidoreductase complex in an A TP 
!phosphoroclastic reaction (Diniz et al., 2004; Upcroft et at., 2006). Alternatively, activation of ! 
the drug can occur via the nitroreductase activities encoded by several genes, namely, rdx, frx i ,I 
and jdx, coding for an oxygen insensitive NADPH nitroreductase, an oxygen insensitive I 
,! 
I 
flavodoxin NADPH nitroreductase and a ferredoxin-linked protein, respectively (Sisson et al., ~ 
2002). 
1.6.3.1 Activation of metronidazole via the pyruvate oxidoreductase complex 
The pyruvate oxidoreductase complex is formed by a metabolic reaction between pyruvate and 
the oxidoreductase enzyme to facilitate pyruvate decarboxylation to form acetyl CoA. This 
reaction generates electrons that are accepted by ferredoxins or flavodoxins that have electron 
efficiency of -430m V or -460m V (Edward, 1980). Ferredoxins and flavodoxins are proteins 
that consist of iron-sulphur clusters and mediate electron transfer in a range of metabolic 
reactions (Valentine, 1964). They are the most electro-negative electron carriers in oxidation-
reduction reactions and serve as oxido-reductase catalysts by transferring electrons from low 
potential donors to electron accepting compounds like metronidazole (Valentine, 1964). 
Metronidazole acts as an electron sink in the pyruvate oxidoreductase complex capturing 
electrons from reduced ferredoxins or flavodoxins thereby reducing the nitro group on the drug 
(Muller, 1983). Once pyruvate is produced in the bacterial cells, it is enzymatically oxidized to 
acetyl phosphate and C02, which causes reduction of ferredoxins (Valentine, 1964). In tum, 
the donation of electrons to metronidazole activates the drug, releasing C02 and H2 as by-
products of the pyruvate oxidoreductase complex (Mortenson et al., 1963). Church and 
Laishley (1995) showed that Clostridium pasteurianum used the hydrogenase I enzyme to 
reduce metronidazole by oxidizing reduced ferredoxins. Sindar et al. (1982) proposed that the 











C. perfringens. Kaihovaara et al. (1998), showed that the drug's activation process in the 
H pylori system is also thought to be mediated by pyruvate oxidoreductase complex, where 
flavodoxins are substituted for ferredoxins and metronidazole can be transformed into a 
bactericidal agent by the electrons generated from the oxidation of pyruvate (Fig 1.3). 
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Figure 1.3: Schematic representation of the pyruvate oxidoreductase complex in H. pylori. Pyruvate gets 
decarboxylated into Acetyl-CoA, electron donation to flavodoxin (dashed line) and subsequently to metronidazole 
to activate the drug. Kaihovaara et al. (1998). 
A pyruvate oxidoreductase enzyme was extracted from B.fragilis NCTC 11295 by Tabaqchali 
et al. (1983), however, ferredoxins have not been extracted from Bacteroides spp. Instead the 
presence of a flavodoxin gene,jZdA, was reported by Diniz et al. (2004) in the B. fragilis 638R 
strain. The genome sequence of B. thetaiotaomicron VPI-5482 (ATCC 29148) also has a gene, 
with a locus tag BT1747, which codes for a putative pyruvate flavodoxin oxidoreductase. 
Recent studies in B. fragilis 638R report the possibility of metronidazole activation occurrence 
at a similar pyruvate oxidoreductase complex (Diniz et aI., 2004) as did former studies i 















There have been numerous reports of resistance to metronidazole implicating the site of 
! 
activation. For example, C. perfringens mutants showing resistance to metronidazole were f 
reported to have diminished levels of pyruvate dehydrogenase and very high levels of lactic ! 
acid (Sindar et at., 1982). Narikawa et al. (1991) used a B. fragilis NCTC 11295 
) 
metronidazole resistant strain to test if lactate dehydrogenase (LDH) was compensating for ~" 
decreased pyruvate oxidoreductase activity. The activity of pyruvate oxidoreductase and LDH 
in this strain was also tested in the presence of increasing concentration of metronidazole. 
Their results indicated that LDH activity was detectable up to 48 mg/L metronidazole; 
however, pyruvate oxidoreductase was undetectable after exposure to 2 mg/L of 
metronidazole. In another study, Britz and Wilkinson (1979) used a B. fragilis clinical isolate 
from a urinary tract infection to show that metronidazole resistant mutants from this strain had 
less pyruvate oxidoreductase activity. Diniz et aZ. (2004) obtained B. fragilis resistant strains 
by passaging the strains in the presence of metronidazole using gradient plates. Using a 
combination of proteomics, as well as biochemical assays, they identified that flavodoxin was 
down-regulated. It was also reported that no pyruvate oxidoreductase was detected in the 
resistant strains and that analysis of the fermentation products showed high levels of lactate 
(Diniz et aZ., 2004). 
Diniz et al. (2004) created a single cross-over insertion mutant in B. fragilis 638R, by 
inactivating the porA gene, coding for pyruvate-ferredoxin oxidoreductase. They also 
inactivated the rdx andfldA genes coding for nitroreductase and flavodoxin, respectively and 
found that all three of these mutants had an increase in metronidazole resistance. When double 
mutants were created, by inactivating the porA and rdx genes, as well as porA andfldA genes, 












1.6.3.2 Metronidazole activation via nitroreductase activity 
Genes encoding nitroreductases are found in H pylori and B. fragilis (Sisson et al., 2002; 
Diniz et al., 2004). As mentioned earlier, an oxygen insensitive NADPH nitroreductase is 
encoded by rdxA, whereas frxA encodes an oxygen insensitive flavodoxin NADPH 
nitroreductase. These enzymes reduce 5-nitroimidozles to mutagenic products that cause DNA 
damage (Sisson et al., 2002). It was reported that mutations in the H pylori rdxA gene resulted 




mutation resulted in a moderate level of resistance. However, inactivation of both rdxA and 
I 
f 
frxA, produced levels of resistance reaching MIC larger than 100 Jlglml (Sisson et al., 2002). In 
addition, inactivation of the frxA together with fdxB, a gene coding for a ferredoxin-linked r 
! 




The reduction of metronidazole via nitroreductase activity does not, however, always result in I 
Ithe formation ofthe toxic intermediate. One of the major metronidazole resistance mechanisms 
in Bacteroides spp. has also been found due to the presence of nim genes (Urban et al., 2002; I 
Gal and Brazier; 2004; Stubbs et al., 2000). These genes encode a nitroimidazole reductase, I 
~ 
which converts 4- or 5- nitroimidazole to 4- or 5-aminoimidazole, preventing the formation of 
I 
t 
the toxic derivatives that are responsible for causing the bactericidal activity of metronidazole 
(Gal and Brazier, 2004). The six reported nim genes, namely, nimA, nimB, nimC, nimD, nimE I 
and nimF are carried on plasmids or located in the chromosomes (Schapiro et al., 2004; Gal 
~ 
and Brazier, 2004; Diniz et al., 2004). Of the six nim genes, nimA, nimC and nimD, were ! 
located on a low copy number mobilization plasmids, pIP417 (7.7 kB), pIP419 (10 kB) and 
I 
pIP421 (4.3 kB), respectively from B.fragilis (Haggoud et al., 1995; Urban et al., 2002; Trinh 
et al., 1995). Despite the transferable nature of the plasmids, epidemiologists suggested that 75 I 
% of resistant isolates contain the chromosomally encoded resistance mechanisms (Urban et 













Studies conducted by Gal and Brazier (2004) showed that out of 206 Bacteroides spp. clinical 
isolates tested, 50 had nim genes, of which nimA was the most prevalent, followed by nimB 
and nimE. The nimC, nimD, and the putative novel gene, nimG, were the least prevalent. The 
nim genes are not always active, and expression has been shown to be promoted by insertion 
sequence elements (IS1168, IS1169, IS1170) (Haggoud et aI., 1995; Gal and Brazier, 2004). 
Homologues of nim have also been found in other bacteria, including Deinococcus 
radiodurans, Helicobacter hepaticus, Clostridium spp. as well as archaea Methanosarcina 
(Leiros et a/., 2004). In a recent study, Leiros et a/. (2004) presented the first available 
structure of a nim family protein, drNimA from D. radiodurans. Based on the native structure 
of the protein, they reported that the Nim protein does function as a reductase and leads to non­
toxic intermediates of metronidazole being formed. 
1.6.4 DNA damage and repair 
The primary DNA damage is caused by short-lived metronidazole intermediates which 
destabilize and unwind the helix causing strand breakage. Mendez et a/. (2001) used a single 
cell gel electrophoresis (SCGE) assay to demonstrate DNA damage by metronidazole in 
lymphocytes obtained from individuals on a 10 day treatment of metronidazole, and reported 
that there was an increase in the frequency of chromosomal aberrations. Reitz et al. (1991) 
analyzed DNA unwinding to measure DNA damage, and showed that metronidazole produced 
DNA single strand breaks in human lymphocytes from patients treated with 4800 mg of the 
drug. This damage was repaired seven days after ending metronidazole therapy. Diniz et al. 
(2000) also reported DNA damage in B. fragilis which had been treated with metronidazole. 
Plant and Edwards (1976) showed that metronidazole caused in vivo degradation of DNA in 
Clostridium bifermentas through inhibiting DNA synthesis. In vitro experiments carried out by 











reduced drug and Sisson et al. (2000) reported high level of DNA breakage and fragmentation 
I 
I 
in H pylori. Metronidazole preferentially causes DNA damage at high A+T % rather than low 
I 
A+T % regions (Edward, 1993). A mixture of thymine and thymidine phosphates are released I 
from DNA by 2- and 5- nitroimidazoles, making the "T" site the more probable targets t 
[ 
r(Edward, 1993). l 
The effectiveness of metronidazole as an antibacterial agent can be influenced by the I f 
1 
efficiency of DNA the repair systems which respond to the damage. Therefore, some of the 
possible mechanisms of DNA repair and their link to metronidazole resistance or sensitivity 
will be reviewed here. The well-studied E. coli repair systems that have been linked to dealing 
with DNA damage by metronidazole will be discussed and similar systems in Bacteroides spp. 
and H pylori will also be reviewed. 
In nucleotide excision repair (NER), the regions of DNA with damaged nucleotides are excised 
and gaps are filled using the complementary strands of DNA as template. NER requires the 
UvrABCD protein complex which is comprised of excinucleases and helicase II gene products 
(Friedberg et al., 1995). E. coli lacking NER was found to be more sensitive to metronidazole 
(Jackson et al., 1984; Yeung et al., 1984). Not much is known about the NER systems in 
Bacteroides spp., however, examination of the published genomes of B. fragilis YCH46 
(Kuwahara et aI., 2004) and B. thetaiotaomicron VPI-5482 (Xu et al., 2003) confirm that 
putative DNA NER genes are present. Earlier work by Abratt et al. (1986, 1990) found that 
B. fragilis had a thymine dimer excision repair system operating under anaerobic and aerobic 
conditions. Additional analysis suggested that the excision repair system in B. fragilis also 
recognized Mitomycin C damage, in a linked but not identical pathway (Abratt et al., 1985). 





















tThe plasmid borne metA gene of B. fragilis was found to confer resistance to metronidazole 
f 
(Dachs et aI., 1995). The MetA protein reduced DNA breakage caused by metronidazole, but it 
did not inactivate metronidazole. This suggested that its mode of action could be by repairing I 
! 
the damage. t 
F 
1 
One of the major ways in which DNA strand breaks are repaired in E. coli is via recombination t 




response to DNA damage. The SOS system is under the regulation of two key proteins, Lex A 
and RecA and is induced by the presence of single stranded DNA (ss-DNA) (Ivancic-Bace et 
ai., 2006; IvanCic-Bace et aI., 2005). LexA acts as a repressor of the genes of the SOS system ,J 
I 
and binds to their promoter regions. RecA acts as a depressor of the SOS, inducing it via the 
auto-cleavage of the LexA repressor (Kuzminov, 1999). The SOS system is induced when I 
replication is inhibited. The accumulation of ss-DNA allows the RecA protein to form I 
;ifilaments on the ss-DNA in the presence ofATP, thus activating RecA (RecA-ss-DNA). !. 
~. 
J 
The role of RecA-ss-DNA is to identify DNA duplex homologs and facilitate strand I, 
t 
recombination. While the mechanism of identifying the DNA duplex homolog is unknown, it f 
? 
~ 
has been suggested that RecA may have two binding sites allowing for both the ss-DNA as f 
I 
well as the duplex homolog to bind to it (Cox, 1995). Upon identification of the DNA duplex 
homologs, the ss-DNA forms hydrogen bonds with the complementary strand of the DNA 
duplex. RecBCD is responsible for the repair of double stranded DNA breaks via promoting I
!,, 
RecA binding to the SSB-covered ssDNA. RecA is then involved homologous recombination. 
RecFOR complex replaces the SSB that is complexed with the ss-DNA and the RecA protein 
and processes the single strand gaps that occur in the daughter strands after reinitiation ofDNA 















E. coli RecA mutants were 30-fold less resistant to metronidazole showing that RecA protein is r 
Ian important component of the repair of DNA damage caused by metronidazole (Dachs et a/., 
1995). It was reported that mutations in the recA gene of H pylori enhanced the sensitivity of I 
that strain to metronidazole, and were also found to be 10 fold more sensitive than the parent I 
strain (Thompson and Blaser, 1995). Chang et al., (1997) have also reported that certain other 
t 
!mutations in recA were associated with metronidazole resistance, possibly through enhanced 
J 
expression of the protein. Both B. fragilis and B. thetaiotaomicron have a RecA protein ! 
i 
(Goodman et al., 1987; Cooper et al., 1997) which may be involved in DNA repair since 
B. thetaiotaomicron recA mutants were reportedly more sensitive to DNA damaging agents, I, 
I 
including metronidazole (Cooper et al., 1997). Genome analysis can assist in identifying other ( i 





1.7 Genetic tools for analyzing genes involved in metronidazole resistance in t 
Bacteroides 1 
Genetic tools for the analysis of Bacteroides spp. have, in the past, been limited. However, in 
recent years, progress in the field of Bacteroides genetics has been significant and the I
t, 
t 
application of these tools has allowed for further analysis of Bacteroides genes (Salyers et al., f 
1 
2000). For example, conjugation of mobilizing plasmids into Bacteroides spp. from E. coli 
I 
! 
relies on plasmids such as RK23 and R751 from the broad host range IncP plasmids, serving to 
~ 
~provide conjugation functions in a range of E. coli-Bacteroides shuttle vectors (Guiney et al., 
1984; Salyers et a/., 2000). These shuttle vectors carry E. coli and Bacteroides spp. resistance f f, 
marker genes for each host and the transfer of origin (orin for E. coli. 
Additional genetic tools, such as transposons, assist in creating random single gene disruptions. 
These genetic elements also carry drug resistance genes that are unrelated to the transposition 














indirect repeat orientation and insert at random into the bacterial chromosome. Once the I 
mutant of interest is identified, plasmid rescue can be used to determine the transposon 	 f 
! 
I 
insertion site, and the transposon itself can be used as a marker for cloning and studying the 	 j ! 
t 
I 
specific gene that has been interrupted. In addition, hybridization methods can be used to 	 i 
I 
t 
check if the mutant has more than one insertion within the chromosome (Salyers et al., 2000). 
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resistance (Smith et al., 1992). These are Tn4551 and Tn4351 that are flanked by the IS 	 ! 
l 
element, IS4351, and Tn4400 that is flanked by IS4400. All of these mediate MLS antibiotic iresistance because of expression of ermF (Smith et al., 1992). Tn4351 is 5092 bp and carries 
tan ermF gene that is expressed in Bacteroides spp. It also carried a tetX gene, that does not I 
confer resistance on Bacteroides spp. but it does so in E. coli when grown aerobically (Salyers I
et ai., 2000). In a recent study, the 4.6 kb Tn5520 isolated from B. fragilis was analyzed ,r 
(Vedantam et aI., 2006). It was found that Tn5520 had only two genes, one that encoded an 
integrase, BipH and the other encoded a single Mob protein, BmpH. The oriT region was a 17 
bp sequence upstream of the bmpH gene. 
Other genetic tools allow for specific genes to be disrupted or deleted. For example, gene 
specific mutagenesis has been proven to be a successful tool in disrupting specific genes in 
Bacteroides spp. (Parker and Smith, 2004; Spence et ai., 2006). Alternatively, an in-frame 
deletion of a specific gene has also been proven to be a valuable genetic tool for mutational 
analysis and to provide insight into how specific genes function (Baughn and Malamy, 2002). 
The use of genetic tools and methodologies in Bacteroides spp. assists in identifying genes 












1.8 Dissertation Aims 
Very little is known about metronidazole resistance in Bacteroides spp. or the mechanisms 
involved in this. In previous work by Casanueva (2004), B. thetaiotaomicron mutants were 
created by random transposon mutagenesis using the method of Tang and Malamy (2000). 
Mutant banks were screened for metronidazole resistant strains and a mutant was isolated that 
displayed resistance to 8 IJ.glml metronidazole in comparison to the parent strain that was only 
resistant to 0.8 IJ.glml ofmetronidazole. 
The aims of this project were, therefore, to characterize the transposon mutant, by identifying 
the location of the transposon insertion and confirm that the interrupted locus was responsible 
for the metronidazole resistance phenotype. Further, the thesis aimed to study the mechanism 
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Bacteroides thetaiotaomicron VPI-5482 metronidazole resistant mutants were created using a I
•modified transposon mutagenesis method outlined by Tang and Malamy (2000). Mutant ! 
I 
libraries were screened on solid medium for metronidazole resistance. One of the mutants f 
isolated, named B. thetaiotaomicron Tn MetR, was resistant to at least 8 Ilg/ml metronidazole in 
comparison to B. thetaiotaomicron VPI-5482, the parent strain (MIC= 0.8 Ilg/ml) and was I 
selected for further study. This chapter addresses the analysis of the region around the i 
I 
! 
ttransposon insertion through plasmid rescue and DNA nucleotide sequencing. To further 
confirm the site of insertion, PCR of the genomic DNA from the mutant was carried out using 
t 
r 
primers derived from the insertion sequences IS4400R and IS4400L, in combination with ! 
! .i 
primers designed from the genes flanking the sites of the transposon insertion. These fragments I 
were amplified and sequenced. The exact site of the transposon insertion was located in an I
intergenic region between two genes of the putative rhamnose gene cluster, provisionally ! 
~ 
annotated as BT3767 and BT3768 in the B. thetaiotaomicron VPI-5482 (ATCC 29148) 
published genome sequence. Southern blot hybridization confirmed that a single copy of the 
transposon had inserted into the chromosome. Physiological analysis showed that 
B. thetaiotaomicron Tn MetR grew slowly in comparison to B. thetaiotaomicron VPI-5482 in 
complete medium. Metronidazole survival studies in complete broth medium confirmed that the 
B. thetaiotaomicron Tn MetR mutant displayed significant resistance to metronidazole 
compared to the B. thetaiotaomicron VPI-5482 parent strain. 
37 
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The aim of this study was to detennine possible metronidazole resistance mechanisms in 
B. thetaiotaomicron using random transposon mutagenesis, an approach that has proven to be a 
successful and invaluable tool for genetic studies (Chen et ai., 2000; Tang and Malamy, 2000). 
Transposons are genetic elements containing additional genes unrelated to the transposon 
function. They encode drug resistance genes that are flanked by copies of insertion sequence 
elements (IS) in direct or indirect repeats. The construction of a B. thetaiotaomicron VPI-5482 
transposon mutant bank was carned out using a modified transposon mutagenesis method 
outlined by Tang and Malamy (2000) as described by Casanueva (2004). The transposon library 
was constructed using an E. coli - Bacteroides conjugation system whereby E. coli HB 101 cells 
carrying the mobilizing IncP plasmid RK23 (Guiney et al., 1984) and the transposon delivery 
vector pYT646B (Fig 2.1) (Chen et al. , 2000) were used as donor cells and mated with recipient 






Figure 2.1: Partial restriction map ofpYT646B (Chen et aI., 2000). 
Plasmid p YT646B (Fig 2.1) contains the Tn440d transposon element, flanked by insertional 
sequence elements, IS4400L and IS4400R, the bla gene and oriT region functional in E. coli. 











anaerobically in B. thetaiotaomicron, respectively, and the erythromycin gene, ermF, 1S 
expressed anaerobically in B. thetaiotaomicron. 
Plasmid, pYT646B is capable of facilitating three possible transposon insertion events in 
Bacteroides species. Firstly, direct transposition of Tn440d could occur, conferring 
erythromycin resistance. Alternatively, an inverse transposition event could occur if the entire 
IS4400R, IS4400L, as well as the tetQ gene, integrated into the chromosome conferring 
tetracycline resistance (Fig. 2.2). In the third event, erythromycin and tetracycline resistance 
could occur if the whole plasmid integrated into the chromosome, forming a co-integrate (Tang 
and Malamy, 2000). 
Genomic DNA 
t tTn440d 
Figure 2.2: Inverse transposon insertion into genomic DNA of Bacteroides species. Transposon insertion shown 
as indicated with IS elements (red arrows), ORl region, bla gene (light blue arrow), tetQ gene (dark blue arrow) 
within genomic DNA (green bands flanking the transposon) . 
Of the B. thetaiotaomicron transposon mutants generated in the library (Casanueva, 2004), one 
displayed resistance to at least 8 Ilglml of metronidazole as compared to the parent strain 
(0.8 Ilglml). The mutant, named B. thetaiotaomicron Tn Me{, was selected for further 
physiological, biochemical and genetic analysis. This chapter describes the growth of the 
mutant in complete medium, confirms its metronidazole resistance phenotype, and evaluates 
whether a single transposon insertion has occurred within the genomic DNA. In addition, it 
identifies the genetic locus of the transposon insertion by plasmid rescue and analyses it using 











2.3 MATERIALS AND METHODS 
2.3.1 Bacterial Strains, Plasmids and Growth Conditions 
B. thetaiotaomicron VPI-5482 is a plasmid-free strain and has been described previously 
(ATCC 29148). B. thetaiotaomicron was grown in Difco brain heart infusion, supplemented 
with haemin, menadione and cysteine (BHIS) broth or agar (l.5% w/v) (Holdeman and Moore, 
1972). All B. thetaiotaomicron cultures were grown at 37°C, in an anaerobic chamber (Model 
1024, Forma Scientific Inc., Marietta, Ohio) containing an atmosphere of oxygen free N2, C02 
and H2 (85:10:5 by volume). E. coli DH5a (Rasmussen et al., 1994) strains were grown 
aerobically on Luria-Bertani (LB) broth or agar (1.5% w/v) at 37°C. The transposon delivery 
vector p YT646B (Tang and Malamy, 2000) was used as a positive control for Southern 
hybridization. The antibiotics gentamicin (200 Ilg/ml), ampicillin (100 Ilg/ml), and tetracycline 
(2 Ilg/ml) were added to BHIS and/or LB whenever necessary. 
2.3.2 General Recombinant DNA Procedures 
B. thetaiotaomicron genomic DNA was prepared according to the method outlined by Wehnert 
et al. (1992). E. coli plasmid DNA was prepared using the QIAGEN® Plasmid Midi Kit (25) 
(QIAGEN). Restriction enzyme digestions were carried out according to the manufacturer's 
instructions. 
2.3.3 Growth studies in complete medium 
B. thetaiotaomicron VPI-5482 and the B. thetaiotaomicron Tn MetR mutant were grown 
separately under anaerobic conditions at 37°C, in 10 ml volume of BHIS broth for 16 h. 
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cultures was monitored at hourly intervals by recording optical density (OD600) using a 
Beckman DU®530 Lifescience UVNis Spectrophotometer. 
2.3.4 Metronidazole survival studies in complete medium 
Mid-logarithmic phase cultures of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn 
MetR were exposed separately to 20 ~glml of metronidazole in BHIS broth. Cultures were 
incubated anaerobically at 37°C. Samples were removed at different time intervals, diluted 
appropriately in BHIS broth and plated onto BHIS agar to determine the surviving fraction from 
viable counts. 
2.3.5 Identification of the transposon insertion site in the B. thetaiotaomicron Tn Me~ 
mutant 
2.3.5.1 Plasmid Rescue 
Genomic DNA from the mutant was digested usmg the restriction enzyme HindIII. The 
fragment adjacent to the transposon was isolated by plasmid rescue (Tang and Malamy, 2000) 
and the junction region on the resulting ampicillin resistant plasmid, containing the bla gene 
was sequenced using primer L58, derived from IS4400R (5'-CAA TAA TGG ACC TCG TAA 
AAG-3') (Chen et al., 2000) (Fig 2.3.). 
HindJlI 
Hind III 
IS4400R genomic DNAbla 
-
L58 
Figure 2.3: Plasmid rescue of B. thetaiotaomicron Tn MetR genomic DNA flanking the transposon insertion 
region. The green band represents B. thetaiotaomicron Tn MetR chromosomal DNA, the black line represents 
pYT646B plasmid DNA where the blue arrow represents the bla gene, and the red arrow represents the IS element 











2.3.5.2 peR of the transposon insertion site in B. thetaiotaomicron Tn MetR genomic DNA 
A forward primer, TnOF (5 /-AAT CGT ACA TIC CAT GGC-3/) was designed to anneal 
within BT3767 approximately 400 bp upstream of the putative site of trans po son insertion. The 
reverse primer L58 (See section 2.3.5.1) was used with the forward primer to amplify the region 
of interest. In addition, a reverse primer, TnRR (5 /-ACC GAA TTT GCG GTC TCC AT-3/) 
was designed to anneal within BT3768 approximately 200 bp downstream of the site of 
transposon insertion and a forward primer, named primer c (51-TAG CAA ACT TTATCC ATT 
CAG-31 ) (Chen et ai., 2000) annealing within the IS4400L region, was used to amplify the 
region downstream of the transposon junction. The PCR fragments obtained were purified 
using the High Pure PCR Clean up Kit (Roche) and submitted for nucleotide sequencing. 
2.3.6 Nucleotide Sequencing 
Sequencing reactions were performed by using the DYEnamic ET Dye terminator cycle 
sequencing kit for MegaBACE (Molecular Dynamics) based on dideoxynucleotide chain 
termination chemistry (Sanger et ai., 1977). Reactions were performed according to 
manufactures' instructions and sequenced on a GeneAmp PCR system 9700 (Perkin Elmer, 
Applied Biosystems) using appropriate primers at concentrations of 5 11M and primer specific 
hybridization temperatures. Sequencing reaction products were analysed using an automated 
capillary DNA sequencing system, the MegaBASE 500 sequencer v2.4 (Molecular Dynamic, 
Amersham Pharmacia Biotech, Amersham Bioscience). Sequences were analysed using 












2.3.7 Southern Hybridization 
Genomic DNA (20 !lg) of both the B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn 
MetR mutant, as well as 20 ng of the 13.1 kb transposon delivery vector, pYT646B, were each 
digested to completion with restriction enzyme Pvull. Digested genomic (20 !lg) and plasmid 
DNA (20 ng) were separated using 0.8 % agarose gel electrophoresis in TRIS-Acetate-EDTA 
buffer and transferred via the capillary alkali transfer procedure to a Hybond-N+ nylon 
membrane (Sambrook et al., 1989). The DNA probe used for hybridization was a 0.9 kb SacI­
EcoRV internal fragment of the pYT646B tetQ gene extracted from a 0.8 % agarose gel using 
the High Pure PCR Product Purification Kit (Roche). The purified fragment was non­
radioactively labelled using the random primed Digoxygenin-ll-dUTP (DIG) labelling and 
detection method (Roche). Hybridization and detection procedures were performed according 












2.4 RESULTS AND DISCUSSION 
2.4.1 Growth of the B. thetaiotaomicron Tn MetR mutant in complete medium 
The growth of the B. thetaiotaomicron Tn MetR mutant, relative to that of the parent strain was 
examined in BHIS broth (Fig. 2.4). B. thetaiotaomicron VPI-5482 grew well in comparison to 
the slower growing B. thetaiotaomicron Tn MetR mutant. After 8 h of growth, 
B. thetaiotaomicron Tn MetR had only reached an OD of --.{J.7 whereas B. thetaiotaomicron 
























-+- B. thetaiotaomicron VPI·5482 --- B. thetaiotaomicron Tn MetR mutant 
Figure 2.4: Growth of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn MetR in BHIS broth. 












Slow growth of metronidazole resistant bacterial strains has also been observed in other 
published studies. For example, Clostridium perfringens metronidazole resistant mutant strains 
grew more slowly than the parent strain from which they were isolated (Sindar et aI., 1982). An 
explanation offered for slow growth in these mutant strains was that it might be due to improper 
catabolic reactions such as the phosphoroclastic reaction (Chapter 1), which would reduce 
energy production and slow down growth. Britz and Wilkinson (1979) also reported slow 
growing B. fragilis mutant strains displaying metronidazole resistance in complete medium, and 
also reported less cell mass in defined medium where glucose was the sole carbon source. 
2.4.2 Metronidazole sunrival studies in complete medium 
B. thetaiotaomicron Tn MetR was originally isolated from BHIS agar containing 8 llglml of 
metronidazole. In order to verify that this mutant was resistant to metronidazole, a survival 
study was performed in which the actively growing mutant, capable of reducing metronidazole, 
was exposed to 20 llglml metronidazole and sampled at different time intervals to monitor 
viability as the log surviving fraction (Fig. 2.5). 
Exposure of B. thetaiotaomicron Tn MetR to metronidazole confirmed that this strain was more 
resistant to metronidazole than the B. thetaiotaomicron VPI-5482, parent strain. The log 
surviving fraction of B. thetaiotaomicron VPI-5482 decreased rapidly when the cells were 
exposed to 20 llglml of metronidazole. The ability of the B. thetaiotaomicron Tn MetR mutant 
to survive may be due to the slower growth resulting in slower activation of metronidazole and 
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-- B. thetaiotaomicron VPI-5482 --B, thetaiotaomicron Tn MetR mutant 
Figure 2.5: Survival studies of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn MetR mutant exposed to 
20 ~g!ml of metronidazole in complete medium. Error bars represent the standard deviation for three replicate 
experiments. 
2.4.3 peR Analysis of transposon insertion site 
Plasmid rescue resulted in a single 4.5 kb plasmid being isolated. This, together with the fact 
that the mutant showed tetracycline resistance and erythromycin sensitivity, indicated that a 
single inverse insertion of Tn440d had occurred witltin the B. thetaiotaomicron Tn MetR 
mutant strain, and that no co-integrate formation or direct transposition (discussed in section 
2.2) had occurred. The nucleotide sequence of the junction region on the rescued plasmid, 
obtained using the L58 primer, was compared with the B. thetaiotaomicron VPI 5482 genome 











B. thetaiotaomicron VPI-5482 locus BT3767, indicating that this gene lay next to the 
transposon insertion site. In order to confinn that the rescued plasmid was a correct reflection of 
the insertion site in the genome, peR of the B. thetaiotaomicron Tn MetR mutant DNA region 
flanking the putative insertion sites was conducted using the genomic DNA and primers that 
were designed from within two locus tags, BT3767 (primer TnOF) and BT3768 (primer TnRR). 
Primer Tn OF was used in combination with the L58 primer from within IS4400R to amplify 
one side of the junction region between the genomic DNA and transposon insertion. The 
downstream junction region was amplified using primer TnRR and a primer, named primer c 
within IS4400L (Fig 2.6). 
Tn 440d 
BT 3767 1154400\ ORI III bla 4 tetQ 154400~1BT 3768 
~ ~ 
TnOF ~ -7 TnRR 
Figure 2.6: Schematic representation (not to scale) of the transposon insertion in an intergenic region between 
BT3767 and BT3768. Transposon (Tn440d) inserted between B. thetaiotaomicron VPI-5482 locus tag BT3767 
(green band) and BT3768 (purple band). Black arrows represent the primers used to amplify the junction regions. 
Visualization of the peR products on 0.8 % agarose gel resulted in a 400 bp and a 200 bp band 
for the upstream and downstream regions respectively (data not shown). Sequence analysis of 
the peR products revealed that the transposon insertion had occurred within an intergenic 
region 12 bp downstream of BT3767 and l31 bp upstream of BT3 786 (Fig 2.6). 
2.4.4 Analysis of Southern Hybridization 
The B. thetaiotaomicron Tn MetR mutant was constructed using a transposon insertion system 











although occasionally, multiple insertions could occur (Tang and Malamy, 2000). In order to 
verify the single insertion, Southern blot analysis was performed by digesting 
B. theta iota omicron VPI-5482, B. thetaiotaomicron Tn MetR, as well as the positive control 
plasmid pYT646B with Pvull and using the SacI-EcoRV internal fragment of the tetQ gene as a 
probe. Restriction enzyme Pvull was selected because pYT646B only has a single Pvull site 
within this fragment of the tetQ gene, which would cause the plasmid to linearise upon 
digestion with this restriction enzyme. Insertion of the transposon into the genomic DNA would 
result in two hybridization bands per copy of the tetQ gene inserted. 
As seen in Fig. 2.7, Lane 1 of the autoradiograph displayed a single band of the linearised 
plasmid. B. thetaiotaomicron VPI-5482 genomic DNA (Lane 2) showed no signal since there 
was no transposon to hybridize to the tetQ probe. B. thetaiotaomicron Tn MetR genomic DNA 
(Lane 3) resulted in a doublet made up of two bands of very similar sizes, identifying a single 
inverse Tn440d insertion within the chromosome, with only a single copy of the tetQ gene 
being present. 
3 
~12.0 kb- 13.1 kb 
E ~11.1 kb 
Figure 2.7: Autoradiograph of Southern hybridization to confmn a transposon insertion in B. thetaiotaomicron Tn 
MetR mutant. Lane I, pYT646B, Lane 2, B. thetaiotaomicron VPI-5482 genomic DNA, and Lane 3, 
B. thetaiotaomicron Tn MetR genomic DNA. All DNA was digested with PvuII and probed with a 0.9 kb SacI­
EcoRV internal fragment of the pYT646B tetQ gene. 
In order to further explain the doublet observed in Lane 3, the published sequence of 











transposon insertion site (Fig. 2.8). Tn440d mutant containing a single insertion between 
BT3767 and BT3768 in the chromosome should result in two bands (12 kb and ILl kb) when 














Figure 2.8: Schematic representation (not to scale) of the three PvuII sites. Pvull sites I and 2 and 3, located 
within BT3763 (green arrow), the tetQ gene (dark blue arrow) of the transposon, and within BT3774 (downstream 
on genomic DNA) of B. thetaiotaomicron VPI-5482, respectively. Sad and EcoRV fragment of the tetQ gene was 
used as the DNA probe. 
2.4.5 Bioinformatic analysis of the transpo son insertion site and flanking regions 
2.4.5.1 Analysis of the transposon insertion site 
DNA sequence analysis of the transposon insertion site in the B. thetaiotaomicron VPI-5482 
genome (A TCC 29148) showed that it had occurred in an intergenic region, 12 bp downstream 
of the BT3767 and 131 bps upstream ofBT3768. These genes are annotated as forming part of 
a cluster having amino acid sequence similarity to the proteins of the E. coli rhamnose catabolic 
pathway (Table 2.1). BT3767 codes for a protein, predicted to have 384 amino acid residues, 
which is thought to play a role in converting L-Iactaldehyde to L-l,2-propandiol, whereas 
BT3768 (299 amino acids) displays amino acid identity to a group of positive transcriptional 
regulators from the AraClXylS family. It was, therefore, of interest to analyze whether these 
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Table 2.1: Sequence identity of B. thetaiotaomicron VPI-5482 predicted gene products to proteins from E. coli 
K12. 
2.4.5.2 Rhamnose catabolism 
The putative rhamnose gene cluster in B. thetaiotaomicron VPI-5482 was found to consist of 
six genes, all transcribed in the same orientation (Fig 2.9A, Table 2.1). The gene nomenclature 
in this study for the B. thetaiotaomicron putative rhamnose pathway has been assigned 
according to the predicted function of each gene as is the convention in the B. thetaiotaomicron 
fucose gene cluster (Hooper et al., 1999). For example, the gene coding for L-rhamnose 
isomerase in B. thetaiotaomicron has been assigned as rhaI. This differs from the 
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Figure 2.9: Rhamnose gene cluster arrangements in B. thetaiotaomicron VPI-5482 , E. coli K-12, S. typhimurium 
LT2 and Rhizobium leguminosarum . Red, dark blue, yellow, green, and light blue, arrows represent the aldolase, 
isomerase, pennease/transport, kinase, and oxidoreductase genes, respectively. The black arrows represent 
regulators and the white arrows represent hypothetical proteins. 
L -rhamnose is a methylpentose sugar that is metabolised and used as a carbon and energy 
source by organisms such as E. coli, Salmonella spp. and by the soil bacterium 
R. leguminosarum (Moralejo et al., 1993; Chen et al., 1987a; Richardson et aI., 2004). In 
E. coli, L-rhamnose is metabolised by an inducible gene cluster (Fig 2.9B) that is mediated by a 
kinase (rhaB), an isomerase (rhaA), a permease (rhaT), and an aldolase (rhaD) and the pathway 
consists of two diverging gene clusters rhaBAD, and rhaSRT (Moralejo et aI., 1993; Power, 
1966). Similarly, in S. typhimurium (Fig 2.9C), the genes are arranged in the same orientation 
as the E. coli gene cluster. However, in both B. thetaiotaomicron (Fig 2.9A) and 
R. leguminosarum (Fig 2.9D), the genes of the rhamnose cluster are in a different orientation to 











orientation. However, in R. leguminosarum, the pathway consists of two diverging gene 
clusters, rhaDI and rhaRSTPQUK. There is no published information on rhamnose catabolism 
in Bacteroides spp. Therefore, other well-studied models, such as E. coli and 
R. leguminosarum, are reviewed here to better understand the events of rhamnose catabolism. 
In E. coli, extensive studies have been carried out to elucidate the function of each of the genes 
in the rhamnose pathway as well as determine the catabolic end products (Fig 2.10). Here, the 
sugar is first brought into the cell by the permease (RhaT). It is then isomerized by L -rhamnose 
isomerase (RhaI), and subsequently phosphorylated by the kinase (RhaK). Finally the aldolase 
(RbaD) cleaves L-rhamnulose-l-phosphate into L-Iactaldehyde and dihydroxyacetone 
phosphate (DHAP) as depicted in Fig 2.1 0 (Chen et al., 1987a). The fate of L-Iactaldehyde in 
E. coli depends on whether growth conditions are aerobic or anaerobic. Under anaerobic 
conditions, L-Iactaldehyde, the common intermediate in both the rhamnose and fucose 
metabolism, gets reduced to L-l,2-propanediol via the NAD-linked propanediol 
oxidoreductase, FucO. This allows the regeneration of oxidized coenzyme, and allows the 
fermentation of rhamnose as well as fucose, a similar pentose sugar, to proceed (Boronat and 
Aguilar, 1981; Baldoma and Aguilar, 1988). 


















Under aerobic conditions, an inactive form of the propanediol oxidoreductase is produced. 
Instead, the L-Iactaldehyde is oxidized to L-Iactate that is, in tum, oxidized to pyruvate via a 
NAD-dependent lactaldehyde dehydrogenase and a flavin-linked lactate dehydrogenase. This 
allows all the carbons from rhamnose and fucose to enter the central metabolic pathways 
(Boronat and Aguilar, 1981; Baldoma and Aguilar, 1988). 
The regulation of the rhamnose catabolic pathway in R. leguminosarum at the molecular level is 
currently under study (Richardson et al., 2004). It has been reported that, unlike the situation in 
E. coli, this pathway contains the rhaSTPQ gene cluster and transports rhamnose via an ABC 
transporter. The periplasmic sugar binding protein is encoded by rhaS, rhaT encodes an ABC­
type protein, where as rOOP and rhaQ encode a permease. The kinase, encoded by rhaK lies 
after a gene encoding the hypothetical protein, RhaU. All of these genes in this organism are 
under the regulation of a negative regulator, RhaR. The genes diverging from this cluster are 
the rhaD, coding for a putative oxidoreductase, and rha!, an isomerase. 
The regulation of the genes in the rhamnose utilization pathway in B. thetaiotaomicron VPI­
5482 (Fig 2.8A) has not previously been studied, although those of the fucose catabolism have 
been elucidated (Hooper et aI., 1999; Chapter I). In E. coli, B. fragilis, as well as Salmonella 
species, the fucO gene, encoding L-lactaldehyde oxidoreductase is located in the fucose gene 
clusters. However, in B. thetaiotaomicron VPI-5482 this gene is found in the putative rhamnose 
gene cluster. It is interesting to note, that in R. leguminosarum, rhaD codes for a putative 
oxidoreductase, however, its function is yet to be elucidated. FucO is a member of the group 
three iron-activated alcohol dehydrogenase that is NAD(P)-dependent (Obradros et aI., 1998; 
Reid and Fewson, 1994). Fe2+-dependent alcohol dehydrogenases contain conserved histidine 











(Montella et ai., 2005; Obradros et ai, 1998). Members of this group of enzymes are induced in 
the presence of a methyl pentose, and remain fully active in the absence of oxygen. In the 
presence of oxygen, they get oxidatively inactivated by an iron catalyzed mechanism (Montella 
et ai., 2005; Obradros et ai., 1998). 
Based on the genome sequence of B. thetaiotaomicron VPI-5482, the orientation and 
arrangement of the genes of the putative rhamnose cluster (Fig. 2.9A) it is possible that they 
may be expressed as an operon on a single transcript and induced by rhamnose. The final gene 
downstream of the cluster, the putative transcriptional regulator, might also be involved in 
regulation of the putative rhamnose cluster. These questions are addressed in Chapter 3. 
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To begin an evaluation of B. thetaiotaomicron Tn MetR that displayed metronidazole resistance 
on plate MIC's, metronidazole survival studies in BHIS broth were conducted and the mutant 
was shown to display resistance to 20 Ilglml metronidazole. This resistance phenotype may 
partially be caused by the slow growth observed in the mutant in complete medium, which may 
be affecting the activation of drug (Chapter 1). Improper catabolic reactions in the mutant may 
be preventing the phosphoroclastic reaction (Pan and Imlay, 2001) and in tum preventing 
sufficient electrons to be generated to activate the drug to its toxic component (Chapter 1). 
Alternatively, the transposon insertion in an intergenic region of the putative rhamnose pathway 
may be exerting an as yet unknown effect which results in the metronidazole resistance 
phenotype. It would, therefore, be of interest to characterize this region further, as well as to 
investigate the effects of this insertion in the mutant. 
Southern hybridization was conducted to confirm a single transposon insertion within the 
genomic DNA of the mutant. In add tion, plasmid rescue and sequence analysis, confirmed the 
site of the insertion in an intergenic region between BT3767 and BT3768 (fucO and rhaR 
respectively). The transposon insertion may have affected either one or both the putative fucO 
or rhaR genes. There is a possibility that the transposon may have disrupted the formation of 
active FucO since the functional stop codon of this protein has not been confirmed. 
Alternatively, the transposon insertion may have affected the transcription of the downstream 
putative rhaR gene. If this gene, in fact, encodes a regulator of the rhamnose gene cluster, it 
may have other implications on the expression of these genes. Transposons are flanked with 
insertion sequence elements (Fig. 2.4) that can act as additional promoter sites (Podglajen et at., 











Based on this study, it would appear that the technique of using random transposon mutagenesis 
may not have been the ideal tool for examining metronidazole resistance, since their insertion 
into the genomic DNA can create mutants like B. thetaiotaomicron Tn MetR where the 
transposon has integrated into an intergenic region. Mutants containing single gene disruptions 
can be complemented to confirm their function. However, a mutant created by an intergenic 
insertion needs to be first characterized to determine how the genes flanking the insertion site 
are affected and how an insertion in this region may be causing a metronidazole resistance 
phenotype. Random transposon mutagenesis is, however, an extremely useful tool for 
identifying genes or pathways involved in metronidazole resistance, which may not appear to 
be obvious candidates for study. 
An alternative approach to addressing the question of what genes might control metronidazole 
resistance phenotype would be to create targeted gene disruptions using a suicide vector such as 
pGERM (Cheng et aI., 2000) whereby the process of homologous recombination ensures the 
targeting of specific candidate genes. A genetic tool such as this may be more effective and 
efficient, in comparison to random transposon mutagenesis, which brings with it the possibility 
of multiple transposon insertions, as well as that of IS elements integrating independently into 
other sites of the chromosome. This latter possibility will be dealt with in Chapter 4. 
Based on the findings in this chapter, two areas of study will be addressed in this dissertation. 
Firstly, the genes of the putative rhamnose cluster will be studied to evaluate whether they are, 
in fact, involved in the catabolism of this substrate (Chapter 3). Secondly, a study will be 
conducted to address how the transposon insertion in the B. thetaiotaomicron Tn Me{ mutant, 
between the fucO gene and the putative transcriptional regulator, rhaR, might be causing a 
metronidazole resistance phenotype (Chapter 4). Further, to rule out the possibility of 
background mutations causing the resistance phenotypes, the mutant would be recreated 
genetically (Chapter 4). 
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Bioinfonnatic analysis of ORFs BT3763 to BT3768 (Chapter 2) suggested that they may constitute 
a rhamnose catabolic gene cluster. This chapter analyzes the gene cluster of the putative rhamnose 
pathway in B. thetaiotaomicron VPI-5482 with respect to transcriptional regulation and function. 
Transcriptional hybridization studies showed that growth in the presence of the substrate, 
L-rhamnose, induced expression of the putative rhamnose catabolic genes in B. thetaiotaomicron 
VPI-5482. ORFs BT3763 BT3768 were shown by reverse transcriptase peR to be expressed on a 
single transcript, rhaKIPAO, whereas BT3768, encoding the putative transcriptional regulator 
(RbaR) of the rhamnose gene cluster, was transcribed independently. Primer extension analysis 
identified the transcriptional start sites, both as cytosine bases, 41 bp upstream of the start codon 
for the putative catabolic genes (rhaK-fucO) and, 27 bp upstream ofthe start codon for the putative 
regulator (rhaR). The -7 promoter sequences of PrhaKJPAO and PrhaR, were identified and shown to 
resemble the B. fragilis promoter consensus motifs. Inactivation of the rhaR gene, in 
B. thetaiotaomicron VPI-5482, resulted in a mutant, B. thetaiotaomicron rhaK, which was unable 
to use L -rhamnose, indicating that this gene may code for a positive transcriptional regulator of the 
rhamnose pathway. The complemented mutant, B. thetaiotaomicron rhaK (PLYLrhaR) was shown 
to restore growth in defined medium supplemented with L -rhamnose as the sole carbon source, 
confinning that the product ofthe rhaR gene is responsible for regulating the catabolic genes in the 












As discussed in Chapter 2, the B. thetaiotaomicron VPI-5482 genome sequence provisionally 
annotates the presence of catabolic genes of the putative rhamnose gene cluster (rha) (Accession 
N° AA076955). The gene nomenclature used in this study to name the genes of the putative 
rhamnose cluster has been described previously (Table 2.1). Having determined that the transposon 
insertion causing the metronidazole resistance phenotype occurred in an intergenic region between 
the fucO and rhaR genes of the putative rhamnose cluster, it was necessary to analyze this cluster 
in order to confirm its function and regulation in the parent strain, B. thetaiotaomicron VPI-5482. 
This would then serve as a basis, on which, to analyze the effectls of the transposon insertion on 
the rhamnose catabolism in B. thetaiotaomicron Tn MetR and determine how this might affect the 
metronidazole resistance phenotype in this strain. Therefore, this chapter deals with the 
characterization of the rhamnose gene cluster with respect to rhamnose utilization. Transcriptional 
hybridization studies carried out by Moralejo et al. (1993) showed that the E. coli rhamnose cluster 
contained the structural genes (rhaBAD). When RNA prepared from E. coli cells grown in glucose 
minimal medium was probed with the genes of interest, no transcription was seen. However, when 
RNA was prepared from cells grown in rhamnose minimal medium, the expected bands were 
visualized. Therefore, a similar approach was used for this study to determine if L-rhamnose as the 
sole carbon source in the growth medium would induce the transcription of the rhaK-rhaR gene 
cluster in B. thetaiotaomicron VPI-5482. Bioinformatic analysis of the rhaR gene showed that the 
derived amino acid sequence shared similarity to a group of transcriptional regulators from the 
AraC/XylS family of regulators. It was of interest, therefore, to determine if this was the regulator 
of the rhamnose catabolic genes in B. thetaiotaomicron, as well as to establish whether it 
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functioned as a positive or negative regulator. A useful approach in this regard is the generation of 
a gene specific mutation using a suicide vector (Hooper et al., 1999). 
The bioinformatic analysis (Chapter 2) also showed that the genes of the putative rhamnose cluster 
may be transcribed on a single RNA transcript as an operon, from a single promoter upstream of 
rhaK. Methods such as 51 RACE (Rapid Amplification of cDNA Ends, version 2; GibcoBRL-Life 
Technologies) have been used in mapping transcriptional start sites of the starch utilization genes 
and carbapenem resistance gene in B. fragilis (Spence et al.,2006; Podglajen et al.,20m, 
respectively). Alternatively, primer extension has also proven to be successful in identifying 
transcriptional start sites (Eikmanns et al., 1994; Moon et al., 2005). This latter method was 
selected for use in this study to identify the transcriptional start sites in the putative rhamnose gene 
cluster. Moon et al. (2005) used reverse transcriptase PCR (RT -PCR) to show that several of the 
ORFs were expressed as an operon in the regulation of the excision of the Bacteroides conjugative 
transposon, CTnDOT. For the purpose of this study, RT-PCR was used to determine if the 











3.3 METHODS AND MATERIALS 
3.3.1 Bacterial Strains, Plasmids and Growth Conditions 
B. thetaiotaomicron VPI-5482 was grown anaerobically on BHIS as described in Section 2.3.1. 
E. coli DH5a and S 17-I strains have been described previously (Rasmussen et al., 1994; Simon et 
al., 1983) and were grown aerobically on Luria-Bertani (LB) broth or agar (l.5% w/v) at 37°C. The 
antibiotics gentamicin (200 Ilg/ml), ampicillin (100 Ilg/ml), tetracycline (2 Ilg/ml) and 
erythromycin (10 Ilg/ml) were added to BHIS and/or LB whenever necessary. Plasmids pGERM 
(Cheng et al., 2000) and pLYLOI (Li et al., 1995) have been described previously. For 
carbohydrate utilization studies, cells were grown in a defined medium (Van Tassel and Wilkinson, 
1978) supplemented with either 0.1 % glucose (Merck), 0.1 % rhamnose (Sigma~ or 0.1 % fucose 
(Sigma®) as the sole carbon source. 
3.3.2 General Recombinant DNA procedures 
B. thetaiotaomicron genomic DNA was prepared according to the method outlined by Wehnert et 
al. (1992). E. coli plasmid DNA was prepared using the QIAGEN® Plasmid Midi Kit (25) 
(QIAGEN). Restriction enzyme digestions were carried out according to the manufacturer's 
instructions. 
3.3.3 RNA Extraction 
B. thetaiotaomicron VPI-5482 was grown for 16 h in 50 ml defined medium supplemented with 
0.1 % of either D-glucose (Merck) or L-rhamnose (Sigma®), and the total RNA was isolated 











electrophoresis in I.S % denaturing formaldehyde agarose gel (Fourney et al., 1988) and it was 
quantified using the NanoDrop® ND-I 00 spectrophotometer (Nano Drop Technologies, Inc). 
3.3.4 Construction of DNA probes for transcriptional hybridization studies 
Internal regions of each of the putative rhamnose genes was peR amplified in SO 111 reaction 
volumes. The master mix containedlOO ng of B. thetaiotaomicron VPI-S482 genomic DNA, O.S 
11M of each primer (Table 3.1), ISO 11M deoxynucleotide triphosphates, 1.S mM of Mg2+, and 2.SU 
Taq I polymerase (Roche). Samples were amplified for 30 cycles with appropriate annealing 
temperatures as shown in Table 3.1. The peR products were purified using the High Pure peR 
Purification Kit (Roche). The amplified products were DIG-labelled as described in Section 2.3.6. 











5'-AGA GTT TGA TCT TGG CTC AG·3' 
5'-CCG TTA TCT AAG CGG TGC C·3' I 
5'-ACG GTT ACCTTGTTA CGA CTT-3' 





rhal 5'·GCA ATA ITG ATG AAC TGC GTG CC·3' 5'-GAT TTC TGC AAT GAA ATC TTC GCC-3' 53 984 
rhaP 5'-GAA AA T CGT CCG GCA CTT GCC·3' 5'-TCA TAC CATCCG CTT CGA AGC C·3' 54.5 701 
rhaA 5'-TAT AGCCATCGGTAGCTTTTGCC·3' 5'·ATT ACT AAA GGT TAC GTT CAG CGC C·3' 53 855 
fucO 5'-CTT ATTTCG GTG CAG GAT GCC·3' 5'·CGAACA TATCGCTCATAGCCC·3' 52.8 507 
rhaR 5'·GCT GAA GGA GCA TCC GTC·3' 5'·GTC TCA TCG CCA GTT CCT CC-3' 53.5 532 
Table 3.1: Oligonucleotides used to amplifY internal fragments of the putative rhamnose genes. List of primers 
internal to each of the genes in the putative rhamnose cluster, expected band sizes and annealing temperatures are 












3.3.5 RNA Transcriptional Hybridization Studies 
RNA was extracted from B. thetaiotaomicron VPI-5482 cells grown in defined medium 
supplemented with 0.1 % of either D-glucose (Merck) or L-rhamnose (Sigma~ and equal amounts 
(l Jlg), were spotted in equal volumes onto a nylon membrane (Roche). The membranes were 
hybridized with the DIG-labelled DNA probes. Hybridization and detection procedures were 
performed according to the manufacturers' instructions. Chemiluminescent signals were detected 
using CDp® Star (Roche). 
3.3.6 Reverse Transcriptase peR 
RNA (1 Jlg) obtained from B. thetaiotaomicron VPI-5482, grown in defined medium supplemented 
with L-rhamnose, was used for the synthesis ofcDNA using the Omniscript® Reverse Transcription 
Kit (Qiagen), according to manufacturer's instructions. cDNA was synthesized from RNA using 
the reverse oligonucleotide (Table 3.2) and each of the cDNAs was amplified with the appropriate 
set of primers to obtain a fragment ofthe intergenic region (Table 3.2). 
Band 
Intergenic size 
(bp)Forward Primers Reverse Primers ReRion 
rhaK-rhal 5'-GAAGCATCGAAA TAGTCGAGAACCG-3' 21005'·CCGTGGCGAATCTATIGCC·3' 
! rhal-rhaP 5'-TGGCAGGCTGATGATGT AACGG-3' 5'-TGGCAGGCTGATGATGTAACGG-3' 1508 
1250rhaP-rhaA 5'-TATCAAGGAAGCTGCIII 5'-T A TITAGGAAGATIGAAAGCAACGG-3' 
rhaA-fucO 11155'-GTAAACAAGGTAGCTGAAGTIGCC-3' 5'-CA TIGAATGCAGCCACCGCC-3' 
fucO-rhaR 5'-CTI ATITCGGTGCAGGATGCC-3' 5'-GTCTCATCGCCAAGTICCTC-3' 1140 
Table 3.2: Oligonucleotides used to amplifY intergenic regions of the putative rhamnose gene cluster. List of reverse 
primers used to synthesize eDNA, and used with the forward primers to amplifY the eDNA are shown. Expected band 











3.3.7 Primer Extension Studies 
The transcriptional start sites of the catabolic genes (rhaK-focO), and the putative transcriptional 
regulator, rhaR were identified using the non-radioactive method of Eikmanns et al. (1994). cDNA 
was synthesized from total RNA extracted from B. thetaiotaomicron VPI-5482, grown in defined 
medium supplemented with L-rhamnose (Sigma~ using the following Cy5 labelled primers: 
RhaKX (5'-CGA TTA ATC TCC TCC AGA TIT AAC CG- 3') corresponding to positions +98 to 
+71 bp downstream of the putative ATG start codon of rhaK, and primer RhaRX (5'-ACC GAA 
TTT GCG GTC TCC ATG -3') corresponding to positions +72 to +53 bp downstream of the 
putative A TG start codon of the putative transcriptional regulator. 
3.3.8 Inactivation of the rhaR gene in B. thetaiotaomicron VPI-5482 
An internal fragment of the rhaR gene was amplified from B. thetaiotaomicron VPI-5482 
chromosomal DNA using PCR (forward primer, iRF 5'-GCT GAA GGA GCA TCC GTC-3' and 
reverse primer, iRR, 5'-GTC TCA TCG CCA GTT CCT CC-3'). The PCR product was blunt 
ended with T4 DNA polymerase, cloned into the SmaI site of the suicide vector pGERM (Cheng et 
al., 2000), and transformed into E. coli DH5a. The resulting construct, pGER1, containing the 
internal fragment of the rhaR gene, was puri fied and retransformed into E. coli S17-I according to 
standard methods (Sam brook et al., 1989). Mobilization of pGERI from E. coli S-17 (pGERI) into 
B. thetaiotaomicron VPI-5482 was performed by an aerobic mating procedure as previously 
described (Li et al., 1995). Briefly, E. coli S-17 (pGERI) was grown for 16 h in LB broth, 
containing ampicillin (l00 llg/m1), while B. thetaiotaomicron VPl-5482 was grown anaerobically 
(16 h) in BHIS broth. Fresh LB or BHIS broth was inoculated with the relevant bacterial strain and 











B. thetaiotaomicron). Twenty millilitres of B. thetaiotaomicron were mixed with 5 ml of E. coli, 
and the cells were pelleted by centrifugation (5,000 rpm for 10 min). The supernatant fraction was 
removed and the cells resuspended in 1 ml of BHIS broth. Aliquots (200 Ill) were plated onto 
HAWP filters (0.45 J.lm, Millipore) placed on BHIS agar with no antibiotics, and incubated 
aerobically at 37°C for 16 h. Bacterial cells growing aerobically on the filters were washed off in 
BHIS broth and held anaerobically at 37°C for one hour. AI iquots (100 Ill) were then spread-plated 
on BHIS agar containing gentamicin (IOO Ilg/ml) and erythromycin (10 Ilg/ml) to select for the 
transconjugants (B. thetaiotaomicron rhaK mutants). 
3.3.9 Confirmation of pGERI insertion in B. thetaiotaomicron rhaR-
Integration of pGERI within the B. thetaiotaomicron rhaK genomic DNA was confirmed using 
PCR. The junction between the rhaR gene in the genomic DNA and the plasmid, pGERI, was 
amplified using the following combinations of primers, RFF (5'-A TG ACT GAG GAT AAT AAT 
ITG GG-3/) with the MI3 forward primer, and RFR (5 /-TTA TTC TTC CCG ACC GAA G-3') 
with the Ml3 reverse primer. The PCR products were purified and sequenced. 
3.3.10 Complementation of B. thetaiotaomicTon ThaR- mutant with pLYLrhaR 
A full length fragment of rhaR, including 239 bp upstream of the gene, was PCR amplified using 
the following primers; forward primer, cRF 5'-GTG AAG GAA GAG GAT TCT CCG G- 3', and 
reverse primer, cRR, 5'-ACA GAT TAA AAC GGA AAG CTT AAA TCA CAT CG-3'. The PCR 
product was digested with HindIII and Xmnl, cloned into the HindIII and SmaI sites of the shuttle 











resultant plasmid, pL YLrhaR was extracted, purified and retransfonned into E. coli S17-1 
according to standard methods (Sambrook et al., 1989). E. coli S-17 (pLYLrhaR) was conjugated 
with B. thetaiotaomicron rhaK mutant, as described previously (Li et al.) 1995). The resulting 
complemented strain was grown on BHIS agar containing erythromycin (10 Ilg/ml), and 
tetracycline (2 llg/m1). The presence of pL YLrhaR in the B. thetaiotaomicron rhaK mutant 
cytoplasm was con finned by extracting plasmid from B. thetaiotaomicron rhaK and 
t
retransfonning it into E. coli OH5a which were then plated on LB agar with ampicillin r 
I 
t 
(100 Ilg/ml). pL YLrhaR was re-extracted from E. coli OH5a and submitted for nucleotide 
sequencing to confinn the presence of the rhaR gene in the plasmid. 
3.3.11 Growth of the Bacteroides strains in defined broth medium 
B. thetaiotaomicron VPI-5482, B. thetaiotaomicron rhaK, as well as B. thetaiotaomicron rhaK 
(pL YLrhaR) were grown separately under anaerobic conditions in 10 ml volume of BHIS broth for 
J6 h, at 37°C. Cultures were diluted (I :50) separately in 100 ml defined broth medium (Van Tassel 
and Wilkins, 1978) supplem nted with 0.1 % of either o-glucose (Merck), L -rhamnose, or 
L-fucose (Sigma@). Growth of these cultures was monitored at hourly intervals by recording the 















3.4 RESULTS AND DISCUSSION 
3.4.1 Transcriptional induction by L-rhamnose 
In order to investigate if transcription of the genes of the putative rhamnose cluster was induced by 
L-rhamnose in the growth medium, transcriptional hybridization studies were performed using 




16S rRNA rhaK rhaI rhaP rhaA fUcO rhaR 
Figure 3.1: Transcription of the putative rha genes of B. thetaiotaomicron VPI-5482 during growth in the presence 
o-gIucose or L-rhamnose as shown by dot blot analysis. Equal volumes (2 Ill) and concentrations of total RNA (l Ilg) 
extracted from B. thetaiotaomicron VPI-5482 grown in defined medium, supplemented with o-glucose (A), or 
L-rhamnose (B) were spotted onto nylon charged membranes. Membranes were probed with DNA probes specific for 
each of the rha genes as described in Section 3.3.4. The 16S rRNA gene (an internal control) was also used as a probe 
to show that equal amounts of RNA were loaded onto each membrane. 
Results indicated that there was increased transcription of all of the rhamnose genes when cells 
were grown in L -rhamnose (B), as compared with growth in D-glucose (A). L -rhamnose, therefore, 
acts as an inducer of the transcription of these catabolic genes. In E. coli, it was shown that 











coding for rhamnulose kinase, was detected in strains carrying point mutations in each of the 
structural genes of the rhamnose operon (Moralejo et aI., 1993). 
3.4.2 Transcription of the genes of rhamnose pathway as an operon 

The B. thetaiotaomicron VPI-5482 rhamnose gene cluster is shown schematically in Fig 3.2. As 

can be seen, all the genes are transcribed in the same orientation and the intergenic regions 

(represented by the pink arrows) between ORFs rhaK, rhaI, rhaP, rhaA. fuca are quite short, 

leading to the hypothesis that the catabolic genes may be co-regulated as an operon, rhaKlPAa. 

The intergenic region between fuca and rhaR, the putative transcriptional regulator is, however, 

longer (142 bp), and may be transcribed independently, possibly from its own promoter. In order to 

determine whether the genes function as an operon, RT -peR was performed. 

50 5 13 96 142 
rhaK rhaJ i+- fucO i+- rhaRf+­
Figure 3.2: Schematic representation (not to scale) of the intergenic region between genes of the putative rhamnose 
pathway. The small black arrows represent the primers that were designed to amplify the intergenic regions (indicated 
by the pink arrows with their corresponding sizes in base pairs). 
Primers were designed to amplify the mRNA of the intergenic regions between each of the genes 
(Table 3.2, Fig 3.2). Each set of primers was tested on genomic DNA as shown in Fig 3.3 (Lanes 1, 
3, 5, 7 and 9) to determine the appropriate optimum conditions that would result in a single band of 
the predicted size (Table 3.2). The reverse primers were used to synthesize cDNA from 











rhamnose (inducing conditions). The cDNA was amplified by peR using the appropriate set of 
primers for each of the intergenic regions. The resulting peR products were run on an agarose gel 








Lane Intergenic region 
1 Genomic rhaK-rhaI 
2 cDNA rhaK-rhaI 
3 Genomic rhal-rhaP 
4 cDNA rhaI-rhaP 
5 Genomic rhaP-rhaA 
6 cDNA rhaP-rhaA 
7 Genomic rhaA -fucO 
8 cDNA rhaA-fucO 
9 Genomic fucO-rhaR 
10 cDNA fucO-rhaR 
Figure 3.3: RT-PCR analysis of the putative rhamnose gene cluster. PCR products from genomic DNA (odd numbers) 
and RT-PCR products from cDNA synthesis (even numbers). Key: Numbers on gel corresponding to PCR product 
loaded onto agarose gel. Molecular weight marker (kb) from lambda (A) DNA digested with restriction enzyme, PstI is 
also shown. 
The results indicated that transcripts were obtained from the intergenic regions of rhaK-rhal, rhaI­
rhaP, rhaP-rhaA, and rhaA-fucO (Lanes 2, 4, 6, and 8 respectively) confinning that these five 
genes are expressed on a single mRNA transcript. However, no cDNA transcript was amplified for 
the fucO-rhaR region (Lane 10), despite visualizing the amplified peR product on the agarose gel 
from genomic DNA (Lane 9). This suggests that rhaR may be expressed independently from the 
catabolic genes from its own promoter. The peR products from cDNA synthesis were purified and 











3.4.3 Identification of the transcriptional start sites using primer extension analysis 
RT -PCR indicated that the catabolic genes were transcribed as an operon, rhaKIP AO, and that 
rhaR may be transcribed independently. Furthermore, genome analysis of the B. thetaiotaomieron 
VPI-5482 rhamnose gene cluster, revealed a 142 bp intergenic gap betweenfueO and rhaR. Primer 
extension analysis was, therefore, performed in order to identify the transcriptional start sites of the 
rhamnose catabolic gene cluster (PrhaKIPAO), as well as that of the putative transcriptional regulator 
(PrhaR)' A single primer extension product was obtained for the catabolic genes, which identified 
the transcriptional start sites to be a cytosine, 41 bp upstream of the start codon for the putative 
kinase gene (rhaK). The transcriptional start site of the putative transcriptional regulator was also a 
cytosine, located 27 bp upstream of the start codon of the rhaR gene. (Fig 3.4 and Fig 3.5, 
respectively). 
Studies carried out by Bayley et al. (2000) showed that B. fragilis had a typical promoter sequence 
with a -7 region containing the consensus sequence TAnnTTTG and a -33 consensus sequence of 
TTTG. This was confirmed by Podglajen et al. (2001) who used 51 RACE to identify the 
transcriptional start sites of the B. fragilis carbapenemase gene, eftA. Thus far, no typical promoter 
sequences for B. thetaiotaomieron have been reported. It is, therefore, interesting to point out that 
the -7 region identified in this study was typical of what was observed in B. fragilis (Fig 3.4C and 
3.5C). However, the -33 regions of both promoters analyzed in this study showed a GCGT 
consensus sequence which is different from that reported in B. fragilis. Future studies will confirm 
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1 TATTTCGGAGAAAACATGCATAAATCATGCTTTTTTTGCATAAAAAGTAAAATTTATACTG 
~~ ~ ~ -33 
(C) 61 ATGTAAGGTTTGGCTATGCAGATTTGTGTCAAAATGCATCCTTTCTATCAAAATGCGTAAG 
-7 +1 
121 GAAAAGGAGGAAGGAACCGCCTATCTTTGCAATGTAGGTAAATGGATACCTTAAATATATA 
181 GACAAATACC AAACAGAACTTTTTTGCAGTCGACCTGGGCGCAACAAGCGGCCGTACA 
241 ATCTTAGGCTCTTTTATTGAAGGCGGATTAAATCTGGAGGAGATTAATCGTTTTCCT 
Figure 3.4: Identification of B. thetaiotaomicron putative rhamnulose kinase (rhaK) transcriptional start site by primer 
extension analysis. (A) Primer extension reaction product (black line) and A's in blue. Transcriptional start (+ 1) site is 
indicated by an arrow. (B) Chromatogram of the corresponding DNA sequencing reaction using the same primer 
RhaKX (underlined in green in C). (C) Nucleotide sequence of the putative rhamnulose kinase, rhaK: ATG start codon 
of rhaK (underlined in orange), transcriptional start site (blue, +1), putative -7 and -33 motifs (underlined in red). 
RhaKX Cy5 labelled reverse primer used to synthesis cDNA (underlined oligonucleotides in green). The 4 sets of 
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(C) 61 TTTTTTACTGTTTAGCGTGTGTTTTTTGAAAATAATTCCTACTTTTGTTCAATTCAATTG 
121 TATGAAAACACGCCTGT r-ACTGAGGATAATAATTTGGGATTAGAATTTAAATACTTGA 
181 TAGTTAATGACATGGACCGCAAATTCGG TGTGGGTGAATACGGTTGGCTATCAGTCT 
Figure 3.5: Identification of B. thetaiotaomicron putative transcriptional regulator (rhaR) transcriptional start site by 
primer extension analysis. (A) Primer extension reaction product (black line) and T's in red. Transcriptional start (+ 1) 
site is indicated by an arrow. (B) Chromatogram of the corresponding DNA sequencing reaction using the same primer 
RhaRX (underlined in green in C). (C) Nucleotide sequence of the putative transcriptional regulator, rhaR: ATG start 
codon ofrhaR (underlined in orange), transcriptional start site (blue, +1), and putative -7 and -33 motifs (underlined in 
red). RhaRX Cy5 labelled reverse primer used to synthesis cDNA (underlined oligonucleotides in green). The 2 sets of 











Tobin and Schleif (1987), identified two inverted repeat OR) sequences of the E. coli rhaR gene of 
the rhamnose pathway, located upstream of -35 region (5'TTTTT-----AAAAA-3') and 
(5'-AAAA------TTTT -3'). They also reported that these elements are often part of the binding site 
which are thought to be involved in regulating the protein binding. In this study, only one IR, 
5'-TTTTT----AAAAA-3' (red arrows, Fig. 3.4C), was found upstream of the -33 region within the 
B. thetaiotaomicron rhaK promoter region. In addition, however, a further three sets of inverted 
repeats were identified. These are, 5'-TTTC---GAAA-3' where - is any base pair (pink arrows), 
5'-TTTG---CAAA-3' (orange arrows) and 5 '-TTT-----AAA-3 , (blue arrows) (Fig. 3.4C). All of 
these IRs were found upstream of the -33 promoter sequence. In the rhaR promoter region, two sets 
of inverted repeats were identified, 5'-ATCC---GGAT-3' (red arrows) and 5'-TTT-AAA-3' (blue 
arrows) (Fig. 3.5C). The first one was found upstream of the -33 promoter sequence and the latter 
spanned the -33 and -7 promoter region. 
3.4.4 Insertional inactivation and confirmation ofB. thetaiotaomicron rhaR" mutant 
Gene specific disruption was performed to determine if the rhaR gene was responsible for 
regulating the rhamnose pathway. A schematic diagram of how the rhaR insertional inactivated 
mutant was created and genetically confirmed is shown in Fig. 3.6. Plasmid pGERI, containing an 
internal fragment of rhaR gene, was inserted into the genomic copy of the B. thetaiotaomicron 
VPI-5482 rhaR gene region via homologous recombination. 
In order to confirm the single insertion of pGERI into the chromosome, PCR was used to amplify 
the junctions between the plasmid pGERI and the external fragments of rhaR gene from either end 











specific to the pUC based plasmid, pGERI, and these were matched with external primers to the 




RFR reverse primer c M 13 forward primer ...... 
~ 
~ ~ 
!RFF forward primer MI3 reverse primer peR D 
Figure 3.6: Schematic representation (not to scale) depicting the homologous recombination method used to create the 
insertionally inactivated rhaR mutant as well as confirmation of the mutation site. A) Plasmid pGERl (circular black 
band) with an internal fragment of the rhaR gene (red hatched band). B) B. thetaiotaomicron VPI-5482 genomic DNA 
(dashed line) flanking the full length rhaR gene (red band). e) The resulting mutant, B. thetaiotaomicron rhaR", with 
an inactivated rhaR gene containing pGERl integrated into the genomic DNA. M13 primers are shown in blue arrows 
and rhaR primers shown in red arrows. D) peR products (blue bands) amplified using M13 primers and gene specific 
primers (RFF and RFR) of the rhaR gene to genetically confirm the insertion ofpGERl into the chromosome. 
The amplified PCR products from either end were visualized on an agarose gel (Fig. 3.7 Lanes 1 
and 4). No bands were visualized from the PCR samples loaded in lanes 2 and 3 given that the 











reactions anneal to the DNA in the same direction (Fig 3.6C). Sequencing of the purified peR 
products using the M 13 primers showed the orientation of pGERl within the B. thetaiotaomicron 
rhaR gene, and confinned the site of integration. 
2 3 4 
0.5 
Figure 3.7: Agarose gel confirming pOERl insertion into B. thetaiotaomicron rhaR" mutant genome using PCR. PCR 
products from RFF primer with MI3 forward primer (Lane I), RFF primer with MI3 reverse primer (Lane 2), RFR 
primer with MI3 forward primer (Lane 3), and RFR primer with MI3 reverse primer (Lane 4). Molecular weight 
marker (kb) from lambda (A.) DNA digested with restriction enzyme, Pst! is also shown. 
3.4.5 Role of RhaR in regulating the B. thetaiotaomicron VPI-5482 rhamnose utilizing 
pathway 
The B. thetaiotaomicron rhaK mutant was created to detennine if the product of this gene was 
responsible for regulating transcription of the rhamnose gene cluster. The role of RhaR in 
rhamnose utilization was further validated by transfonning the plasmid pL YLrhaR into the 
B. thetaiotaomicron rhaK mutant to observe if this strain would restore growth in the rhamnose 
minimal medium. The presence of the cytoplasmic copy of pL YLrhaR was verified by extracting it 
from the complemented strain, B. thetaiotaomicron rhaK (PL YLrhaR). The yield of plasmid was 











plasmid was re-extracted from the resulting ampicillin resistant E. coli DH5a and the correct 
pL YLrhaR construct was verified by nucleotide sequencing. 
The B. thetaiotaomicron rhaK mutant was unable to grow in defined medium supplemented with 
L-rhamnose as the sole carbon source. B. thetaiotaomicron rhaK (pLYLrhaR), however, grew in 
the minimal medium with L-rhamnose to the same extent as B. thetaiotaomicron VPI-5482 parent 
strain (Table 3.3). The results showed that RhaR is required to be active in order for it to positively 
regulate the uptake and catabolism of L-rhamnose. 
I Absorbance (600nm) at 8 h 
Strains r-- I 
L-rhamnose i 
i D-glucose L-fucose 
, 
0.633 (± 0.09) ! 1.74 (± 0.05) 0.76 (± 0.03) B. thetaiotaomicron VPI-5482 l 
I 
0.77(±0.11)B. thetaiotaomicron rhaK mutant 0.11 (± 0.00) 1.65 (± 0.08) i 
1.78 (± 0.02) 0.62 (± 0.02) B. thetaiotaomicron rhaK (PL YLrhaR) 0.66 (± 0.05) 
~~ 
i L-­
Table 3.3: Growth of the Bacteroides strains at 8 h in defined medium supplemented with t-rhamnose, D-giucose or 
t-fucose as the sole carbon source. The initial starting OD (600nm) of the cultures in the defined mediums was ~O.l 
and grown for 8 h. Data points represent the mean values of three experiments, and the standard deviation is shown in 
brackets (±). 
The B. thetaiotaomicron rhaK mutant was able to grow in medium supplemented with D-glucose 
or L-fucose (Table 3.3), demonstrating that RhaR plays an essential role in specifically regulating 
the utilization of L-rhamnose. In E. coli, it was reported that a point mutation in rhaR abolished 












3.4.6 	 Bioinformatic analysis of the B. thetaiotaomicron positive transcriptional regulator, 
RhaR 
Bioinfonnatic analysis of the B. thetaiotaomicron VPI-5482 rhaR gene reflected that it encoded a 
putative protein with an AraC binding region and a helix tum helix motif (Fig 3.8). It also shared 
(28 %) amino acid sequence identity with RhaR of E. coli which has been shown to act as a 
positive regulator and is a member of the AraC/XylS family of regulators (Gallegos et al., 1997). 
so 180 1 0 2 . 0 2 0 
Figure 3.8: Schematic representation of B. thetaiotaomicron VPI-5482 RhaR amino acids showing conserved domains 
of the Arne_binding and the helix-turn-helix motifs . (http;llwww.ncbi.nlm.nih.govlblatIBlasl.cgi). 
The AraClXylS family consists of positive transcriptional regulators that have been shown to 
regulate a diverse number of genes and their functions. Some of these control single operons or 
genes, and others control mUltiple genes fonning a complex regulatory network (Tobes and Ramos, 
2002; Gallegos et al., 1997). Approximately lOO proteins are known to belong to the AraC/XylS 
family, and a few examples are given below. The proteins from this family can be divided into 
three main groups based on their regulatory functions, namely, the regulation of carbon 
metabolism, stress response and pathogenesis (Gallegos et al .. 1997). AraC/XylS family of proteins 
are found in many organisms, such as E. coli. S. typhimurium. Citrobacter freundii and 
Pseudomonas putida. Some of the proteins that are involved ill the regulation of carbon 
metabolism include, AraC, RafR, RhaS/RhaR and XylS which are reported to regulate the 
degradation of arabinose, raffinose, rhamnose and xylose, respectively. Stress response regulation 
in E. coli and S. typhimurium involves the SoxS positive regulator protein. An example of a 











The conserved features of AraClXylS positive regulators are the size of the proteins and the 
location of the conserved domains. Members of this family of regulators are 200-300 residues long, 
with a few exceptions like HrpB from B. solanacearum, the Ada protein from Mycobacterium 
tuberculosis, and Ybbb from Bacillus subtilis, all of which are 500 residues long. All members of 
this family of regulators contain a 17 residue conserved consensus domain (Gallegos et al., 1997). 
In E. coli, the rhamnose pathway is regulated by RhaSR (Chapter 2, Fig 2.98) where RhaS is 30 % 
identical to RhaR at the amino acid level (Wickstrom et al., 2005). In E. coli, RhaR is the 
transcriptional activator of the rhaRS operon, whereas RhaS is the transcriptional activator of the 
genes required for rhamnose catabolism (rhaBAD), as well as the rhamnose transporter gene, rhaT 
(Wickstrum and Egan, 2004; Gallegos et aI., 1997). In S. typhimurium (Chapter 2, Fig 2.9C) the 
RhaR and RhaS are also part of the AraClXylS family of regulators and act in a similar manner to 
the E. coli orthologues (Nishitani and Wilcox, 1991). 
Based on the analysis of AraClXylS family of regulators conducted by Gallegos et al. (1997), the 
AraC regulator was found to contain a conserved consensus domain of 17 residues that is part of 
the C-terminus helix turn helix motif. However, sequence conservation at the N-terminus helix turn 
helix motif was low. It was also reported that while AraC might contact DNA sequences via two 
helix turn helix motifs, this may not be a general rule for members of this family. In order to 
analyze the putative conserved domains of RhaR in B. thetaiotaomicron, the RhaR amino acid 
sequence from the E. coli, S. typhimurium and B. thetaiotaomicron were aligned using Lynnon 
Biosoft DNAMAN software v 4.13 and the NCBI BLAST program (Altschul et al., 1997), to 
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Figure 3.9: Multiple sequence alignment of RhaR. Amino acid sequences are shown for RhaR from (A) 
E. coli K12, (B) S. Typhimurium LT2 and (C) B. thetaiotaomicron VPI-5482. Amino acid residues that are identical in 
all sequences (100 %) are indicated in yellow shading and are displayed in the consensus lane. Residues that are 50 % 














Sequence alignment showed that 13 of the 17 highly conserved residues that constitute the 
C-terminus helix turn helix reported by Gallegos et al. (1997), have been identified in the RhaR ! 
tamino acids of B. thetaiotaomicron VPI-5482 (Table 3.4). 
~rac Family 
aI, consensus
I B. thetaiotaomicTon 
i VPI-5482 ThaR 
i conserved residuesb 
IA-----S---L---F--nG-u-n--nR---A---L-n-----UV--IIV----GF-----F---FKlR---G--P---R 
-------S--------F ----G--------------A ---L---------I-------------G F -----F ---F --------G--P---R 
Table 3.4: Comparison of the amino acid sequence for the AraC family of positive transcriptional regulators and 
B. thetaiotaomicron VPI-5482 RhaR. 

a AraC family consensus sequence as described by Gallegos et al. (1997), where represents any amino acid 
 , 
b B. thetaiotaomicron VPI-5482 RhaR conserved amino acid residues from positions 223 to 292 in Fig 3.9. 1 
I 




VPI-5482 RhaR is the positive regulator of the rhamnose operon, since the presence of the active 
















In order to understand how the transposon insertion in an intergenic region of the putative 
rhamnose pathway was causing the metronidazole resistance phenotype, studies needed to be 
conducted to understand and confirm if the genes in this gene cluster were, in fact, involved in 
rhamnose utilization in B. thetaiotaomicron VPI-5482. 
The results of this study verify that the genes in this cluster are involved in rhamnose catabolism, 
as they were shown to be induced by the presence of this substrate in the growth medium. It is 
possible that other metabolites of L-rhamnose may also induce the rhamnose gene cluster, and 
future studies should be conducted to create point mutations in each of structural genes and 
determine if transcriptional activity is observed from these mutants grown in the presence of 
L-rhamnose (Moralejo et ai., 1993). 
The rhamnose genes in B. thetaiotaomicron VPI-5482 were also shown to be transcribed as a 
single operon (rhaKlPA0). Inactivation of the rhaR gene in the parent strain resulted in a mutant 
that was unable to utilize L-rhamnose as the sole carbon source. However, it was able to utilize 
D-glucose and L -fucose confirming that RhaR plays a critical role as a positive regulator of the 
rhamnose pathway in B. thetaiotaomicron VPI-5482. 
Future studies should involve two areas of analysis. Firstly, the function of each of the catabolic 
genes in this pathway should be identified. In order to do this, gene specific mutations in each of 
the catabolic genes could be created and their functional roles characterized (Hooper et al., 1999; 











rhamnose catabolic enzymes in B. thetaiotaomicron VPI-5482, purified proteins can be produced 
as described in Tobin and Schlief(l990). 
Secondly, in order to confirm that RhaR is in fact the positive regulator, the DNA binding site for 
RhaR protein should be determined. This can be done using deletion mapping of the promoter 
regions and DNA mobility shift assays (Egan and Schleif, 1993). In studies conducted in E. coli, 
purification of the AraC DNA binding domain permitted measurements of the protein's specific 
activity, as well as of its DNA binding affinity (Timmes et al., 2004). In this study on the 
B. thetaiotaomicron promoters several inverted repeats were identified and their possible role in 
RhaR binding should be evaluated. This can be done using DNase I footprinting and mutational 
analysis. These techniques were successful in showing that in E. coli RhaS binds to an inverted 
repeat region of the DNA in the promoter PrhaBAD (Tobin and Schleif, 1987). 
The findings reported in this chapter represent an overview and a basic understanding of the 
regulation of the rhamnose gene cluster in B. thetaiotaomicron VPI-5482. In the context of this 
thesis as a whole, these findings formed the foundation for asking further questions, namely, how 
does the transposon insertion in an intergenic region of the rhamnose pathway affect the utilization 
of rhamnose in the B. thetaiotaomicron Tn MetR mutant, and more importantly, how might this be 
causing the observed metronidazole resistance phenotype (section 2.4.2)? These questions are 














Effects of the transposon insertion in the B. thetaiotaomicron Tn MetR 
mutant 
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The B. thetaiotaomicron Tn MetR mutant was shown to utilize L-rhamnose as the sole carbon 
source indicating that the catabolic and regulatory genes of the rhamnose cluster were still ! 
I 
t 
functional and had not been disrupted by the transposon. Furthermore, the B. thetaiotaomicron 
, 
Tn MetR mutant grew better in this defined medium than the parent strain. A metronidazole 
resistance phenotype was also observed in the minimal medium supplemented with L -rhamnose 
as the sole carbon source, which was not attributed to slow growth as seen in complete medium 
(Chapter 2). Transcriptional hybridization studies on the B. thetaiotaomicron Tn MetR mutant 
showed higher levels of transcription of all the rha genes in the operon as well as the rhaR 
gene, under both inducing and non-inducing conditions, in comparison to B. thetaiotaomicron 
VPI-5482. 
In Chapter 3, BT3768 was shown to encode the positive transcriptional regulator, RhaR, of the 
rhamnose gene cluster. In order to confirm that the metronidazole resistance phenotype 
observed in B. thetaiotaomicron Tn MetR was due to the up-regulation of the rha genes, caused 
by the transposon insertion upstream of rhaR, a B. thetaiotaomicron strain overexpressing the 
rhaR gene on a cytoplasmic element was constructed, B. thetaiotaomicron (pL YLrhaR). 
Physiological, genetic and biochemical analysis of this strain, grown in L -rhamnose as the sole 
carbon source, showed that increased expression of RhaR caused a metronidazole resistance 
phenotype. At the molecular level, B. thetaiotaomicron (PLYLrhaR) showed increased 
transcription of all the genes in the rha operon in comparison to B. thetaiotaomicron VPI-5482. 
This was comparatively less then the effect observed in B. thetaiotaomicron Tn MetR 
containing the transposon upstream of rhaR, and may be due the lower copy number of 
pL YLrhaR found in the cytoplasm of B. thetaiotaomicron (pL YLrhaR). The biochemical 
analysis of both B. thetaiotaomicron Tn MetR as well as B. thetaiotaomicron (PLYLrhaR) 
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showed that in both these strains, the lactate dehydrogenase (LDH) levels were elevated, and 
pyruvate oxidoreductase levels were depleted, relative to the B. thetaiotaomicron VPI-5482 
parent strain. Both of these are key enzymes that are implicated in metronidazole activation 
(Narikawa et al., 1991; Sindar et al., 1982; Britz and Wilkinson, 1979). 
4.2 INTRODUCTION 
The aim of this study was to determine how the transposon insertion was affecting the 
regulation of the rhamnose pathway in B. thetaiotaomicron Tn MetR, and whether it played a 
role in the observed metronidazole resistance (Chapter 2). 
In Chapter 2, it was reported that B. thetaiotaomicron Tn MetR displayed a metronidazole 
resistance phenotype, as well as slower growth in complete medium when compared to the 
parent strain. It was possible that the observed resistance phenotype was caused by a slower rate 
of metronidazole activation due to the slower growth. Therefore, it was of interest to determine 
if this strain would display resistance to metronidazole if slow growth was not a variable. In 
addition, it was important to establish whether the transposon insertion in an intergenic region 
of the rhamnose gene cluster in B. thetaiotaomicron Tn MetR had affected the functionality of 
this rhamnose pathway and whether the transposon was responsible for causing the 
metronidazole resistance phenotype by specifically affecting the expression of the rhamnose 
genes. 
The transposon insertion in the fucO-rhaR intergenic region may have affected FucO, RhaR or 
possibly both. It may have disruptedfucO, preventing the active formation of FucO. Briefly, as 
mentioned in Chapter 2, the fucO gene codes for a putative lactaldehyde reductase also known 
as a L-l,2-propanediol oxidoreductase, which is responsible for reducing L-Iactaldehyde to 
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L-l,2-propanediol, using NADH as a cofactor (Montella et ai., 2005). In this regard, a 
biochemical assay to test for the production L-l ,2-propanediol would verify the functionality of 
FucO in B. thetaiotaomicron Tn MetR• This biochemical assay would also provide insight into 
rhamnose catabolism in B. thetaiotaomicron VPI-5482, as there have been no published reports 
on propanediol production in this organism. 
Alternatively, the transposon may have affected the expression of the positive regulator, RhaR. 
The transposon, Tn440d is flanked by two insertion sequence (IS) elements, IS4400R and 
IS4400L. IS elements have been shown to activate genes in B. fragilis (Podglajen et ai., 1994; 
Podglajen et aI., 2001), in which case, increased transcription of a positive regulator may result 
in increased levels of RhaR and possibly in tum, the rest of the rhamnose catabolic genes. In 
B. thetaiotaomicron Tn MetR, both the IS elements (IS4400R and IS4400L) are in the same 
orientation as the positive transcriptional regulator, RhaR (Fig. 4.1). Furthermore, IS4400L may 





fucO IS4400R .. bla .. tetQ IS4400L- rhaR 
Figure 4.1: Schematic representation (not to scale) of the transposon insertion betweenfucO and rhaR. Arrows in 
red represent insertion sequence elements (IS4400L and IS4400R) . Dark blue arrow represents, tetQ gene 
expressing tetracycline resistance in Bacteroides species, and the light blue arrow represents the bla gene. Green 
and purple bands represent thefucO and rhaR chromosomal genes, respectively. 
In order to investigate the effects of the transposon insertion on the expression of the rha genes 
in the B. thetaiotaomicron Tn MetR mutant, transcriptional hybridization studies were used as 
described by Kullin et al. (2006). In addition, the insertion site was analyzed at the DNA level 
relative to the rhaR promoter, P rhaR. If the transposon insertion has affected the rha genes, and 











then a similar mutant would need to be recreated to verify that no other silent mutations exist 
within B. thetaiotaomicron Tn MetR. 
As discussed in Chapter 1, previous studies have reported in the literature that metronidazole 
resistant mutants of several different organisms displayed higher levels of lactate 
dehydrogenase (LDH) activity and depleted pyruvate ferredoxin oxidoreductase activity (Sindar 
et at., 1982; Britz and Wilkinson, 1979; Narikawa et al., 1991). Sindar et al. (1982) found that 
C. perfringens mutants displayed this phenotype. Similarly, Diniz et al. (2004) did not detect 
any pyruvate oxidoreductase activity in B. fragilis metronidazole resistant mutants, but higher 
levels of LDH activity were measured. Determining the levels of LDH and pyruvate 
oxidoreductase activity in the Bacteroides strains of this study, may provide insight into the 
metronidazole resistance phenotype being observed (Chapter 2), given that pyruvate 
oxidoreductase is a key enzyme in the activation of metronidazole (Chapter 1). 
4.3 MATERIALS AND METHODS 
4.3.1 Bacterial Strains and growth conditions 
All the B. thetaiotaomicron strains were grown anaerobically on BHIS as described in Section 
2.3.1. E. coli DH5a and S 17-1 strains have been described previously (Rasmussen et al., 1994; 
Simon et al., 1983, respectively) and were grown aerobically on Luria-Bertani (LB) broth or 
agar (1.5% w/v) at 37°C. The antibiotics gentamicin (200 Jlg/ml), ampicillin (100 Ilg/ml), and 
tetracycline (2 Jlglml) were added to BHIS and/or LB whenever necessary. Plasmid pL YLOI 
has been described previously (Li et al., 1995). 
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4.3.2 General Recombinant DNA procedures 
B. thetaiotaomicron genomic DNA was prepared according to the method outlined by Wehnert 
et al. (1992). E. coli plasmid DNA was prepared by using the QIAGEN® Plasmid Midi Kit (25) 
(QIAGEN). Restriction enzyme digestions were carried out according to manufacturer's 
instructions. 
4.3.3 Growth of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn MetR mutant 
in defined medium supplemented with L-rhamnose 
B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn Mef were grown under anaerobic 
conditions at 37°C in defined medium supplemented with 0.1 % L-rhamnose as described by 
Van Tassel and Wilkinson (1978). Cultures were grown separately in 10 ml volume of BHIS 
broth for 16 h. Cultures were then diluted (1 :50) in 10 ml of defined broth medium and growth 
of these cultures was monitored at hourly intervals by recording optical density (OD6oo) using a 
Beckman DU®S30 Lifescience UVNis Spectrophotometer. 
4.3.4 RNA extractions 
The B. thetaiotaomicron strains were grown for 16 h in 50 ml defined medium supplemented 
with 0.1 % of either D-glucose (Merck) or L-rhamnose (Sigma®), and the total RNA was 
isolated according to method of Aiba et al. (1981). The quality of the RNA was confirmed by 
electrophoresis in 1.5 % denaturing formaldehyde agarose gel (Fourney et aI., 1988) and it was 
quantified using the NanoDrop® ND-l 00 spectrophotometer (Nano Drop Technologies, Inc). 
4.3.5 Construction of DNA probes for transcriptional hybridization studies 
Internal fragments of the genes rhaK, rhaI, rhaP, rhaA, fucO and rhaR were used to make DNA 











4.3.6 RNA Transcriptional hybridization studies 
RNA was extracted from B. thetaiotaomicron strains grown in defined medium supplemented 
with 0.1 % of either D-glucose (Merck) or L-rhamnose (Sigma®) and equal amounts (1 flg), were 
spotted in equal volumes onto a nylon membrane (Roche). The membranes were hybridized 
with the DIG-labelled DNA probes. Hybridization and detection procedures were performed 
according to the manufacturers' instructions. Chemiluminescent signals were detected using 
CDP@ Star (Roche). 
4.3.7 L-l, 2-propanediol assays 
All the B. thetaiotaomicron cultures were grown separately in defined broth media 
supplemented with L-rharnnose under anaerobic conditions at 37°C. After 16 h growth, cultures 
were centrifuged, and the concentration of L-l, 2- propanediol in the culture supernatant was 
measured in Molar (M) units by the method of Jones and Riddick (1957) using 1,2- propanediol 
(Merck) as a standard. The experiment was performed in triplicate, and a total of three readings 
were taken for each assay. 
4.3.8 Construction of B. thetaiotaomicron VPI-5482 rhaR overexpresser 
The plasmid, pL YLrhaR, containing the full length fragment of the rhaR gene and 239 bp 
upstream of the gene, was constructed using pL YLOI as described in Section 3.3.10 (Li et aI., 
1995). The plasmid was extracted from transformed E. coli DH5u, purified and was 
retransformed into E. coli S17-1 according to standard methods (Sambrook et al., 1989). 
E. coli S-17 (PL YLrhaR) was conjugated with B. thetaiotaomicron VPI-5482, as described 
previously. The resulting B. thetaiotaomicron (pL YLrhaR) was grown on BHIS agar with 
tetracycline (2 flglml). Confirmation of the presence of pL YLrhaR in the cytoplasm of 




















4.3.9 Metronidazole survival studies in defined medium 
Mid-logarithmic phase cultures of the B. thetaiotaomicron cultures were exposed separately to 
15 /lglml of metronidazole in defined medium supplemented with L-rhamnose. Cultures were 
incubated anaerobically at 37°C. Samples were removed at different time intervals, diluted 
appropriately and plated onto BHIS agar to determine the surviving fraction from viable counts. 
4.3.10 Preparation of cell free extracts (CFE) 
Cell free extracts (CFE) of the B. thetaiotaomicron cultures were prepared anaerobically. Cells 
were harvested by centrifugation (8K, 4°C, 10 min) after 16 h growth in defined media 
supplemented with L-rhamnose. Pellets were washed three times under anaerobic conditions in 
10 mM Tris-HCL, pH 8.0 (for the lactate dehydrogenase assay), or 10 mM phosphate buffer 
with 250 /lM p-mercaptoethanol, pH 7.0 (for the pyruvate oxidoreductase assay), and 
resuspended in 5 ml of the same buffers, respectively. Cells were ruptured by sonication using 
an MSE sonicator at amplitude of 18-24 /lM for periods of 30 sImI of cell suspension in tubes 
chilled at O°c. Cell debris was removed by centrifugation (8K, 4°C, 20 min), the supernatant 
was collected (CFE), and protein concentrations were determined by the method of Bradford 
(1976) using BioRad reagents according to the manufacturer's instructions (Bio Rad 
Laboratories). 
4.3.11 Lactate dehydrogenase assays 
Enzyme assays were carried out by using the method outlined in Abbe et aZ. (1982). Lactate 
dehydrogenase (LDH) activity was measured anaerobically at 37°C by the rate of decrease in 
extinction coefficient of NADH at an absorbance of 340 nm using a Beckman DU®530 
Lifescience UV/Vis Spectrophotometer. The assay mixture consisted of 0.24 mM NADH, 0.50 















I mg of protein was used. The reaction was started by adding the pyruvate substrate. A standard 
curve was set up using various concentrations of NADH prior to the assay and enzymatic 
activity was recorded as flM NADHlmg protein/min at 340nm. This experiment was performed 
in triplicate, and a total of five readings were taken for each assay. 
t4.3.12 Pyruvate oxidoreductase assay , 
I 
[ 
Enzyme assays were carried out by using the method outlined in Lindmark and Muller (1973). 
Pyruvate oxidoreductase activity was measured spectrophotometrically at an absorbance of 
600nm using a Beckman DU®530 Lifescience UVNis Spectrophotometer, with methyl I 
f 
viologen as the electron acceptor at 37°C under anaerobic conditions. The assay mixture f 
consisted of 10 mM potassium phosphate buffer (PH 7.0), 2.5 mM potassium pyruvate, 250 
mM ~-mercaptoethanol, 0.25 mM CoA in a final volume of 1 ml, and 1 mg of protein was used. 
The reaction was started by adding the pyruvate, and the change in absorbance at 600nm was 
recorded before and after the addition of pyruvate. The difference in the measure of the slope 
was taken as the measure of enzyme activity and was recorded as flM of methyl viologen/mg 
protein/min at 600nm. This experiment was performed in triplicate, and a total of five readings 
were taken for each assay. 
4.4 RESULTS AND DISCUSSION 
4.4.1 Growth of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn MetR in 
defined medium containing L-rhamnose 
Growth studies of B. thetaiotaomicron VPI-5482 in comparison with the B. thetaiotaomicron 
Tn MetR mutant were initially conducted in complete medium (Chapter 2), and the results 
showed that the mutant grew more slowly than the parent strain. Since the transposon insertion 












had affected the ability of the B. thetaiotaomicron Tn MetR mutant to utilize L-rhamnose as a 
sole carbon source. Therefore, growth studies were also performed in defined broth medium 
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Figure 4.2: Growth pattern of B. thetaiotaomicron VPI-5482 and B. thetaiotaomicron Tn MetR in defmed medium 
supplemented with L- rhamnose as sole carbon source. Data points represent the mean values of 3 experiments. 
Standard error of the experiments is shown as error bars. 
Growth in the broth medium supplemented with L-rhamnose as the sole carbon source (Fig 4.2), 
showed that B. thetaiotaomicron Tn MetR grew better than the parent strain, indicating that the 
transposon insertion had not inhibited the utilization of L -rhamnose in this mutant. The wild 











24 hr (data not shown). These findings indicated that the transposon insertion in thefucO-rhaR 
intergenic region had not disrupted the functioning of any of the enzymes expressed by the 
genes of the rhamnose operon, but may even have enhanced their expression resulting in better 
growth in the presence of rhamnose. RNA transcriptional hybridization studies were, therefore, 
undertaken to determine if this was so. 
4.4.2 Transcriptional hybridization analysis of B. thetaiotaomicron VPI-5482 and 
B. thetaiotaomicron Tn MetR under inducing and non-inducing conditions 
In section 4.2, it was proposed that, since the transposon is flanked with IS elements, and is 
integrated between the fucO-rhaR genes, it may be possible that it was affecting the expression 
of the rhaR encoding the regulator of the rhamnose operon. In addition, the B. thetaiotaomicron 
Tn MetR mutant grew better than the parent strain in the presence of rhamnose. Transcriptional 
analysis of the RNA was, therefore, conducted after growth in the presence of rhamnose 
(inducing conditions) or glucose (non-inducing conditions) (Fig 4.3A and Fig 4.3B) to 
determine if there were changes in the expression of the rha genes and if this may be linked to 
the metronidazole resistance phenotype. 
During growth in the presence of rhamnose (Fig 3.4A), B. thetaiotaomicron Tn MetR (M) 
showed an increase in the transcription of each of the rhamnose genes in comparison to 
B. thetaiotaomicron VPI-5482 (WT). During growth in the presence of glucose (Fig 3.4B), 
transcription of the genes of the rha cluster in the parent strain (WT) was barely detectable with 
the exception of the rhaR gene, coding for the positive regulator, which may be constitutively 
expressed under these conditions. In contrast, however, B. thetaiotaomicron Tn MetR showed 
increased transcription even in the absence of rhamnose. 
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Figure 4.3: Transcription of the rha genes in B. thetaiotaomicron VPI-5482 (WT) and B. thetaiotaomicron Tn 
Met (M) as shown by dot blots analysis under inducing (A) and non-inducing (B) conditions. Cultures were 
grown anaerobically in L-rhamnose (A) or D-glucose (B) medium. An equal (2 J.ll) volume and concentration of 
total RNA (1 J.lg) were spotted in duplicate onto a nylon charged membrane. Membranes were probed with DNA 
probes specific for each of the rha genes as described in Section 3.3.4. The l6S rRNA gene (an internal control) 
was also used as a probe to show that an equal amount of RNA was loaded onto each membrane. 
This data, suggested that the transposon insertion in B. thetaiotaomicron Tn MetR was 
increasing transcription of the rhaR gene which, in turn, could up-regulate the expression of the 
whole operon, rhaKIPAO. Furthermore, transcription of the rhamnose genes in the mutant did 
not require rhamnose as an inducer since the increased transcription was seen in RNA extracted 











Menon and Lee (1990) conducted studies on the transcriptional activation of the E. coli 
arabinose (araBAD) operon. Briefly, AraC, regulates the transcription of the arabinose operon 
in E. coli, and is a member of the AraClXylS family of positive transcriptional regulators 
(Gallegos et ai., 1997). The protein binds L-arabinose, the inducer, to activate transcription of 
the ara operon (Menon and Lee, 1990). It has been reported that AraC is biologically active in 
ligand-free and ligand-bound forms; therefore, in the absence of L-arabinose, AraC activates the 
araBAD operon promoter, PSAD, to 1 % in comparison to the induced level (Menon and Lee, 
1990). In the B. thetaiotaomicron Tn MetR mutant, it is evident that an inducer is not required to 
constitutively transcribe the rhamnose genes. Growth in the presence of rhamnose, however, 
further induces the transcription of the RhaR and hence the rhamnose operon, rhaKIP AO. 
4.4.3 Analysis of IS4400L in relation to the RhaR promoter region in the 
B. thetaiotaomicron Tn MetR mutant 
A bioinformatic approach was used to determine how the transposon may have been 
responsible for the overexpression of rhaR. Based on the location of the transposon, and the 
orientation of IS4400L relative to the transcriptional direction of rhaR (Fig 4.1), it was possible 
that the IS element may be acting as an additional promoter (Fig 4.4). 
Figure 4.4 illustrates the DNA sequence obtained from sequence analysis of the transposon 
insertion site relative to the promoter region and coding sequence of rhaR. Three possible 
typical Bacteroides putative -7 hexamers were identified within the IS4400L sequence, as 


















Figure 4.4: Position of IS4400L in relation to transcriptional start site of rhaR. Nucleotide sequence of IS4400L 
(purple letters), the flanking B. thetaiotaomicron nucleotide sequence (black letters), resident -7 and -33 hexamers 
and transcriptional start site (red and blue letterls underlined, respectively), and A TG start codon of rhaR (orange 
letters underlined). The putative -7 hexamers within the IS element are highlighted in yellow. (Mahillon and 
Chandler, 1998). 
It not unusual for IS elements to act as strong promoters and activate genes (Mahillon et ai., 
1999; Schneider and Lenski, 2004). IS elements are less than 2.5 kb in size, contain inverted 
repeats (lR) and are genetically compact DNA sequences encoding functions involved in 
translocation within and between bacterial genomes (Mahillon et ai., 1999). Nearly the entire IS 
element is consumed by 1 or 2 ORFs that encode the Tpase enzyme, and the IR found in the IS 
elements assist in Tpase binding (Mahillon and Chandler, 1998). There are over 600 IS 
elements identified, and approximately 20 distinct groups (Mahillon and Chandler, 1998; 
Mahillon et ai., 1999). 
Many studies have shown that IS elements, or in some cases, compound transposons that are 
flanked by IS elements, can activate genes. For example, Ciampi et al. (1982) characterized 
TnIO transposon in S. typhimurium mutants and showed that when TnIO was inserted in the 
ribosomal RNA region of the histidine (his) operon there was weak expression of the his genes 











have been shown to activate the bgl operon in E. coli, irrespective of the elements being 
inserted upstream or downstream of the promoter region (Reynolds et al., 1981). Yet again, the 
integration of IS1 and IS5 elements in the flagellar regulon (/hID) region of E. coli mutants 
resulted in increased motility compared to the parent strain (Barker et al., 2004). IS1, IS2 and 
IS5 have been shown to have outwardly directed -35 promoter hexamers that are located in the 
terminal IR of the IS elements (Mahillon and Chandler, 1998). During transposition events, if 
these elements are integrated at the appropriate distance from the host's -10 hexamer, then new 
promoters are created, expressing the genes downstream. 
In Bacteroides spp., approximately 9 IS elements have been found, belonging to a range of IS 
families, viz: 1 from the IS30 family, 2 from IS4 and [S21 and 4 from IS5 family (Mahillon and 
Chandler, 1998). IS4400, IS4351L and IS4351R have been categorized under the IS30 family 
having one and the same name, IS4351 that was originally identified in B. fragilis V479-1 
(Accession N° M 17124). Soki et a1. (2006) reported that nine nimA genes were activated by 
IS1168 and three of the nimC genes were activated by IS1170. Podglajen et a1. (1994) reported 
that IS 1186 activated the expression of the carbapenem gene, cftA in B. fragilis causing 
resistance. They later identified the typical Bacteroides consensus promoter sequences within 
two IS elements, IS1187 and IS1188 that were found upstream of cfiA (Podglajen et ai., 2001). 
Based on the analysis of the IS4400L in relation to RhaR, there is a strong possibility that the IS 
element may be activating the rhaR gene, possibly in the absence and presence of the substrate, 
L-rhamnose, as observed in the transcriptional studies. 
4.4.4 Enzymatic assays ofL-l,2-propanediol 
Hybridization analysis (Section 4.4.2), showed that there was transcription of the fucO gene 











FucO protein was still in question since the transposon insertion may have disrupted the end of 
the fucO gene. It was, therefore, of interest to determine the functionality of FucO in 
B. thetaiotaomicron Tn MetR in relation to its parent strain. This was done using a biochemical 
assay to test for the production of L-I ,2-propanediol during growth in rhamnose (Table 4.1). As 
mentioned earlier (Section 4.2, Chapter I) the fucO gene codes for an oxidoreductase which, in 
E. coli, has been found oxidize L-Iactaldehyde to L-I,2-propanediol under anaerobic conditions 
(Montella et al., 2005). 
Strains L-l,2-propanediol (M) 
B. thetaiotaomicron VPI-5482 0.166 (± 0.123) 
B. thetaiotaomicron Tn Met/{ 0.366 (± 0.259) 
Table 4.1: L-l,2-propanediol activity measured in supernatant of B. thetaiotaomicron VPI-5482 and 
B. thetaiotaomicron Tn MetR• Data represents the mean value of three experiments, and the standard deviation for 
the experiments is shown in brackets (±). 
In this study, the results of the assay indicated that levels of L-1,2-propanediol produced by 
B. thetaiotaomicron Tn MetR were not significantly different from those produced by 
B. thetaiotaomicron VPI-5482. The detection of L-I,2-propanediol in B. thetaiotaomicron 
VPI-5482 culture supernatant is the first report in this organism of anaerobic L-rharnnose 
catabolism leading to the production of L-l ,2-propanediol from L-Iactaldehyde. 
The results of this study confirmed that the transposon insertion had not disrupted the fucO 
gene and suggested that the effects of the transposon insertion in the mutant may solely be 
due to up-regulation the gene coding for a positive transcriptional regulator, rhaR, and hence 











4.4.5 Construction of B. thetaiotaomicron overexpressing tbe positive regulator, RbaR 
In Section 4.4.3 it was shown that B. thelaiotaomicron Tn MetR containing a transposon flanked 
with an IS element upstream of the promoter region of the rhaR gene encoding the positive 
regulator, may be able to activate this gene. This together with the hybridization studies 
(Section 4.4.2) showed that the transposon insertion in B. thetaiolaomicron Tn MetR caused an 
overexpression of the regulator and, in turn, the rest of the rhamnose catabolic genes. In order 
to re-create the transposon mutant, and determine whether the metronidazole resistance 
phenotype was caused by the up-regulation of RhaR, an additional copy of rhaR, together with 
its own promoter region, was introduced into B. Ihelaiotaomicron VPI-5482 on a multicopy 
plasmid. Plasmid pL YLrhaR was conjugated into B. thetaiotaomicron VPI-5482, to create 
B. thelaiotaomicron (pL YLrhaR), and its presence in the cytoplasm was verified as described in 
Section 3.3.10 by tetracycline resistance, plasmid extraction and sequencing. 
4.4.5.1 Transcriptional bybridization analysis of B. thetaiotaomicron VPI-5482 and 
B. thetaiotaomicron (pL YLrbaR) 
In order to determine that the rhamnose genes were being overexpressed in a similar manner to 
that observed in B. thetaiolaomicron Tn MetR, transcriptional hybridization studies were 
performed on RNA extracted from B. thetaiotaomicron (PLYLrhaR) and B. thetaiotaomicron 
VPI-5482 grown in the presence of L-rhamnose (Fig 4.5). 
The results showed an increased amount of transcript from all the rha genes from 
B. thetaiolaomicron (PLYLrhaR) in comparison to the parent strain. The difference in 
transcriptional activity was, however, not as pronounced as seen in B. thetaiotaomicron Tn 
MetR compared to the parent strain. This may be due to a lower level of RhaR, expressed from 











B. thetaiotaomicron Tn MetR mutant. pLYLOl from which pLYLrhaR was constructed is a low 




Figure 4.5: Transcription of the rha genes of B. thetaiotaomicron VPI-5482 (WT) and B. thetaiotaomicron 
(PL YLrhaR) (OXP) as shown by dot blots analysis under inducing conditions. Cultures were grown anaerobically 
in L-rhamnose medium. An equal (2 Ill) volume and concentration of total RNA (I Ilg) were spotted in duplicate 
onto a nylon charged membrane. Membranes were probed with DNA probes specific for each of the rha genes as 
described in Section 3.3.4 . The 16S rRNA gene (an internal control) was also used as a probe to show that an equal 
amount of RNA was loaded onto each membrane. 
4.4.6 Metronidazole survival studies in dermed medium supplemented with L-rhamnose 
Survival studies of B. thetaiotaomicron Tn MetR in complete medium had shown slower growth 
and metronidazole resistance relative to the parent strain (Chapter 2). It may be possible that the 
metronidazole resistance phenotype in the complete medium may have been due to the slow 
growth. Therefore, in order to determine if B. thetaiotaomicron Tn MetR would still display a 
metronidazole resistance phenotype, it was exposed to metronidazole in a defined medium 
supplemented with L-rhamnose as the sole carbon source, where the mutant grew better than the 
parents strain (Fig 4.2). It was also of interest to determine if overexpression of the rhamnose 
genes was linked to metronidazole resistance. B. thetaiotaomicron (PL YLrhaR) was, therefore, 
also exposed to metronidazole under the same growth conditions as B. thetaiotaomicron Tn 











exposed to 15 J.lg/ml of metronidazole and sampled at different time intervals to monitor 





B. thetaiotaomicron VPI-5482 
B. thetaiotaomicron Tn MetR 
Log surviving fraction after 
40 min in L-rhamnose 
- 2.78 _(± 0.001) 
- 1.65 (± 0.007) 
I 
! 
B. thetaiotaomicron (pL YLrhaR) - 1.88 (± 0.010) 
Table 4.2: Log surviving fraction of the Bacteroides strains exposed to 15 f.lglml of metronidazole in defined broth 
medium supplemented with L-rhamnose as sole carbon source after 40 min. Data represents the mean value of 
three experiments, and the standard deviation for the experiments is shown in brackets (±). 
Exposure of B. thetaiotaomicron Tn MetR and B. thetaiotaomicron (pL YLrhaR) to 
metronidazole in this defined medium showed that they were more resistant to metronidazole 
than B. thetaiotaomicron VPI-5482. This study proved that under these growth conditions, a 
slower growth rate does not contribute to the resistance phenotype in B. thetaiotaomicron Tn 
MetR but was due to increased expression of rhaR. The B. thetaiotaomicron rhaR" mutant did 
not grow in defined medium supplemented with L-rhamnose, therefore, sensitivity to 
metronidazole could not be carried out. 
The metronidazole resistance in B. thetaiotaomicron (PL YLrhaR) was only slightly less than in 
the B. thetaiotaomicron Tn MetR mutant, which may be attributed to the difference in the 
amount of RhaR being expressed by the plasmid. These results showed that overexpressing the 
positive transcriptional regulator, RhaR, of the rhamnose gene cluster in B. thetaiotaomicron 
VPI-5482 contributed to a metronidazole resistance phenotype. This is the first study to report 














4.4.7 Analysis of lactate dehydrogenase and pyruvate oxidoreductase activity in the 
i 
parent and metronidazole resistant strains 	 I 
I 
B. thetaiotaomicron Tn MetR and B. thetaiotaomicron (PLYLrhaR) had been shown to display 
a metronidazole resistance phenotype during growth in the presence rhamnose. In order to I 
determine if increased expression of RhaR had affected the enzymes responsible for I 
f 
metronidazole activation, biochemical studies were undertaken to determine their activity 	 f 
f 
(Table 4.3). Elevated levels oflactate dehydrogenase (LDH) and depleted or undetectable levels I 
I 
I 
of pyruvate oxidoreductase have been implicated in metronidazole resistance (Discussed in 





Strains Lactate dehydrogenase Pyruvate oxidoreductase 
j.tM NADHlmg protein/min j.tM methyl viologen/mg 
protein/min 
B. thetaiotaomicron VPI-5482 3.24 (± 3.27) 0.230 (± 0.06) 
B. thetaiotaomicron Tn MetR 16.23 (± 6.04) 0.035 (± 0.05) 




Table 4.3: Enzymatic activity of lactate dehydrogenase and pyruvate oxidoreductase measured from cell free 
extracts grown anaerobically in the presence of L-rhamnose from B. thetaiotaomicron VPI-5482, 
B. thetaiotaomicron Tn MetR mutant and B. thetaiotaomicron (pL YLrhaR). Data represents the mean value of 
three experiments, and the standard deviation for the experiments is shown in brackets (±). 
The results showed that the lactate dehydrogenase activity of B. thetaiotaomicron Tn MetR and 
B. thetaiotaomicron (pLYLrhaR). during growth in the presence of L-rhamnose, was higher 
than B. thetaiotaomicron VPI-5482. whereas pyruvate oxidoreductase activity in these resistant 
strains was very low in comparison to the parent strain (Table 4.3). These results strongly 
suggest that the lower pyruvate oxidoreductase activity observed in the resistant strains may be 
contributing to the observed metronidazole resistance phenotype since it is a key enzyme 













The mechanism of metronidazole resistance is not well understood. However, in vitro studies 
have shown that resistant strains displayed higher levels of lactate or lactate dehydrogenase and, 
on occasion, no detectable levels of pyruvate oxidoreductase, a key enzyme that is thought to 
activate metronidazole (Edwards, 1993). In summary, Kulda (1999) reported that T. vaginalis 
metronidazole resistant strains had no detectable pyruvate oxidoreductase activity, and a higher 
lactate dehydrogenase activity in comparison to the parent strain. Also reported, is that the 
resistant strains became homolactic ferrnenters, converting 92 % of glucose into lactate (Kulda, 
1999). Metronidazole resistant strains of Giardia duodenalis and T. vaginalis were reported to 
down-regulate pyruvate oxidoreductase and ferredoxin or have no detectable pyruvate 
oxidoreductase activity, respectively (Upcroft et al., 2006). Kaihovaara et al. (1998) showed 
that a metronidazole resistant H pylori strain had lower pyruvate oxidoreductase, and reported 
that metronidazole susceptible strains had lower lactate dehydrogenase activity. No pyruvate 
oxidoreductase activity was detected in C. perfringens metronidazole resistant strains (Sindar et 
al., 1982). 
There have been no reports on lactate dehydrogenase or pyruvate oxidoreductase activity in any 
B. thetaiotaomicron metronidazole resistant strains. However, there have been studies carried 
out on the more pathogenic organism, B. fragilis. N arikawa et al. (1991) reported very high 
levels of lactate dehydrogenase in a B. fragilis metronidazole resistant strain. In a more recent 
study, Diniz et al. (2004) created B. fragilis metronidazole resistant strains and reported that 
lactate dehydrogenase was up-regulated, but flavodoxin was down-regulated and there was no 
detectable pyruvate oxidoreductase activity in the resistant strain. The metronidazole resistance 
in the B. thetaiotaomicron Tn MetR mutant and B. thetaiotaomicron (pL YLrhaR) may be 












In order to evaluate how the transposon insertion in the fucO-rhaR intergenic had affected the 
B. thetaiotaomicron Tn MetR mutant, as well as to determine if the transposon insertion was 
responsible for causing the observed metronidazole resistance phenotype, several physiological, 
genetic and biochemical studies were conducted. The physiological evaluation aimed to 
determine whether the transposon had affected the mutant's ability to utilize L-rhamnose as the 
sole carbon source. It was also used to determine if the metronidazole resistance in this strain 
was related to the slow growth rate observed in complete medium (BHIS) as reported in 
Chapter 2. Growth studies were performed in the defined medium and the results indicated that 
the B. thetaiotaomicron Tn MetR mutant could utilize L -rhamnose, and did so better than the 
parent strain. Resistance to metronidazole was tested under these growth conditions, and the 
results demonstrated that B. thetaiotaomicron Tn MetR was resistant to 15 Ilg/ml of 
metronidazole regardless of the growth rate. 
The increase in growth rate under the inducing conditions was examined at the genetic level by 
determining the transcriptional activity of the genes of the rhamnose operon. In addition, the 
transcription of the genes was also examined under non-inducing conditions revealing that the 
transposon in B. thetaiotaomicron Tn MetR was overexpressing the genes of the rhamnose 
operon in comparison to the parent strain. This was also evident under the inducing conditions. 
In the B. thetaiotaomicron Tn MetR mutant, the transposon is flanked with IS elements. An 
analysis of this strongly suggested that the IS4400L may have formed a strong constitutive 
promoter functioning in conjunction with the existing inducible rhaR promoter of 
B. thetaiotaomicron VPI-5482 as identified in Chapter 3. Increased levels of the positive 











genes. Future studies can be conducted to identify the exact promoter region within the IS 
element by using primer extension or mapping with S'RACE as conducted by Podglagen et al. 
(2001). Since the B. thetaiotaomicron rhaR" strain (Chapter 3) did not utilize Lxhamnose, dot 
blots to show altered transcriptional levels in the defined medium could not be conducted. 
The functionality of the fucO gene product, lactaldehyde reductase, was then examined at the 
biochemical level, where B. thetaiotaomicron Tn MetR was shown to produce L-I,2­
propanediol in equal amounts to the parent strain. These results showed that the fucO gene had 
not been disrupted by the transposon insertion, further confirming that the main effect of the 
transposon insertion was in causing overexpression of the rha genes. Additional biochemical 
studies were conducted to determine the levels of lactate dehydrogenase (LDH) and pyruvate 
oxidoreductase enzymes in the various strains, since both these enzymes are thought to be 
involved in metronidazole resistance. Pyruvate oxidoreductase, in particular, has been reported 
to be involved in metronidazole activation (Narikawa et a1., 1991; Upcroft et al., 2006; Diniz et 
al., 2004). B. thetaiotaomicron Tn MetR was shown to have elevated levels of lactate 
dehydrogenase and depleted levels of pyruvate oxidoreductase in comparison to the parent 
strain under inducing conditions. These finding were consistent with other metronidazole 
resistant strains reported in literature. 
One of the common factors observed in the B. thetaiotaomicron Tn MetR mutant under the 
inducing and non-inducing conditions was the increased transcription of the rha genes. 
Therefore, in order to prove that overexpression of rhaR alone can cause the metronidazole 
resistance phenotype, and to show that no other silent mutations exist in the B. thetaiotaomicron 
Tn MetR mutant, the rhaR gene, together with its own promoter, was introduced into the 















(pL YLrhaR), was also physiologically, genetically and biochemically characterized under 
inducing conditions. B. thetaiotaomicron (pL YLrhaR) was shown to have elevated expression 
of the rha genes in comparison to the parent strain, and displayed resistance to 15 IJglml of 
metronidazole. The biochemical analysis of this strain showed that LDH activity was high and 
pyruvate oxidoreducatase activities were similar to those observed in B. thetaiotaomicron Tn 
MetR. Despite the similar enzymatic activities, the physiological resistance phenotype as well as 
the hybridization activity was not quite as pronounced as that observed in the 
B. thetaiotaomicron Tn MetR mutant, which may have been due to the copy number of 
pL YLrhaR plasmid, resulting in less RhaR being produced than in the B. thetaiotaomicron Tn 
MetR mutant. To alternatively demonstrate and verify the transcriptional activity observed 
between the overexpresser and the parent strain, a qualitative analysis using Real Time peR 
can be preformed in the future. Future studies can focus on two-dimensional electrophoresis as 
conducted by Diniz et al. (2004) to identify differentially expressed proteins between 
B. thetaiotaomicron Tn MetR mutant, B. thetaiotaomicron (PLYLrhaR) and the parent strain 
under inducing and non-inducing conditions. 
A recent study conducted by Manjunatha et al., (2006) showed that certain Mycobacterium 
tuberculosis mutants were resistant to a group of nitroimidazoles including PA-824, a 
nitroimidazole prodrug compound used in the treatment of tuberculosis. The mechanism of 
resistance in these mutants involved the loss of a specific glucose-6-phosphate dehydrogenase 
or its cofactor F 420, deazaflavin, since the two enzymes provide electrons to reduce the drug, 
demonstrating the role of a carbohydrate intermediate in metronidazole resistance. 
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The results of this study conclude that overexpression of the rhamnose operon can cause a 
metronidazole resistance phenotype. This is the first study to report a link between metabolism 
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5.1 General Conclusions 
Metronidazole is a valuable drug for the treatment of Bacteroides infections. However, 
resistance to the drug in clinical isolates of B. fragilis has been reported in several cotmtries 
including South Africa, UK, France, Morocco, India, and Htmgry (Lubbe et al., 1999; Gal and 
Brazier, 2004; Breuill et al., 1989; Haggoud et al., 2001; Chaudry et aI., 2001). Clinical isolates 
of H. pylori and T. vaginalis have also been reported to show resistance to metronidazole 
(Kaihovaara et al., 1998; Upcroft et al., 2006), and these and other organisms are under 
constant study to tmderstand the mechanisms of metronidazole resistance (Upcroft et aI., 2006; 
Diniz et al., 2004; Narikawa et al., 1991; Kaihovaara et aI., 1998; Sindar et al., 1982; Britz and 
Wilkinson, 1979). 
The work presented in the current study was, therefore, designed to focus on the mechanismls 
of metronidazole resistance in a B. thetaiotaomicron transposon-generated metronidazole 
resistant mutant (Casanueva, 2004), with a view to possibly extending the understanding of the 
resistance mechanism in the more pathogenic organism, B. fragilis. The major findings of this 
study led to the conclusion that, overexpression of the rhamnose carbohydrate utilizing 
pathway, via the positive transcriptional regulator, RhaR, in B. thetaiotaomicron VPI-5482 
caused a metronidazole resistance phenotype. Although B. fragilis does not have a rhamnose 
utilizing pathway, it does have a fucose utilizing pathway that is similar to the rhamnose 
pathway and results in the formation of a common metabolic intermediate, L-Iactaldehyde. This 
is metabolized to L-l,2-propanediol via the product of the fucO gene which is located within 
this putative fucose gene cluster in B. fragilis. It is noteworthy that the increasing availability of 
different genome sequence databases establishes the foundation on which comparative 











In this study, the transposon generated metronidazole resistant mutant, B. thetaiotaomicron Tn 
MetR was characterized using a range of experimental approaches. Tang and Malamy (2000) 
reported the possibility of multiple transposon integrations within the chromosome during 
transposon mutagenesis. This was not the case in B. thetaiotaomicron Tn MetR since only a 
single copy of the tetQ gene was found in this strain conferring only tetracycline resistance 
which is the case with an inverse transposition event. No co-integrate or direct transposition 
events had occurred since this strain was not resistant to either tetracycline and erythromycin, 
or erythromycin alone, respectively. The location of the transposon insertion was identified in 
an A-T rich intergenic region between two locus tags, BT3767 and BT3768 of the putative 
rhamnose pathway. Based on the predicted function and amino acid sequence similarity to the 
rhamnose pathway in E. coli, the genes were namedfucO and rhaR respectively. 
Initially, it was observed that B. thetaiotaomicron Tn MetR was resistant to metronidazole in 
complete medium. It also displayed slower growth than the parent, a phenotype resembling 
other reported metronidazole resistant strains (Gal and Brazier, 2004; Sindar et al., 1982; Britz 
and Wilkinson, 1979). It was later shown that the slow growth did not contribute to the 
metronidazole resistance phenotype when the cells were grown in minimal medium 
supplemented with L-rhamnose as the sole carbon source. Here the growth rate of the mutant 
exceeded that of the parent, yet a metronidazole resistance phenotype was still observed. 
Since the transposon had integrated into an intergenic region and no genes were directly 
disrupted, it was important to identify which gene/s were responsible for the metronidazole 
resistance phenotype. Therefore, the putative rhamnose cluster in B. thetaiotaomicron VPI­











how the transposon had affected this carbohydrate pathway and how it was causing a 
metronidazole resistance phenotype. 
Other well-documented studies on rhamnose carbohydrate utilization systems in organisms 
such as E. coli and Rhizobium leguminosarum were used as a platform to address the key 
molecular questions (Moralejo et al., 1993; Powers, 1966; Richardson et al., 2004). Evidence 
presented in this study indicated that the rha gene cluster encodes the rhamnose utilization 
system in B. thetaiotaomicron VPI-5482. Support for this is bioinformatic analysis of the genes. 
In addition, transcriptional analysis of the putative rhamnose cluster confirmed that the six 
ORFs, named rhaK rha/, rhaP, rhaA, fucO and rhaR were induced by the substrate 
L-rhamnose. Of these, five genes (rhaK - fucO) were expressed on a single operon, rhaKIPAO. 
RT-PCR of the 142 bp intergenic region between fucO - rhaR, did not result in a product, 
suggesting that rhaR may be expressed from its own promoter. Bayley et al. (2000) and 
Podglajen et al. (2001) both identified typical B. fragilis promoters containing a -7 and -33 
promoter consensus sequence. Two promoter sites, PrhaKIPAO and P rhaR were identified in this 
study and contained the B. fragilis -7 promoter consensus sequence. However, the -33 promoter 
consensus sequence for both PrhaKIPAO and PrhaR were not those typical of B. fragilis. Instead, the 
-33 regions of both PrhaKIPAO and PrhaR showed a GCGT consensus sequence in 
B. thetaiotaomicron. It is possible that B. thetaiotaomicron may have its own unique -33 
consensus sequences and this warrants further study. 
In this study, it was shown that expression of the rha operon was mediated at the level of 
transcription by RhaR, which was shown to be responsive to L -rhamnose. RhaR functioned as a 
positive transcriptional regulator with similarities to the family of AraClXylS type regulators. A 
rhaR mutant, B. thetaiotaomicron rhaK, was unable to grow in minimal medium supplemented 
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with L-rhamnose as the sole carbon source, although it was able to utilize other carbohydrates 
such as o-glucose and L -fucose. Complementing the B. thetaiotaomicron rhaK mutant with 
RhaR on a plasmid restored growth in the defined medium. The focus of the future work 
should consist of identifying the binding site for RhaR upstream of RhaK using deletion 
mapping of the promoter region and DNA mobility shift assays (Egan and Schleif, 1993). 
Functionality of each of the rhamnose genes should also be confirmed by constructing and 
analyzing mutants with single rhamnose catabolic gene disruptions (Hooper et al., 1999). 
As mentioned earlier. (Section 2.4.2.5, Fig. 2.9) the E. coli rhamnose pathway lacks the fucO 
gene, however, it is found in the fucose pathway. Chen et al. (l987b) reported that anaerobic 
growth of E. coli on rhamnose induced the fucose regulon, including the fucO gene. Single 
mutations in the genes coding for the isomerase, kinase, aldolase and transcriptional regulators 
of both the rhamnose and fucose regulons, prevented rhamnose from inducing the fucose 
regulon. It is possible that a similar process might take place in B. thetaiotaomicron, since this 
organism has both regulons, a difference between this and E. coli being that the fucO gene in 
B. thetaiotaomicron lies within the rhamnose pathway. It would be of interest to determine if 
there is a cross induction ofthe rhamnose pathway by L -fucose in B. thetaiotaomicron. 
The transposon insertion in an intergenic region in B. thetaiotaomicron Tn MetR did not disrupt 
the rhamnose pathway since the mutant was able to grow in minimal medium with 
L -rhamnose as the sole carbon source. The strain displayed better growth in this medium 
compared to the parent, and also displayed a metronidazole resistance phenotype. The effects of 
the transposon insertion were further analyzed to determine whether the fucO gene, upstream of 











A biochemical study was conducted to detennine if fucO had been affected, and the results 
revealed some significant findings. Firstly, the parent strain was shown to produce 
L-l,2-propanediol under anaerobic conditions from cultures grown in L-rhamnose. This 
suggests that rhamnose catabolism in B. thetaiotaomicron VPI-5482 may be similar to E. coli, 
where FucO is responsible for converting L-Iactaldehyde to L-l,2-propanediol anaerobically 
(Boronat and Aguilar, 1981). Secondly, the ability of B. thetaiotaomicron Tn MetR to produce 
L-l,2-propanediol at the same levels as the parent strain confinned that the fucO gene was 
unaffected by the transposon and that there was active fonnation of FucO protein in order for 
the reaction to proceed. 
Transcriptional hybridization studies showed that the transposon insertion in the mutant had 
increased the expression of the rhaR gene coding for the positive transcriptional regulator, and 
subsequently the rest of the rhamnose pathway. While there is no conclusive evidence as to why 
increased transcription of rhaR was observed in B. thetaiotaomicron Tn MetR, it was proposed 
that the insertion sequence element on the transposon was acting as an addition constitutive 
promoter activating the genes (Schneider and Lenski 2004; Barker et ai., 2004; Soki et ai., 
2004; Podglajen et ai., 2001; Kallastu et ai., 1998; Mahillon et al., 1999). In support of this, 
nucleotide sequencing of IS4400L, which lies upstream of rhaR, identified three putative 
promoter sequences. Furthennore, B. thetaiotaomicron Tn MetR was shown to express the 
rhamnose catabolic genes under non-inducing conditions in comparison to the parent strain. 
Together, this evidence strongly suggested that IS4400L could be transcribing the positive 
transcriptional regulator, RhaR, even in the absence of the substrate, and thus causing the 
expression of the rhamnose genes. Future studies should involve identifying these possible 














A unique observation investigated in this study, was that the increased expression of the 
rhamnose genes resulted in a metronidazole resistance phenotype in B. thetaiotaomicron Tn 
MetR. This was confirmed to be the cause of the metronidazole resistance phenotype, since the 
RhaR overexpressor, B. thetaiotaomicron (pL YLrhaR), containing an additional copy of rhaR 
on a plasmid, also displayed metronidazole resistance in minimal medium supplemented with 
L-rhamnose as the sole carbon source. This result confirmed that no other undetected mutations 
conferring metronidazole resistance existed within B. thetaiotaomicron Tn MetR. 
Inefficient activation of metronidazole within the bacterial cells has been shown to be a 
mechanism of metronidazole resistance. A key enzyme thought to be involved in this 
mechanism of activation is pyruvate oxidoreductase, which is coupled with either ferredoxins 
or flavodoxin. The decarboxylation of pyruvate via the pyruvate oxidoreductase generates 
electrons that activate the drug. However, in certain metronidazole resistant strains, levels of 
lactate dehydrogenase are higher and levels of pyruvate oxidoreductase are lower in comparison 
to the parent strains (Diniz et ai., 2004; Upcroft et al., 2006; Narikawa et al., 1991). In this 
study, increased enzymatic activity of lactate dehydrogenase and decreased pyruvate 
oxidoreductase in the resistant strains, B. thetaiotaomicron Tn MetR and B. thetaiotaomicron 
(PL YLrhaR), supported the findings in literature. 
Based on this information and the overall findings of this study, two possible models will now 













5.1.1 Modell: Decreased activation of metronidazole through reduced pyruvate 
oxidoreductase activity 
If rhamnose catabolism in B. thetaiotaomicron yields L-Iactaldehyde and dihydroxyacetone 
phosphate (DHAP), then DHAP would be isomerized to glyceraldehyde phosphate (GAP) 
(Prestwich, 2004) and in turn participate in pyruvate metabolism. Decarboxylation of pyruvate 
(Chapter 1) would then lead to the formation of Acetyl CoA and the electrons generated would 
be used to activate metronidazole. 
RhaP, RhaI, RhaK 
L-rhamnose • L-rhamnulose-1-phosphate 
FucO •L-1,2-propanedio1 
~  .. 
NAD NADH GAP .. 
PEP 
LDH 
L-Iactate .~--......;;;=----------"•• Pyruvate 
Me~Clivalion ... e- J1 
+ 
~ - POR 
Acetyl CoA 
Dihydroxyacetone phosphate 
Figure 5.1: Proposed model for the metronidazole resistance phenotype in B. thetaiotaomicron Tn MetR and the 
B. thetaiotaomicron (PL YLrhaR) overexpressor. RbaP, RhaI, RbaK, RhaA, FucO represent, rhamnose symporter, 
rhamnose isomerase, rhamnulose kinase, rhamnulose-l-phosphate aldolase, and lactaldehyde reductase, 
respectively. GAP, PEP, LDH and POR represents glyceraldehyde phosphate, phosphoenol pyruvate, lactate 
dehydrogenase and pyruvate (ferredoxins/flavodoxin) oxidoreductase, respectively. e' donation to activate 
metronidazole is represented with a blue arrow. 
However, if increased levels of rhamnose catabolism cause a shift in the metabolic pathway, 











lactate dehydrogenase (LDH) as reported in E. coli (Boronat and Aguilar, 1981). The 
concurrent reduction in pyruvate oxidoreductase activity would then lead to a decrease in 
metronidazole activation and account for the increased resistance observed in this study. 
Furthermore, since the resistance to metronidazole in B. thetaiotaomicron Tn MetR mutant was 
observed in complete medium, the resistance may not be solely linked to rhamnose utilization. 
However, this strain did also grow slower in the complete medium which may explain the why 
the resistance was observed in the complete medium. 
5.1.2 Model 2: Reduction of metronidazole to an inactive compound 
Overexpression of one or more of the rhamnose catabolic genes may have directly affected the 
amount of activated metronidazole formed through reducing it to an inactive compound. For 
example, organisms containing nitroreductases, such as Enterococcus casseliflavus and 
Enterococcus galliniarum were shown to be resistant to metronidazole (Rafii et al., 2003). It 
was reported that the nitroreductase identified in these strains should have reduced the drug, but 
the active form was not detected. It has also been reported that, like the nim genes, these 
nitroreductases may not metabolize metronidazole into toxic compounds since metronidazole 
susceptible Clostridium perfringens were reported to grow well in spent cultures of the 
Enterococcus spp. that were incubated with metronidazole (Rafii et al., 2003). 
In B. thetaiotaomicron Tn MetR, it may be possible that overexpreSSIOn of lactaldehyde I 
oxidoreductase, which IS an NAD-dependent dehydrogenase, and like the pyruvate l 
I
oxidoreductase contains an iron cluster, may also reduce intracellular metronidazole, but not ! 
Iresult in an activated compound. There are no reports of L-l,2-propanediol oxidoreductase I 
having any flavodoxins or ferredoxins dependent mechanisms in B. thetaiotaomicron. 
However, in S. typhimurium, it is reported that propanediol metabolism results in excretion of 
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propanol into the medium and this provides the cells with an electron sink to help balance redox 
reactions (Walter ef ai., 1997). It would, therefore, be of interest to investigate, in vitro, if 
metronidazole can be reduced by the L-I,2-propanediol oxidoreductase, in the presence of 
ferredoxins or flavodoxins, and whether the product would be in the toxic or non-toxic form. 
It is also a possibility that any of the genes in the rhamnose operon may be responsible for 
causing a metronidazole resistance phenotype. Future studies may including making single 
point mutations in each of the gene and determine the mutant's sensitivity to metronidazole. 
Alternatively, knocking out the first gene, i.e. rhaK, and introducing an additional copy of the 
regulator in this mutant on a plasmid would determine is rhamnose is solely responsible for 
metronidazole sensitivity. Finally, it is also unknown if RhaR may be controlling the 
expression of some other genes out side of the rhamnose gene cluster. 
The linking of metronidazole resistance to carbohydrate metabolism is potentially of clinical 
importance and warrants further study in the presence of carbon sources other than rhamnose. 
Future studies should also address the possible role of the NAD(P)-linked dehydrogenase, 
FucO, in metronidazole reduction, since the fucO gene is also found in the fucose pathway of 
the more pathogenic organism, B. fragilis. This may provide further insight into the various 












Abbe K, Takahashi S and Yamada T. (1982) Involvement of oxygen-sensitive pyruvate formate-lyase in 
mixed-acid formation by Streptococcus mutans under strictly anaerobic conditions. Journal of 
Bacteriology. 152: 175-82. 
Abrabams GL and Abratt VR. (I998} The NADH-dependent glutamate dehydrogenase enzyme of 
Bacteroidesjragilis bfl is induced by peptides in the growth medium. Microbiology. 144: 1659-1657. 
Abratt VR, Jones DT and Woods DR. (1985) Isolation and Physiological Characterization of Mitomycin 
C-SensitiveIUV-Sensitive Mutants in Bacteroides fragilis. Journal of General Microbiology. 131: 2479­
2483. 
Abratt VR, Lindsey GL and Woods DR. (1986) Pyrimidine Dimer Excision Repair of DNA in 
Bacteroides jragilis Wild-Type and Mitomycin C-SensitiveIUV-Sensitive Mutants. Journal of General 
Microbiology. 132: 2577-2581. 
Abratt VR, Peak MJ, Peak JG, Santangelo JD and Woods DR (1990) Induction and Repair of DNA f 




Aiba H, Adhya S and de Crombrugghe B. (1981) Evidence for Two Functional gal Promoters in Intact [
Escherichia coli cells. Journal ofBiological Chemistry. 256: 11905-11910. i 
Akimoto S, Ono T, Tsutsui H, Kinouchi T, Kataoka K and Ohnishi Y. (1994) Complete Sequence of I 
the Bacteroides jragilis YCH46 Neuraminidase-Encoding Gene. Biochemical and Biophysical Research 
Communications. 203: 914-921. IAltschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller Wand Lipman DJ. (1997) Gapped ! 
BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Research. 
25: 3389-3402. 
Anderson KL and Salyers AA. (1989) Biochemical Evidence that Starch Breakdown by Bacteroides 
thetaiotaomicron Involves Outer Membrane Starch-Binding Sites and Periplasmic Starch-Degrading 
Enzymes. Journal ofBacteriology. 171: 3192-3198. 
Arthur M, Brisson-Noel A and CourvaJin P. (1987) Origin and Evolution of Genes Specifying 
Resistance to Macrolide, Lincosamide and Streptogramin Antibiotics: Data and Hypotheses. Journal 0/ 
Antimicrobial Chemotherapy. 20: 783-802. 
Baggio L and Morrison M. (1996) The NAD(P)H-Utilizing Glutamate Dehydrogenase of Bacteroides 
thetaiotaomicron Belongs to Enzyme Family I, and its Activity Is Affected by Trans-Acting Gene(s) 
positioned Downstream ofGdhA. Journal ofBacteriology. 178: 7212-7220. 
Baldoma L and Aguilar J. (1988) Metabolism of ducose and L-rhamnose in Escherichia coli: aerobic­
anaerobic regulation of L-Iactaldehyde dissimilation. Journal ofBacteriology. 170: 416-421. 
Barker CS, Pruss BM, Matsumura P. (2004) Increased motility of Escherichia coli by insertion 















Baughn AD and Malamy MH. (2002) A mitochonrdrial-Iike aconitase in the bacterium Bacteroides 
fragilis: implication for the evolution of the mitochonrdrial Krebs cycle. Proceedings 0/ the National 
Academy o/Sciences o/the United States 0/America. 7: 4662-7. 
Bayley DP, Rocha ER and Smith CJ. (2000) Analysis of cepA and other Bacteroides /ragilis genes 
reveals a unique promoter structure. FEMS Microbiology Letters. 193: 149-154. 
Boronat A and Aguilar J. (1981) Metabolism of L-Fucose and L-Rhamnose in Escherichia coli: 
Differences in Induction ofPropanediol Oxidoreductase. Journal 0/Bacteriology. 147: 181-185. 
Breuill J, Burnat C, Patey 0 and Dublanchet A. (1989) Survey of Bacteroides fragilis susceptibility 
patterns in France. Journal 0/Antimicrobial Chemotherapy. 24: 69-75. 
Briselden AM, Moncla BJ, Stevens CE and Hillier SL. (1992) Sialidase (Neuraminidases) in Bacterial 
Vaginosis and Bacterial Vaginosis-Associated Microflora. Journal o/Clinical Microbiology. 30: 663-666. 
Britz ML and Wilkinson RG. (1979) Isolation and Properties of Metronidazole-Resistant Mutants of 
Bacteroides /ragilis. Antimicrobial Agents and Chemotherapy. 16: 19-27. 
Burt S, Meldrum S, Woods DR and Jones DT. (1978) Colonial Variation, Capsule Formation, and 
Bacteriophage Resistance in Bacteroides thetaiotaomicron. Applied and Environmental Microbiology. 35: 
439-443. 
Carlos MC, Carlos ZC, Hecht DW, Citron DM, Goldenstien EJC, Silva J, Feldman TY and RodIoff 
AC. (2006) Characterization of the Bacteroides fragilis pathogenicity island in human blood cultures. 
Anaerobe. 1: 17-22. 
Casaneuva A. (2004) Identification of Bacteroides metronidazole resistant genes. Thesis for the degree of 
Doctor of Philosophy. University ofCape Town. 
Cerdeno-Tarraga AM, Patrick S, Crossman LC, Blakely G, Abratt V, Lennard N, Poxton I et aI., 
(2005) Extensive DNA Inversion in the B. fragilis Genome Control Variable Gene Expression. Science. 
307: 1463-65. 
Chang KC, HoSW, Yang JC and Wang JT. (1997) Isolation of a genetic locus associated with 
metronidazole resistant in Helicobacter pylori. Biochemical and Biophysical Research Communications. 
236: 785-788. 
ChaudryR, Mathur P, Dhawan B and Kumar L. (2001) Emergence of metronidazole resistant 
Bacteroidesfragilis in India. Emerging Infectious Diseases. 7: 485-486. 
Chen T, Dong H, Tang YP, Dallas MM, Malamy MH, Duncan MJ. (2000) Identification and Cloning 
of Genes from Porphyromonas gingivalis after Mutagenesis with a Modified Tn4400' Transposon from 
Bacteroides fragilis. Infection and Immunity. 68: 420-423. 
Chen Y, Kinouchi T, Kataoka K, Akimoto S, Ohnishi Y. (1995) Purification and Characterization ofa 
Fibrinogen-Degrading Protease in Bacteroides /ragilis Strain YCH46. Microbiology and Immunology. 39: 
967-977. 
Chen YM, Lu Z and Lin ECC. (1987a) NAD-Linked Aldehyde Dehydrogenase for Aerobic Utilization 











Cben YM, Tobin JF, Zbu Y, Scbleif RF, and Lin E C (1987b) Cross-induction of the L-fucose system 
by L-rhamnose in Escherichia coli. Journal ofBacteriology. 169: 3712-3719. 
Cheng Q, Yu MC, Reeves AR and Salyers AA. (1995) Identification and Characterization of a 
Bacteroides Gene, csuF, which encodes an Outer Membrane Protein that Is Essential for Growth on 
chondroitin sulphate. Journal ofBacteriology. 177: 3721-3727. 
Cheng Q, Paszkiet BJ, Shoemaker NB, Gardner JF and Salyers AA. (2000) Integration and Excision 
of a Bacteroides Conjugative Transposon, CTnDOT. Journal ofBacteriology. 182: 4035-4043. 
Cheng Q, Suntanto Y, Sboemaker NB, Gardner JF and Salyers AA. (2001) Identification of genes 
required for excision of CTnDOT, a Bacteroides conjugative transposon. Molecular Microbiology. 41: 
625-632. 
Cho KH, Cbo D, Wang GR and Salyers AA. (2001) New regulatory gene that contributed to control of 
Bacteroides thetaiotaomicron starch utilization genes. Journal ofBacteriology. 183: 7198-7205. 
Churcb DL and Laishley EJ. (1995) Reduction of Metronidazole by Hydrogenase from Clostridia. 
Anaerobe. 1: 81-92. 
Ciampi MS, Scbmid MB and Roth JR. (1982) Transposon TnlO provides a promoter for transcription of 
adjacent sequences. Proceedings ofthe National Academy ofSciences ofthe United States ofAmerica. 16: 
5016-20. 
Comstock LE and Coyne MJ. (2003) Bacteroides thetaiotaomicron: a Dynamic, Niche-Adapted Human 
Symbiont. BioEssays. 25: 926-929. 
Comstock LE, Coyne MJ, Tzianabos AO and Kasper DL. (1999a) Inter-strain Variation of the 
polysaccharide B Biosynthesis Locus of Bacteroides fragilis: Characterization of the Region from Strain 
638R. Journal ofBacteriology. 181: 6192-6196. 
Comstock LE, Coyne MJ, Tzianabos AO, Pantosti A, Onderdonk AB and Kasper DL. (I 999b) 
Analysis of a Capsular polysaccharide Biosynthesis Locus of Bacteroides fragilis. Infection and Immunity. 
67: 3525-3532. 
Cooper AJ, Kalinowski AP, Shoemaker NB and Salyers AA. (1997) Construction and Characterization 
of a Bacteroides thetaiotaomicron recA Mutant: Transfer of Bacteroides Integrated Conjugative Elements Is 
RecA Independent. Journal ofBacteriology. 179: 6221-6227. 
Cox MM. (1995) Alibrnment of 3 (but not 4) DNA Strands within a RecA Protein Filament. Journal of 
Biological Chemistry. 270: 26021-26024. 
Coyne MJ, Kalka-Moll W, Tzianabos AO, Kasper DL and Comstock LE. (2000) Bacteroides fragilis 
NCTC9343 Produces at Least Three Distinct Capsular Polysaccharides: Cloning, Characterization, and 
Reassignment of Polysaccharide Band C Biosynthesis Loci. Infection and Immunity. 68: 6176-6181. 
Coyne MJ, Reinap B, Lee MM and Comstock LE. (2005) Human Symbionts Use a Host-Like Pathway 











~ , ,,'" 
Coyne MJ, Tzianabos AO, Mallory Be, Carey VJ, Kasper DL and Comstock LE. (2001) 
Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis. Infection and Immunity. 
69: 4342-4350. 
Coyne MJ, Weinacht KG, Krinos CM and Comstock LE. (2003) Mpi Recombinase Globally 
Modulates the Surface Architecture of a Human Commensal Bacterium. Proceedings of the National 
Academy ofSciences ofthe United States ofAmerica. 100: 10446-10451. 
Cummings JR. (1984) Colonic absorption: the importance of short chain fatty acids in man. 
Scandinavian Journal ofGastroenterology. 93: 89-99. 
D'Elia IN and Salyers AA. (l996a) Contribution of a Neopullulanase, a Pullulanse, and an a-Glucosidase 
to Growth ofBacteroides thetaiotaomicron on Starch. Journal ofBacteriology. 178: 7173-7179. 
D'Elia IN and Salyers AA. (1996b) Effect of Regulatory Protein Levels on Utilization of Starch by 
Bacteroides thetaiotaomicron. Journal ofBacteriology. 178: 7180-86. 
Dachs GU, Abratt VR and Woods DR. (1995) Mode of Action of Metronidazole and a Bacteroides 
fragilis metA Resistance Gene in Escherichia coli. Journal ofAntimicrobial Chemotherapy. 35: 483-496. 
Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ. (2004) Differential gene expression in a 
Bacteroides fragilis metronidazole-resistant mutant. Journal ofAntimicrobial Chemotherapy. 54: 100-8 
Dinz CG, Santose SG, Pestana ACNR, Farias LM and Carvalho MAR. (2000) Chromosomal Breakage 
in the B. fragilis group induced by Metronidazole Treatment. Anaerobe. 6: 149-153. 
Dunne RL, Dunn LA, Upcroft P, O'Donoghue J and Upcroft JA. (2003) Drug resistance in the 
sexually transmitted protozoan Trichomonas vaginalis. Cell Research. 13: 239-249. 
Edwards DI. (1980) Antimicrobial Drug Action, p235-243. MacMillan Press Ltd., London. 
Edwards DI. (1993) Nitroimidazole drugs-action and resistance mechanisms. Review. Journal of 
Antimicrobial Chemotherapy. 31: 9-20 
Egan SM and Schleif RF. (1993) A regulatory cascade in the inducation of rhaBAD. Journal of 
Molecular Biology. 234:87-98. 
Eikmanns BJN, Thumb-Shmitz L. Eggeling KU, LUdtke and Sahm H. (1994) Nucleotide sequence, 
expression and transcriptional analysis of the Corynebacterium glutamicum gltA gene encoding citrate 
synthase. Microbiology. 140: 1817 -1828. 
Fang H, Edlund C, Hedberg M and Nord CEo (2002a) New Findings in beta-lactam and metronidazole 
resistant Bacteroides fragilis group. International Journal ofAntimicrobial Agents. 19: 361-70. 
Fang H, Edlund C, Nord CE and Hedburg M. (2002b) Selection of Cefotoxin-Resistant Bacteroides 
thetaiotaomicron mutants and Mechanisms involved in p-Lactam Resistance. Clinical Infectious Diseases. 
35: S47-53. 
Fang H, Hedberg M, Edlund C, Jarstand C, Fordor E and Nord CEo (1999) Characterization of p­














Fourney RM, Miyakoshi J, Day RS III, and Paterson Me. (1988) Northern blotting: efficient RNA 
staining and transfer. Focus. 10: 5-7. 
Franco AA, Cheng R, Chung GT Wu S, Oh HB and Sears CL. (1999) Molecular Evolution of the 
Pathogenicity Island of Enterotoxigenic Bacteroides fragilis Strains. Journal 0/Bacteriology. 181: 6623­
6633. 
Friedberg EC, Walker GC aod Siede W. (1995) DNA Repair and Mutagenesis. American Society for 
Microbiology Press. Washington DC, 191-232,440-456. 
Fuller MF and Reeds PJ. (1998) Nitrogen cycling in the gut. Annual Review o/Nutrition. 18: 385-411. 
Fuloo I, Pierard D, Muyldermans G Vandoorslaer ~ Soetens O. Roseel P, Lauwers S. (2003) 
Prevalence of Fragilysin Gene in Bacteroides fragilis Isolates from Blood and Other Extraintestinal 
Samples. Journal o/Clinical Microbiology. 41: 4428-4430. 
Gal M and Brazier JS. (2004) Metronidazole resistance in Bacteroides spp. carrying nim genes and the 
selection of slow-growing metronidazole resistant mutants. Journal 0/Antimicrobial Chemotherapy. 54: 
109-116. 
Gallegos MT, Schleif R, Bairoch A, HotTman K and Ramos JL. (1997) AraC/XyIS Family of 
Transcriptional Regulators. Microbiology and Molecular Biology Reviews. 61: 393-410. 
Gibson FC yd, Onderdonk AB, Kasper DI and Tzianabos AO. (1998) Cellular Mechanism of Intra­
abdominal Abscess Formation by Bacteroidesfragilis. Journalo/Immunology. 160: 5000-5006. 
Gibson SA and Macfarlane GT. (1988a) Studies on the Proteolytic Activity of Bacteroides fragilis. 
Journal o/General Microbiology. 134: 19-27. 
Gibson SA and Macfarlane GT. (1988b) Characterization of Proteases formed by Bacteroides fragilis. 
Journal o/General Microbiology. 134: 2231-2240. 
Gibson SA, McFarlane C, Hay S and MacFarlane GT. (1989) Significance of microflora in proteolysis 
in the colon. Applied Environmental Microbiology. 55: 679-83. 
Godoy VG, Dallas MM, Russo TA and Malamy MH. (1993) A Role for Bacteroides fragilis 
Neuraminidase in Bacterial Growth in Two Model Systems. Infection and Immunity. 61: 4415-4426. 
Goodman HJK, Parker JR, Southern JA and Woods DR. (1987) Cloning and Expression in 
Escherichia coli of a recA-Like Gene from Bacteroides /ragilis. Gene. 58: 265-271. 
Guiney DG, Hasegawa P and Davis CEo (1984) Plasmid Transfer from Escherichia coli to Bacteroides 
fragilis: Differential Expression of Antibiotic Resistance Phenotypes. Proceedings o/the National Academy 
o/Sciences o/the United States 0/America. 81: 7203-7206. 
Gupta A, V1amakis H, Shoemaker N and Salyers AA. (2003) A New Bacteroides Conjugative 
Transposon That Carries an ernB Gene. Applied and Environmental Microbiology. 69: 6455-6463. 
Haggoud A, M'Hand RA, Reysset G, M'Daghir EI, Benbachir M and Moumni M. (2001) Prevalence 
and characteristics of nim genes encoding 5-nitroimidazole resistance among Bacteroides strains isolated in 























Haggoud A, Trinh S, Moumni M and Reysset G. (1995) Genetic Analysis of the Minimal Replicon of 
Plasmid pIP417 and Comparison with the Other Encoding 5-Nitroimidazole Resistance Plasmids from 
Bacteroides spp. Plasmid. 34: 132-143. 
Holdeman LV and Moore WECo (1972) Anaerobe Laboratory Manual. 4th Ed. Virginia Polytechnic 
Institute and State University Anaerobe Laboratory, Blacksburg, V A. 
Holdeman LV, Kelly RW and Moore WECo (1984) Genus I. Bacteroides Castellani and Chalmers 1919, 
1959. In Bergeys Manual ofSystematic Bacteriology, pp 604-631. Edited by Krieg, N. R. and Holt, 1. G. 
Williams and Wilkins. Baltimore. 
Hooper LV, Xu J, Falk PG, Midtvedt T and Gordon JI. (1999) A Molecular Sensor that Allows a Gut 
Commensal to Control its Nutrient Foundation in a Competitive Ecosystem. Proceedings of the National 
Academy ofSciences ofthe United States ofAmerica. 96: 9833-9838. 
Hylemon PB, Fricke RJ, Kubaska WM, Cohen BI, Mosbach EH. (1983) Metabolism of bile acid 
oxazoline derivatives by hepatocyte monolayer cultures and intestinal anaerobic bacteria. Steroides. 42: 
!105-14. 
f 
Ingham HR, Eaton S, Venables CW and Adams PC. (1978) Bacteroides fragilis Resistant to J 
Metronidazole after Long-Term Therapy. Lancet. 214. i 
! 
Ingham HR, Hall CJ, Sisson PR, Tharagonnet D and Selkon JB. (1980) The Activity of Metronidazole 
against Facultative Anaerobic Bacteria. Journal ofAntimicrobial Chemotherapy. 6: 343-347. ! 
IIrino N, Nakayama K and Nakayama H. (1986) The recQ Gene of Escherichia coli K12: Primary 
Structure and Evidence for SOS Regulation. Molecular and General Genetics. 205: 298-304. 
Ishikura H, Arakawa S, Nakajima T, Tsuchida N and Ishikawa I. (2003) Cloning of the Tannerella 
forsyntensis (Bacteroides forsythus) siaHI gene and purification of the sialidase enzyme. Journal of I
Medical Microbiology. 52: 1101-07. I 
f 
Ivancic-Bace I, Salaj-Smic E and Brcic-Kostic K. (2005) Effects of recJ, recQ and recFOR mutations 
on recombination in nuclease-deficient recB recD double mutants of Escherichia coli. Journal of 
Bacteriology. 187: 1350-1356. 
Ivancic-Bace I, Vlasic I, Salaj-Smic E and Brcic-Kostic K. (2006) Genetic Evidence for the 
Requirement of RecA Loading Activity in SOS induction after UV Irradiation in Escherichia coli. Journal 
ofBacteriology. 188: 5024-5032. 
Jenkins S. (200 I) Infections due to anaerobic bacteria and the role of antimicrobial susceptibility testing of 
anaerobes. Reviews in Medical Microbiology. 12: 1-12. 
Johnson JL and Ault DA. (1978) Taxonomy of the Bacteroides. n. Correlation of phenotypic 
characteristics with deoxyribonucleic acid homology grouping for Bacteroides fragilis and other 
saccharolytic Bacteroides species. International Journal ofSystemic Bacteriology. 28: 257-68. 
Jones LR and Riddick JA. (1957) Colorimetric Determination of 1,2-propanediol and Related 











Kaihovaara P, Nikanne JH, Oukari MV, Kosunen TV and Salaspuro M. (1998) Flavodoxin-dependent 
pyruvate oxidation, acetate production and Metronidazole reduction by Helicobacter pylori. Journal of 
Antimicrobial Agents and Chemotherapy. 41: 171-177. 
Kallastu A, Horak Rand Kivisaar M. (1998) Identi fication and Characterization of IS1411, a New 
Insertion Sequence Which Causes Transcriptional Activation of the Phenol Degradation Genes in 
Pseudomonas putida. Journal ofBacteriology. 180: 5306-12. 
Koch RL and Goldman P. (1979) The Anaerobic Metabolism of Metronidazole Forms N-(2­
Hydroxyethyl)-Oxamic Acid. Journal ofPharmacology and Experimental Therapeutics. 208: 406-410. 
Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DI and Comstock LE. (2001) 
Extensive Surface Diversity of a Commensal Microorganism by Multiple DNA Inversions. Nature. 414: 
555-558. 
Kulda J, Tachezy J and Cerkasovova A. (1993) In Vitro Induced Anaerobic Resistance to Metronidazole 
in Trichomonas vaginalis. Journal ofeukaryotic Microbiology. 40: 262-269. 
Kulda J. (1999) Trichomonads, hydrogenosomes and drug resistance. International Journal for 
Parasitology. 29: 199-212. 
Kullin B, Abratt VR and Reid SJ. (2006) A functional analysis of the Bifidobacterium longum cscA and 
scrP genes in sucrose utilization. Applied Microbiology and Biotechnology. Epublished ahead of print. 
Kuwahara T, Yamashita A, Hirakawa H, Nakayama H, Toh H, Okada N, Kuhara S, Hattori M, 
Hayashi T and Ohnishi Y. (2004) Genomic Analysis of Bacteroides fragilis Reveals Extensive DNA 
Inversions Regulating Cell Surface Adaptation. Proceedings of the National Academy of Sciences of the 
United States ofAmerica. 101: 14919-14924. 
Kuzminov A. (1999) Recombinational Repair of DNA Damage in Escherichia coli and Bacteriophage A. 
Microbiology and Molecular Biology Reviews. 63: 751-813. 
Kwon DH, EI-Zataari FAK, Kato M, Osato MS, Reddy R, Yamaoka Y and Graham DY. (2000) 
Analysis of rdxA and Involvement of Additional genes Encoding NAD(P)H Flavin Oxidoreductase (FrxA) 
and Ferredoxin-Like Protein (FdxB) in Metronidazole Resistance of Helicobacter pylori. Antimicrobial 
Agents and Chemotherapy. 44: 2133-2142. 
Leiros HKS, Kozielski-Stuhrmann S, Kapp V, Terradot L, Leonard GA and McSweeney M. (2004) 
Structural Basis of 5-Nitroimidazole Antibiotic Resistance: the crystal structure ofNimA from Deinococcus 
radiodurans. Journal ofBiological Chemistry. 279: 55840-55849. 
Li LY, Shoemaker NB and Salyers AA. (1995). Location and Characteristics of the Transfer Region ofa 
Bacteroides Conjugative Transposon and Regulation of Transfer Genes. Journal of Bacteriology. 177: 
4992-4999. 
Lindmark DG and Muller M. (1973) Hydrogenosome, a Cytoplasmic Organelle of the Anaerobic 
Flagellate Tritrichomonas foetus, and its Role in Pyruvate Metabolism. Journal of Biological Chemistry. 
248: 7724-7728. 
Linn SP, Chan T and Salyers AA. (1983) Isolation and Characterization of Two Chondroitin Lyases 
from Bacteroides thetaiotaomicron. Journal ofBacteriology. 156: 859-866. 
124 
" .. , ... ,""'" K :;l tam::
 
l
In .. ,..",. 
l  










Lubbe MM, Stanley K, Chalkley LJ. (1999) Prevalence of nim genes in anaerobic/facultative anaerobic 
bacteria isolated in South Africa. FEMS Microbiology Letters. 172: 79-83. 
MacFarlane GT and (~ibson GR. (1991) Utilization of pancreatic trypsin by proteolytic and non­
proteolytic Bacteroides fragilis type bacteria. Current Microbiology. 23: 143-148. 
MacFarlane GT, Cummings JH and Allison C. (1986) Protein Degradation by Human Intestinal 
Bacteria. Journal ofGeneral Microbiology. 6: 1647-56. 
Macrina FL and Smith CJ. (1992) Gene transmission, MLS, and tetracycline resistance in Bacteroides. 
In Genetics and Molecular Biology of Anaerobic bacteria. Edited by Sebald M. Springer-Verlag, New 
York. 
Mahillon J and Chandler M. (1998) Insertion sequences. Microbiology and Molecular Biology Reviews 
3: 725-774. 
Mahillon J, Leonard C and Chandler M. (1999) IS elements and constituents of bacterial genomes. 
Research in Microbiology. 150: 675-687. 
Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, Norton JE, Daniels L, Dick T, Pang SS 
and Barry CEo (2006). Identification of a nitroirnidazo-oxazine-specific protein involved in PA-824 
resistance in Mycobacterium tuberculosis. Proceedings ofthe National Academy ofSciences ofthe United 
States ofAmerica. 103: 431-436. 
Marais A, Bilardi C, Cantet F, Mendez GL and Megrand F. (2003) Characterization of the rdxA and 
frxA involved in metronidazole resistance in Helicobacter pylori. Research in Microbiology. 154: 137-144. 
Menendez D, Rojas E, Herrera LA, Lopez MC, Sordo M, Elizondo G and Wegman PC. (2001) DNA 
breakage due to Metronidazole Treatment. Mutation Research. 478: 153-158. 
Menon KP and Lee NL. (1990) Activation of ara operons by a truncated AraC protein does not require 
inducer. Proceedings ofthe National Academy ofSciences ofthe United States ofAmerica. 10: 3708-12. 
Merrick MJ and Edwards RA. (1995) Nitrogen control in Bacteria. Microbiology Review. 59: 604-622. 
Miyamae S, Veda 0, Yoshimura F, Hwang J, Tanaka Y and Nikaido H. (2001) A MATE Family I
Multidrug Efflux Transporter Pump out Fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrobial 
Agents and Chemotherapy. 45: 3341-3346. 
Moncrief JS, Duncan AJ, Wright RL, Barroso LA and Wilkins TD. (1998) Molecular Characterization I 

of the FragiJysin Pathogenicity Islet of Enterotoxigenic Bacteroides fragilis. Infection and Immunity. 66: 
1735-1739. I 

Montella C, Bellsolell L, PereZ-Luque R, Badia J, Baldoma L, Coli M and Aquilar J. (2005) Crystal 
Structure of an Iron-Dependent Group III Dehydrogenase That lnterconverts L-Lactaldehyde and L-l,2­
propanediol in Escherichia coli. Journal ofBacteriology. 187: 4957-4966. 
Moon K, Shoemaker NB, Gardener JF and Salyers AA. (2005). Regulation of Excision Genes of the 




r",,.,.,e..,.n,,n ... n . 
-
lYlO.teClUur rHFlIIFlC"J  
rO'DlCILOI:!'V U\J..,' U<CL..
i  Hnr-/PY'.niri,o", if! tc.!int,am:nicjra  










Moore RA, Beckthold B and Bryan LE. (1995) Metronidazole Uptake in Helicobacter pylori. Canadian 
Journal ofMicrobiology. 41: 746-749. 
Moralejo P, Egan SM, Hidalgo E and Aguilar J. (1993) Sequencing and Characterization of a Gene 
Cluster Encoding the Enzymes for L-rhamnose Metabolism in Escherichia coli. Journal ofBacteriology. 
175: 5585-5594. 
Mortenson LE, Valentine RC and Carnahan JE. (1963) Ferredoxin in the Phosphoroclastic Reaction of 
Pyruvic Acid and its relation to Nitrogen Fixation in Clostridium pasteurianum. Journal of Biological 
Chemistry. 238: 794-800. 
Muller M and Lindmark DG. (1976) Uptake of Metronidazole and its Effect on Viability in 
trichomonads and Entamoeba invadens under Anaerobic and Aerobic Conditions. Antimicrobial Agents and 
Chemotherapy. 9: 696-700. 




Narikawa S, Suzuki T, Yamamoto M and Nakamura M. (1991) Lactate Dehydrogenase Activity as a 
Cause of Metronidazole Resistance in Bacteroides fragilis NCTC 11295. Journal of Antimicrobial i 
Chemotherapy. 28: 47-53. I 
!
Neu He. (1995) Emergence and Mechanisms of Bacterial Resistance in Surgical Infections. American 
Journal ofSurgery. 169: S13-S20. 
Nishitani J and Wilcox G. (1991) Cloning and characterization of the L-rhamnose regulon in Salmonella ! 
typhimurium LT2. Gene. 105: 37-42. !
Obradors N, Cabiscol E, Aguilar J and Ros J. (1998) Site-Directed Mutagenesis Studies of the Metal­
Binding Center of the Iron-Dependent Propanediol oxidoreductase from Escherichia coli. European 
Journal ofBiochemistry. 258: 207-213. I 
Onderdonk AB, Cisneros RL, Finberg R, Crabb JH and Kasper DL. (1990) Animal Model System for i 




Pan N and Imlay JA. (2001) How Does Oxygen Inhibit Central Metabolism in the Obligate anaerobe f 
Bacteroides thetaiotaomicron. Molecular Microbiology. 39: 1562-1571. 
Parker AC and Smith CJ. (2004) A Multicomponent System if Required for Tetracycline-Induced I
Excision ofTn4555. Journal ofBacteriology. 186: 438-444. i 
I 
IPaster BJ, Dewhirst FE, Olsen I and Fraser GJ. (1994) Phylogeny of Bacteroides, Prevotella, and 
IPorphyromonas Spp. And Related Bacteria. Journal ofBacteriology. 176: 725-732. 
f 
~ Patrick S, Lutton DA and Crockard AD. (1995) Immune Reactions to Bacteroides fragilis Populations I 
fwith Three different Types of Capsule in a Model ofInfection. Microbiology. 141: 1969-1976. t 
Patrick S, Parkhill J, McCoy L, Lennard N, Larkin MJ, Collins M and Blakely G. (2003) Multiple i 
Inverted DNA Repeats of Bacteroides fragilis that Control Polysaccharide Antigenic Variation Are Similar 
to the Hin Region Inverted Repeats ofSalmonella typhimurium. Microbiology. 149: 915-924. 
126 















Patrick S, Reid JH and Larkin MJ. (1984) The Growth and Survival of Capsulate and Non-Capsulate 
Bacteroidesfragilis in Vivo and In Vitro. Journal ofMedical Microbiology. 17: 237-246. 
Plant CW and Edwards DI. (1976) The effect of tinidazole, metronidazole, nitrofurazone on nucleic acid 
synthesis in Clostridium hifermentans. Journal ofAnilmicrobial Chemotherapy. 2:230-209. 
Podglajen I, Breuil J and Collatz E. (1994) Insertion ofa novel DNA sequence, IS1186, upstream of the 
silent carbapenemase gene cfLA, promotes expression of carbapenem resistance in clinical isolates of 
Bacteroides fragilis. Molecular Microbology. 12: 1 05-114. 
Podglajen I, Brenil J, Roant A, Monsempes C and Collatz E. (2001) Multiple Mobile Promoter Regions 
for the Rare Carbapenem Resistance Gene of Bacteroides fragilis. Journal ofBacteriology. 183: 3531­
3535. 
PowerJ. (1966) The L-Rhamnose Genetic System inEscherichiacoliK-12. Genetics. 55: 557-568. 
Prestwicb KN. (2004) Anaerobic Metabolism. Available at: 
http://www.ho!vcross.eduldepartments/biology/kprestwilintrolintro docs/intro noteslBio) 31 Anaerobic.pdf 
Last accessed: ] Oth August, 2006. 
Pnmbwe L, Glass D and Wexler H. (2006a) Efflux Pump Overexpression in Multiple-Antibiotic­
Ressitant Mutants ofBacteroides fragilis. Antimicrobial Agents and Chemotherapy. 50: 3150-3153. 
Pumbwe L, Veda 0, Yoshimura F, Chang A, Smith R and Wexler H. (2006b) Bacteroides fragilis 
BmeABC Efflux Systems Additively Confer Intrinsic Antimicrobial Resistance. Journal ofAntimicrobial 
Chemotherapy. 58: 37-46. 
Rafii F, Wynne R, Heinze TM and Paine DD. (2003) Mechanism of metronidazole-resistance by isolates 
of nitroreductase-producing Enterococcus galliniarum and Enterococcus casseliflavus from the human 
intestinal tract. FEMS Microbiology Letters. 29: 195-200. 
Rajeev L, Salyers AA and Gardner JF. (2006) Characterization of the integrase ofNBU I, a Bacteroides 
mobilizable transposon. Molecular Microbiology. 61: 978-990. 
Rasmussen BA, Gluzman Y and Tally FP. (1990) Cloning and Sequencing of the Class-B ~-Lactamase 
Gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrobial Agents and Chemotherapy. 34: 1590­
1592. 
Rasmussen BA, Gluzman Y and Tally FP. (1991) Escherichia coli Chromosomal Mutations That Permit 
Direct Cloning of the Bacteroides fragilis Metallo-~-Lactamase Gene, ccrA. Molecular Microbiology. 5: 
1211-1219. 
Rasmussen JL, Odelson DA and Macrina FL. (1986) Complete nucleotide sequence and transcription of 
ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. Journal 
ofBacteriology. 168: 523-533. 
Rasmussen BA, Keeney D, Yang Y and Bush K. (1994) Cloning and Expression of Cloxacillin­
Hydrolyzing Enzyme and a CeJphaJosporinase from Aeromonas Sobria AER J4M in E. coli requirements 
for an E. coli Chromosomal Mutation for Efficient Expression of the Class D Enzyme. Anitmicrobial 
Agents and Chemotherapy. 38: 2078-85. 
127 











Reeves A, Wang G and Salyers AA. (1997) Characterization of Four Outer Membrane Proteins that Play 
a Role in utilization of Starch by Bacteroides thetaiotaomicron. Journal ofBacteriology. 179: 643-649. 
Reeves AR, D'Elia IN, Frais J and Salyers AA. (1996) A Bacteroides thetaiotaomicron Outer 
Membrane Protein That Is Essential for Utilization of Maltooligosaccharides and Starch. Journal of 
Bacteriology. 178: 823-830. 
Reid MF and Fewson CA. (1994) Molecular characterization of microbial alcohol dehydrogenases. 
Critical Review Microbiology. 20: 13-56. 
Reitz M, Rumpf M and Knitza R (1991) DNA single strand-breaks in lymphocytes after metronidazole 
therapy. Drug Research. 41: 155-156. 
Reitzer LJ. (1996) Ammonia assimilation and the biosynthesis of glutamine, glutamate, aspartate, 
asparagines, L-alanine and D-alanine. In Escherichia coli and Salmonella typhimurium. Cellular and 
Molecular Biology, pp391-407. Edited by Neidhard FC, Ingrahm J, Brooks Low K, Magasanik B, 
Schaechter M and Umbarger HE. American Society for Microbiology. Washington DC. 
Reynolds AE, Felton J and Wright A. (1981) Insertion of DNA acti vates the cryptic big operon in E. coli 
K12. Nature. 293: 625-629. 
Reysset G, Haggoud A, Su W J and Sebald M. (1992) Genetic and molecular analysis of pIP417 and 
pIP419: Bacteroides plasmids encoding 5-Nitroimidazole resistance. Plasmid. 27: 181-190. 
Richardson JS, Hynes MF, Oresnik IJ. (2004) A genetic locus necessary for rhamnose uptake and 
catabolism in Rhizobium leguminosarum bv. trifolii. Journal ofBacteriology. 24: 8433-42 
Robsertson KP, Smith JC, Gough AM and Rocha ER (2006) Characterization of Bacteroides fragilis 
Hemolysin and Regulation and Synergistic Interactions of HlyA and HlyB. Infection and Immunity. 74: 
2304-2316. 
Rocha ER and Smith CJ. (1995) Biochemical and Genetic Analyses of a Catalase from the Anaerobic 
Bacterium Bacteroides fragilis. Journal ofBacteriology. 177: 311] -3119. 
Rocha ER and Smith JC. (1997) Regulation of Bacteroides fragilis katB mRNA by Oxidative Stress and 
Carbon Limitation. Journal ofBacteriology. 179: 7033-39. 
Rocha ER and Smith JC. (1999) Role of Alkyl Hydroperoxide Reductase (ahpCF) Gene in Oxidative 
Stress Defense of the Obligate Anaerobe Bacteroides fragilis. Journal ofBacteriology. 181: 5701- I O. 
Rocha ER, Herren CD, Smalley DJ and Smith CJ. (2003) The complex oxidative stress response of 
Bacteroides fragilis: the role of OxyR in control ofgene expression. Anaerobe. 9: 165-173. 
Rocha ER, Owens G Jr and Smith CJ. (2000) The Redox-Sensitive Transcriptional Activator OxyR 
Regulates the Peroxide Response Regulon in the Obligate Anaerobe Bacteroides fragilis. Journal of 
Bacteriology. 182: 5059-5069. 
Rustia M and Shubik P. (1972) Induction of Lung Tumours and Malignant Lymphomas in Mice by 














Salyers AA, Gupta A and Wang Y. (2004) Human intestinal bacteria as a reservoir for antibiotic 
resistance genes. TRENDS in Microbiology. 9: 412-416. 
Salyers AA, Bonheyo G and Shoemaker NB. (2000) Starting a New Genetic System: Lessons from 
Bacteroides. Methods. 20: 35-46 
Salyers AA, Vercelloti J, West S and Wilkins T. (1977a) Fermentation of Mucin and Plant 
Polysaccharide by Strains of Bacteroides from the Human Colon. Applied and Environmental 
Microbiology. 33: 319-322 
Salyers AA, West S, Vercelloti J and Wilkins T. (1977b) Fermentation of Mucins and Plant 
Polysaccharides by Anaerobic Bacteria from the Human Colon. Applied and Environmental Microbiology. 
34: 529-533 
Sambrook JT, Fritsch EF and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. 
Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. 
Schapiro JM, Gupta R, Stefansson E, Fang FC and Limaye AP. (2004) Isolation of Metronidazole­
Resistance Bacteroidesjragilis Carrying the nimA Nitroreductase Gene from a Patient in Washington State. 
Journal ofClinical Microbiology. 42: 4127-4129. 
Schmidt JW, Rajeev L, Salyers AA and Gardner JF. (2006) NBUI integrase: evidence for an altered 
recombination mechanism. Molecular Microbiology. 60: 152-164. 
Schneider D and Lenski RE. (2004) Dynamics of insertion sequence elements during experimental 
evolution of bacteria. Research in Microbiology. 155: 319-327. 
Shah HN and Collins MD. (1989) Proposal to Restrict the Genus Bacteroides (Castellani and Chambers) 
to Bacteroides fragilis and Closely Related Species. International Journal ofSystematic Bacteriology. 39: 
85-87. 
Shah, H. N. (1992) The genus Bacteroides and related taxa, p. 3593-3607. In A. Balows, H. G. Truper, M. 
Dworkin, W. Harder, and K.-H. Schleifer (ed.), The Prokaryotes, 2nd ed, vol. 4. Springer-Verlag, New York 
Shoemaker NB, Vlamakis H, Hayes K and Salyers AA. (2001) Evidence for extensive resistance gene 
transfer amongst Bacteroides spp. and among Bacteroides and other genera in the human colon. Applied 
and Environmental Microbiology. 67: 561-568. 
Shoemaker NB, Wang GR and Salyers AA. (2000) Multiple gene products and sequences required for 
excision ofthe mobilizatble integrated Bacteroides element NBUI. Journal ofBacteriology. 182: 928-936. 
Simon R, Priefer U and Puhler A. (1983) A broad host range mobilization system for in vivo genetic 
engineering: transposon mutagenesis in gram negative bacteria. Journal ofBiotechnology. 1: 784-791. 
Sindar P. Britz ML and Wilkinson RG. (1982) Isolation and Properties of Metronidazole Resistant 
Mutants of Clostridium perfringens. Journal ofMedical Microbiology. 15: 503-509. 
Sisson G, Goodwin A, Raudonikiene A, Huges N, Mukhopadhyay K, Berg D and Hoffman P. (2002) 
Enzymes Associated with Reductive Action and Action ofNitazoxanide, Nitrofurans and Metronidazole in 
Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 46: 2116-2123. 
129 












Sisson G, Jeong JY, Goodwin A, Bryden L, Rossler M, Lim-Morrison S, Raudonikiene A, Berg D and 
Hoffamn P. (2000) Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in 
Helicobacter pylori and Escherichia coli Containing a cloned H pylori rdxA' (Nitroreductase) Gene. 
Journal ofBacteriology. 182: 5091-5096. 
Smith CJ, Rogers MB and McKee ML. (1992) Heterologous Gene Expression in Bacteroidesfragilis. 
Plasmid. 27: 141-154. 
Soki J, Gal M, Brazier JS, Rotimi YO, Urban E, Nagy E, Duerden BI. (2006). Molecular investigation 
of genetic elements contributing to metronidazole resistance in Bacteroides strains. Journal of 
Antimicrobial Chemotherapy. 57: 212-20. 
Sonnenburg ED, Sonnenburg JL, Manchester JK, Hansen EE, Chiang HC and Gordon JI. (2006) A 
hybrid two-component system protein of a prominent human gut symbiot couples glycan sensing in vivo to 
carbohydrate metabolism. Proceedings of the National Academy of Sciences of the United States of 
America. 103: 8834-39. 
Spence C, Wells WG and Smith CJ. (2006) Characterization of the Primary Starch Utilization Operon in 
the Obligate Anaerobe Bacteroides fragilis: Regulation by Carbon Source and Oxygen. Journal of 
Bacteriology. 188: 4663-4672. 
Stubbs SL, Braizer Js, Talbot PR and Duerden BI. (2000) PCR restriction fragments length 
polymorphism analysis for Identification of Bacteroides spp and Characterization of nitroimidazole genes. 
Journal ofChemotherapy. 38: 3209-32] 3. 
Suau A, Bonnet R, Sutren M, Gordon J, Gibson GR, Collins MD and Dore J. (1999) Direct Analysis 
of 16s rRNA from Complex Communities Reveals Many Novel Molecular Species Within the Human Gut. 
Applied Environmental Microbiology. 65: 4799-4807. 
Tabaqchali, S, Pantosti A, and Oldfield S. (1983) Pyruvate dehydrogenase activity and metronidazole 
susceptibility in Bacteroides fragilis. Journal ofAntimicrobial Chemotherapy. 11: 393-400. 
Tang YP and Malamy MH. (2000) Isolation of Bacteroides fragilis Mutants with In Vivo Growth 
Defects by Using Tn4400', a Modified Tn4400 Transposition System, and a New Screening Method. 
Infection and Immunity. 68: 415-419. 
Tang YP, Dallas MM and Malamy MH. (1999) Characterization of the Batl (Bacteroides Aerotolerance) 
Operon in Bacteroides fragilis: Isolation of a B. fragilis Mutant with Reduced Aerotolerance and impaired 
Growth in in vivo Model Systems. Molecular Microbiology. 32: 139-149. 
Thomson SA and Blaser MJ. (1995) rsolation of the Helicobacter pylori recA Gene and Involvement of 
the recA Region in Resistance to Low pH. Infection and Immunity. 63: 2185-2] 93. 
Timmes A, Rodgers M and Schlief R. (2004) Biochemical and Physiological Properties of the DNA 
Binding Domain ofAraC Protein. Journal ofMolecular Biology. 340: 731-738. 
Tobes R and Ramos JL. (2002) AraC-XyIS database: a family of positive transcriptional regulators in 
bacteria. Nucleic Acids Research. 30: 318-321. 
Tobin JF and Schleif RF. (1987) Positive regulation of the Escherichia coli L-rhamnose operon is 












Tobin JF and Schleif RF. (1990) Purification and properties of RhaR, the positive regulator of the L­
rhamnose operons of Escherichia coli. Journal ofMolecular Biology. 211: 75-89. 
Trinb Sand Reysset G. (1996) Detection by PCR ofthe nim genes Encoding 5-Nitroimidazole Resistance 
in Bacteroides Spp. Journal ofClinical Microbiology. 34: 2078-2084. 
Trinh S, Haggoud A, Reysset G and Sebald M. (1995) plasmids plP419 and pIP421 from Bacteroides: 
5-Nitroimidazole Resistance Genes and Their Upstream Insertion Sequence Elements. Microbiology. 141: 
927-935. 
Tzianabos AO, Onderdonk AB, Smith RD and Kasper DL. (1994a) Structure-Function Relationships 
for Polysaccharide-Induced Intra-Abdominal Abscesses. Infection and Immunity. 62: 3590-3593. 
Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS and Kasper DL. (1994b) Structural 
Characteristics of Polysaccharides that Induce Protection against Intra-Abdominal Abscess Formation. 
Infection and Immunity. 62: 4881-4886. 
Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ and Kasper DL. (1992) The 
Capsular Polysaccharide ofBacteroides fragilis Comprises Two Ionically Linked Polysaccharides. Journal 
ofBiological Chemistry. 267: 18230-18235. 
Ueda 0, Wexler H, Hirai K, Sbibata Y, Yosbimura F and Fujimura S. (2005) Sixteen Homologs of the 
Mex-Type Multidrug Resistance Efflux Pumps in Bacteroides fragilis. Antimicrobial Agents and 
Chemotherapy. 49: 2807-2815. 
Upcroft JA, Dunn LA, Wright JM, Benakli K, Upcroft P. and Vanelle P. (2006) 5-Nitroimidazole 
Drugs Effective against Metronidazole-Resistant Trichomonas vagina lis and Giardia duodenalis 
Antimicrobial Agents and Chemotherapy. 50: 344-347 
Urban E, Soki J, Brazier JS, Nagy E and Duerden BI. (2002) Prevalence and Characterization of nim 
genes ofBacteroides spp. Isolated in Hungary. Anaerobe. 8: 175-179 
Valentine RC. (1964) Bacterial Ferredoxins. Bacteriological Reviews. 28: 497-517 
Van Tassel RL and Wilkins TD. (1978) Isolation of Auxotrophs of B. fragilis. Canadian Journal of 
Microbiology. 24: 1619-1621. 
Van Rooyen JM, Abratt VR and Swell BT. (2006) Three dimentional structure of a Type III Glutamine 
Synthetase by single-particle reconstruction. Journal ofMolecular Biology. 4: 796-810. 
Va reI VH and Bryant MP. (1974) Nutritional Features of Bacteroides fragilis subsp. Fragilis. Applied 
Microbiology. 28: 251-257. 
Vedantam G, Knopf S and Hecht DW. (2006) Bacteroides fragilis mobilizable transposon Tn5520 
requires a 71 base pair origin of transfer sequence and a single mobilization protein for relaxosome 
formation during conjugation. Molecular Microbiology. 59: 288-300. 
Voogd CE, van der Stel JJ and Jacobs JJJAA. (1974) The Mutagenic Action of Nitroimidazoles. I 











Walter D, Ailion M and Roth J. (1997) Genetic Characterization of the pdu Operon: Use of 1,2­
Propanediol in Salmonella typhimurium. Journal ofBacteriology. 179: 1013-1022. 
Wang Y, Kalka-Moll WM, Roehr) MH and Kasper DL. (2000) Structural Basis of the Abscess­
Modulating Polysaccharide A2 from Bacteroides fragilis. Proceedings ofthe National Academy ofSciences 
ofthe United States ofAmerica. 97: 13478-13483. 
Wang Y, Rotman ER, Shoemaker NB and Salyers AA. (2005) Translational Control of Tetracycline 
Resistance and Conjugation in the Bacteroides Conjugative Transposon CTnDOT. Journal ofBacteriology. 
187: 2673-80. 
Weaver J, Whitehead TR, Cotta MA, Valentine PC and Salyers AA. (1992) Genetic Analysis of a 
locus on the Bacteroides ovatus Chromosome which Contains Xylan Utilization Genes. Applied and 
Environmental Microbiology. 58: 2764-2770. 
Wehnert GU, Abratt VR and Woods DR. (1992) Molecular analysis of a gene from Bacteroides fragilis 
involved in metronidazole resistance in Escherichia coli. Plasmid. 27: 242-5. 
Weisburg WG, Oyaizu Y, Oyaizu Hand Woese CR. (1985) Natural relationship between Bacteroides 
and Flavobacteria. Journal ofBacteriology. 164: 230-236. 
Wickstrum JR and Egan SM. (2004) Amino acid contacts between sigma 70 domain 4 and the 
transcription activators RhaS and RhaR. Journal ofBacteriology. 18: 6277-85. 
Wickstrum JR, Santangelo TJ, Egan SM. (2005) Cyclic AMP receptor protein and RhaR synergistically 
activate transcription from the L-rhamnose-responsive rhaSR promoter in Escherichia coli. Journal of 
Bacteriology. 19: 6708-18. 
Xu J and Gordon JI. (2003) Honor Thy Symbiont. Proceedings ofthe National Academy ofSciences of 
the United States ofAmerica. 100: 10452-10459. 
Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, Hooper LV and Gordon JI. 
(2003) A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis. Science. 299: 2074­
2076. 
Xu J, Chiang HC, Bjursell MK and Gordon JI. (2004) Message from a Human Gut Symbiont: 
Sensitivity Is a Prerequisite for Sharing. Trends in Microbiology. 12: 21-28. 
Yeung TC, Beaulieu BB Jr, McLafferty MA and Goldman P. (1984) Interaction of Metronidazole with 
DNA Repair Mutants ofEscherichia coli. Antimicrobial Agents Chemotherapy. 25: 65-70. 
132 
